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Abstract 
 
This thesis explores leadership styles associated with innovation in the National Health Service 
in England, drawing on a review of leadership theories and concepts, and comparing what is found with 
an organisation in the United States recognised as a high performer in this area.  Although leadership 
has been studied extensively, most research has focused on the political and military spheres. More 
recent work has also examined the role of leadership in sectors such as manufacturing and technology, 
both areas where it is essential to encourage and nurture innovation. Yet, in the health sector, where 
innovation is now high on the health policy agenda in many countries, there is a paucity of research on 
how leadership can foster a culture of innovation. It cannot be assumed that leadership theories and 
concepts developed in other sectors will automatically apply to the health sector, given its many complexities 
and specificities, including multiple and sometimes competing objectives, such as the need to match 
technological advances with cost containment. Moreover, these objectives may vary in different settings, 
reflecting the contextual embeddedness of health systems.  
This research asks what leadership styles have been adopted by those working at senior leadership 
and management levels in organisations created to support innovation within the NHS in England. To place 
these findings in a broader context, these findings will be compared with those obtained from a leading 
health sector organisation identified as a global leader in innovation that served as the US Pilot Study for this 
research. It will relate these findings to theory and previous empirical research on leadership for innovation 
while exploring the application of these findings to the health sector.  
The research uses a mixed method approach, commencing with a review of the literature to 
identify leadership styles and critical appraisal of evidence associating different styles with the extent 
and nature of innovation, which in turn has informed development of an instrument to be used in a 
survey (quantitative element) of those in leadership roles. The instrument draws extensively on that used by 
Handy (1996) to assess organisational culture. The survey questions are linked to leadership theories and 
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concepts identified in the literature review and seek to identify the leadership styles adopted in the 
organisations studied. The findings inform the qualitative phase of the study, in which interviews with key 
informants are used to interpret and understand the quantitative results.  
The study findings have been used to generate a ‘Leadership Framework’ for assessing leadership 
styles in organisations seeking to foster innovation in the NHS. This is based upon the leadership styles 
described in the literature and leadership theories and concepts driving health innovation and to a minor 
extent to those adopted in a successful innovator in the United States health sector.  The research concludes 
by offering contextually appropriate recommendations based on theory and empirical evidence. 
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Chapter 1 Introduction 
 
This thesis is about three types of organisations created within the National Health Service in 
England to promote innovation. The idea arose from the Organisational and Policy Analysis I undertook 
as part of the degree of Doctor in Public Health, during which I was attached to one of them. This 
stimulated an interest in leadership, and specifically in the narrower field of leadership that promotes 
innovation. These health organisations are: Collaborations for Leadership in Applied Health Research 
and Care (CLAHRCs), Academic Health Science Centres (AHSCs), and Academic Health Science Networks 
(AHSNs).  
Collectively, CLAHRCs, AHSCs and AHSNs are charged with finding solutions to the translation 
gap in health research. The translation gap in health research has “two dimensions: “the translation of 
basic and clinical research into ideas and products, the so-called T1 gap; and concern for introducing 
those ideas and products into clinical practice, the so-called T2 gap”  (Currie, Lockett, & Enany, 2013, p 
27). Some participants in this study referred to this translation gap as the delay in moving the results of 
health research from “bench to bedside.” The roles of these organisations are described in more detail 
later in this chapter. 
As the terms “leadership” and “innovation” are at the core of this thesis, it is essential to define 
them at the outset. For the purposes of this thesis, leadership is defined as “the process of influencing 
others to understand and agree about what needs to be done  and how to do it, and  the process of 
facilitating individual  and collective efforts to accomplish shared objectives” Yukl (2006) as cited in 
Deng, Bligh, Kohles, Schyns, and Hansbrough (2010), p.451. Innovation is defined as “a broad set of 
activities involving the creation and implementation of concepts and products new to an organisation”  , 
Basu and Green (1997) as cited in Schermuly, Meyer, and Dammer (2013), p.133.   
It is also important to state what this thesis is not about. The thesis concentrates on leadership 
for innovation, in other words where the primary goal is innovation. Clearly, innovation takes place 
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organically throughout the NHS, alongside other streams of work. These innovations relate to products, 
such as new medicines or technologies, processes, such as new models of care, positions, such as tele-
surgery, and paradigms, such as the many changes in clinical practice that followed from the 
introduction of computerised tomography or minimally invasive surgery (Tidd & Bessant, 2013). New 
ideas are constantly emerging and being developed by those who identify better ways of performing 
their roles. However, the promotion of innovation is not their primary task. The specific focus of this 
thesis, on organisations whose primary purpose is promoting and implementing innovation, means that 
these roles and functions are not examined. Nor does it include parts of the NHS that have very specific 
responsibilities in narrow technical areas, such as NHS Genomic Medicine Centres, where the target 
audience is very narrowly circumscribed.   
The scope of the thesis is also, necessarily, circumscribed in terms of the literature that it draws 
most directly on. There is a very large literature on leadership and on innovation per se., Some of this 
relates to the characteristics of individual leaders, such as Great Man Theory (Borgatta, Bales, & Couch, 
1954) or Trait Theory (Colbert, Judge, Choi, & Wang, 2012). Other writers have focused on leadership for 
change, which may but need not necessarily involve innovation, such as Lewin’s (Lewin, Lippitt, & White, 
1939) and Likert’s (Likert, 1967) theories. Other work relates to achievement of organisational goals 
(Hersey, Blanchard, & Johnson, 2007; Vroom & Yetton, 1973), which again is important for any 
organisation, but not specifically to the promotion of innovation.  
Nor does it explore the extensive literature on theories of innovation, such as the debate on 
radical versus incremental innovation, ideas of creative destruction (Schumpeter, 2010), the extent to 
which organisations focus inwards or outwards (Chesbrough, Vanhaverbeke, & West, 2006), the role of 
innovation of components or linkages (Henderson & Clark, 1990), or the substantial research on 
diffusion of innovation (Rogers, 2010). However, in both cases, while not directly relevant to my thesis, 
this literature has informed my thinking. 
DRPH THESIS                                                                                                                     10 
 
The research for this thesis was undertaken in one US organisation, an Academic Health Science 
Center, and in six British organisations, one Academic Health Science Centre (AHSC) and its associated 
Academic Health Science Network (AHSN), and five Collaborations for Leadership and Applied Health 
Research and Care (CLAHRCs).  
AHSCs in the UK were established following a 2007 review of healthcare in London led by Lord 
Darzi. The expectation is that they will draw on their world-class research and health education to 
improve patient care and healthcare delivery. In particular, they are to translate scientific discoveries 
from the laboratory to the bedside, to enable more patients to benefit from innovative treatments. The 
first to be established was at Imperial College, in London, which merged with the Hammersmith 
Hospital and St Mary's NHS trusts. This model was rolled out across the NHS in England in 2013. The 
structure adopted by individual AHSCs is a matter for local decision making, but the goal is to support 
health and care improvements for large populations in different parts of the country. There are 
currently seven in England and two in Scotland.  
AHSNs connect NHS and academic organisations, local authorities, non-governmental 
organisations, and industry, acting as catalysts to create the conditions to facilitate change across 
entire health and social care economies. They have an explicit focus on improving outcomes for 
patients. They are expected to identify and spread health innovation at pace and scale, driving the 
adoption and spread of innovative ideas and technologies across large populations.  
CLAHRCs are “collaborative partnerships between a university and the surrounding NHS 
organisations, focused on improving patient outcomes through the conduct and application of applied 
health research” (CLAHRC Partnership Programme, 2014), (p.1). Practically, this involves collaborations 
between local providers of NHS services and NHS commissioners, universities, other relevant local 
organisations and the relevant Academic Health Science Network. 
 Thirteen CLAHRCs have been established. Their main focus is on research targeted at chronic 
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disease and public health interventions. Specifically, their goals are to (NIHR, 2018):  
• develop and conduct applied health research relevant across the NHS and translate research 
findings into improved outcomes for patients; 
• create a distributed model for the conduct and application of applied health research that links 
those who conduct applied health research with all those who use it in practice across the health 
community; 
• create and embed approaches to research and its dissemination that are specifically designed to 
take account of the way that healthcare is delivered across the local Academic Health Science 
Network; 
• increase the country’s capacity to conduct high quality applied health research focused on the needs 
of patients; 
• improve patient outcomes locally and across the wider NHS; and 
• contribute to the country’s growth by working with the life sciences industry. 
 
CLAHRCS are funded and accountable to the National Institute of Health Research, the research 
and development organisation established by the Department of Health and Social Care to support the 
National Health Service in England and ultimately to the Department of Health and Social Care, through 
annual reviews and are funded on a five year cycle, with continuation conditional on a successful 
reapplication. Figure 1 shows the financing and accountability flows for AHSCs (left panel) and AHSNs 
(right panel) that involve NHS and academic bodies, although as noted, there are also relationships with 
various other entities, including industry and local government.  
These organisations have complementary roles. At the risk of simplification, the AHSCs are 
engaged in basic sciences and their translation into clinical practice, CLAHRCs are engaged in applied 
health research, including the development of new means of assessing health needs and implementing 
new models of care, and AHSNs are responsible for scaling up innovations. 
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Figure 1  Funding and Accountability flows in the NHS 
 
Note: As discussed, this structure is still evolving. For example, as noted by this study’s interviewees, 
“since 2016, the ‘Monitor’ is now part of ‘NHS Improvement’ and the ‘Department for Business 
Innovation and Skills’ is now called the ‘Department for Business, Energy & Industrial Strategy’. In 
addition, Public Health England which reports to the Department of Health, oversees local authorities 
and which supports NHS England, is not depicted in Figure 1.” 
Source: Ovseiko et al. (2014), p.3. 
 
As noted above, the origins of this thesis lie in my experience in undertaking the Organisational 
and Policy Analysis (OPA) component of my professional doctorate. As will be explained more fully in 
Chapter: 8, the Integrating Statement, this was undertaken in an AHSN; an organisation charged with 
fostering innovation and spreading service improvement in the National Health Service (NHS)1 in 
                                                          
1 The United Kingdom’s National Health Service is comprised of four National Health Services, including, 
England,  Northern Ireland, Scotland and Wales. Reference to the ‘NHS’ is this thesis refers to the English 
National Health Service (NHS) unless otherwise noted. 
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England, in which I was embedded in for approximately three months in 2015. I selected an AHSN 
because of my background in the private sector in the United States of America (US or USA), and, 
specifically, in innovator organisations. I chose that specific AHSN because it was one of the first to be 
established, was nearing the end of its second year of operation and was transitioning from a funding 
model based on a core operating grant to a partially self-financing model. This transition was planned to 
take place over a five-year time span.  
The AHSN’s management and statements by those working in the wider NHS seemed to agree 
that leadership was the key to health innovation (Ferlie et al., 2017; NHS England, 2011, December 5, 
p.1), but there was no practical framework to guide leadership development that aligned the leadership 
styles of  senior leadership and management (leaders/managers) responsible for health innovation with 
empirically supported leadership theories and concepts of health innovation (Weintraub, 2016).  
The leadership theories and concepts driving health innovation discussed in this DrPH thesis 
(henceforth the thesis) are supported by quantitative and qualitative literature in the health and other 
industrial sectors. As described by Creswell (2014b), management theories should be predictive of 
phenomena (i.e., health innovation in this instance). However, there is no guarantee that they will lead 
to the predicted results under all circumstances. Therefore, health sector leaders/managers need to 
exercise due diligence in the application of these leadership theories and concepts. They should 
especially consider the organisational ‘Context’ in which these leadership theories and concepts are 
applied. In certain instances, leadership is the “emergent property of the interaction between the 
leader/manager, the organization member and the situation” (V. Iles 
Personal Communication, 13 May 2018). 
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Unlike in natural sciences, social science theories are rarely, or never, according to some, 
universally applicable (Gorton, 2012). This view has been endorsed in relation to management theories 
by Miller & Tsang (2010), who note “some challenges to testing management theories … inherent to the 
complex, open and changing nature of organisations and their contexts” (p.139).  
Many of the organisations established by the NHS in England explicitly draw on models of health 
innovation adopted in the US, and specifically the American Academic Health Science Centers (AHSCs). 
These bring together universities, medical schools, teaching hospitals, translational medical facilities, 
business development units and, in some cases, venture capital facilities. However, so far, the learning 
process has been informed mainly by study of published materials on the US centres and, especially, 
study visits. There has not, as far as can be ascertained, been any explicit attempt to compare aspects of 
these ostensibly similar organisations in the two countries.  
As an American, with both financial and operational leadership experience in the US health 
system, I was struck by many important differences between the UK National Health Service and the US 
health system in ideas, concepts, and discourses. Consequently, while the primary focus of my research 
is on organisations in the UK, as a subsidiary research aim I plan to take advantage of this comparative 
perspective to the extent that is possible within the limited scope of a DrPH thesis. 
1.1 Background to the Research Study 
 
1.1.1 Different Contexts, Similar Challenges 
The UK’s National Health Service operates within what is, in international terms, a financially 
highly constrained situation. In 2013, public and private healthcare spending in the UK was approximately 
£127.5 billion and £25.5 billion, respectively, which amounted to 8.5% of Gross Domestic Product 
(Nuffield Trust, 2016). 
Leaders of the NHS, which provides universal health coverage in England, have recognized that, if it is 
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to improve patient outcomes while meeting Treasury demands for annual savings due to a projected 
budgetary shortfall, estimated at “£60 billion by 2025”, it will require innovative leadership. That is innovative 
leadership leading to “a fundamental change to the way in which people currently work. At the heart of 
this is strong leadership – both  clinical and managerial at all levels in the system. It will require all 
leaders to identify and tackle the behaviours and cultures that can stand in the way of innovation. We 
will need to align system incentives to support and encourage innovation”   (NHS England, 2011, 
December 5, p.1). 
The US health system, while very much more generously funded, also sees improved leadership of 
health innovation as a means of improving health outcomes and reducing health system costs. For example, 
the National Science Foundation (NSF) has formed the NSF Innovation Corps (I-Corps™), in collaboration with 
the National Institutes of Health, to train researchers in health innovation leadership (National Science 
Foundation, 2014, June 14).  
Today, the UK and the US  health systems are also similarly challenged by the estimated 17 years 
required to translate scientific discoveries into health actions (Brownson, Kreuter, Arrington, & True, 2006; 
Morris, Wooding, & Grant, 2011). However, the US health system differs from the NHS in many respects. 
For example, the US health system is one of a few in the world which depends, to a substantial extent, 
on market-based private health insurance, while government funded health coverage (as in the NHS) 
plays a much smaller role, covering selected groups in the population, such as the elderly (Medicare), 
the poor (Medicaid), and military veterans (US Department of Veterans Affairs). Since the end of World 
War II, large US employers and, later, the US federal government, have favoured preserving the role of 
private health insurance companies in managing payments for services through the administration of 
healthcare group purchasing plans. The implementation of the Patient Protection and Affordable Care 
Act (ACA), signed into law in March 2010 by President Barack Obama, builds upon the expansion of 
market-based private insurance to increase accessibility of health insurance, including measures such as 
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mandatory requirements to purchase coverage.2 
Another particular characteristic of the US health system is that households, who are the 
principals (i.e., customers/patients) in a principal-agent relationship with healthcare providers, generally 
view their relationships, first with their provider agents (e.g., physicians, hospitals, pharmacies, private 
urgent care centres) and, second with financial intermediaries which may  include: 1.) private health 
insurers (e.g., BlueCross BlueShield); 2.) federal government (e.g., Medicare for the elderly); 3.) states 
(e.g., Medicaid recipient coverage for the poor funded jointly by the federal government and the states); 
and 4.) local government (e.g., county health department clinics; healthcare districts). However, it is 
principally the financial intermediaries, except for self-pay patients, that are contractually responsible to 
remit the amounts due by households to health providers. 
According to the Organisation for Economic Co-Operation and Development [OECD] (2015, 
March 13), the US health system was the most costly among 13 high income countries and also reported 
poorer health outcomes (The Commonwealth Fund, 2015, October 8). Yet, despite the differences between 
the US and UK health systems, the leadership of both has recognized that at least part of the solution to 
their common cost and health outcome problems depends on improving the leadership of health innovation. 
1.1.2 The Innovation Process 
The innovation process has been depicted by Tidd and Bessant (Figure 2) as a multi-stage process in 
which, if all of the elements are present, should allow an organisation to search, select, implement and 
capture innovative ideas (Tidd & Bessant, 2013). Although developed as a generic model, drawing on 
insights from many sectors, there is no reason to believe that it would not be applicable in a public or 
private health organisation. 
 
                                                          
2 Since the inauguration of Donald J. Trump as the 45th President of the United States on 20 January 
2017, actions by the new President may lead to changes and possible repeal of the ACA. In particular, 
the new President objects to the mandatory requirement to purchase coverage. 
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 Figure 2  The Innovation Process 
 
Source: Tidd and Bessant (2013), p.60. 
In the ‘Search” phase of the innovation process depicted in Figure 2, leaders/managers need to 
establish clear pathways and processes to bring new ideas/opportunities to the attention of senior 
leadership. In health organisations, this is broader than just tapping into an organisational network or 
relational assets of the senior leadership. It includes pulling ideas from patients and a myriad of other 
stakeholders while involving multiple levels of leaders/managers. As described by the NHS, “we will 
need to create ‘pull’ for new ideas from patients and the NHS, rather than relying on the traditional top 
down ‘push’(NHS England, 2011, December 5, p.1).  
To ‘Select’ among a continuous flow of ideas/opportunities, a health organisation must have a 
strategic plan to guide leaders/managers to select from what is often a choice among these myriad 
ideas/opportunities, most of which will seem, at least at first glance, plausible and which are based on 
the best of human intentions. To move forward without a strategic plan would risk losing focus and 
using scarce resources in an inconsistent and possibly unproductive manner.  
In the ‘Implementation’ phase, the idea/opportunity is brought into reality. This may be in the 
form of: 1.) Product Innovation (e.g., new drug therapy); 2.) Process Innovation (which can range from 
new and complex models of care or even simple measures such as using volunteers to feed inpatients); 
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3.) Position Innovation (e.g., perform remote electronic monitoring of patient formerly admitted to 
hospital); and Paradigm Innovation (e.g., patients driving idea/opportunity generation within the health 
organisation)(Tidd & Bessant, 2013).  
To ‘Capture’ the organisational benefits of an innovation strategy including  “Health & Wealth” 
as described by NHS England (2011, December 5) requires deployment of the accumulated leadership 
and management knowledge and administrative/technical skills acquired in the prior three innovation 
phases depicted in Figure 2, plus the capacity to launch and sustain the innovation. With respect to 
health organisations, particularly those that are part of the NHS, often this involves the acquisition of a 
new and different set of leadership and management knowledge as well as administrative, technical, 
and financial skills combined with hands-on experience regarding issues arising with innovative start-up 
organisations (collectively herein referred to as resources). These resources, which in the past have been 
more often associated (rightly or wrongly) with the private sector of the economy, are essential for 
capturing the value of an organisation’s innovation strategy. As described by Mazzucato (2015), venture 
capital firms in the US have succeeded because these entities brought more than money. They 
possessed other resources necessary to ‘Capture ‘the benefits of an innovation strategy. 
Mazzucato (2015) argues that there is widespread acceptance in major developed countries 
that: 
“The State’s role is not just to create knowledge through national labs and universities, but also 
to mobilize resources that allow knowledge and innovations to diffuse broadly across sectors of 
the economy. It does this by rallying innovation existing networks of by facilitating the 
development of new ones that bring together a diverse group of stakeholders. However, having 
a national system of innovation… is not sufficient.  The State must also lead the process…” (p.40) 
 
With regards to the preceding viewpoint, government health agencies and health organisations 
have much to learn from the experiences of other sectors and, to the extent feasible, could incorporate  
a number of these private sector participants in their innovation strategy (Tidd & Bessant, 2013, pp 24-
28). 
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Leadership of innovation has been viewed by Storey and Holti (2013) as key to innovative health 
research, education and improvements in high-quality care. Yet while leadership of innovation per se has 
been researched extensively, particularly in the manufacturing and technology sectors, there is a paucity of 
studies within the health sector. As described by Antes, Mart, and DuBois (2016) in a qualitative study of 
National Institutes of Health (NIH-US) funded genetic researchers, “leadership and management roles in 
research have received scant empirical examination” (p.1).There are also few studies on the role of 
senior health leadership (i.e., senior administrative leadership) and management in fostering innovation 
(Goffin & Mitchell, 2010; Ovseiko et al., 2014; Weberg, 2009; M. West, Armit, Eckert, West, & Lee, 2015).  
As described in this thesis, leadership is key to health innovation. So why are there no studies of 
leadership of health innovation that explicitly seek to develop a practical framework that aligns the leadership 
styles adopted by health organisation leaders/managers with empirically supported leadership theories 
and concepts that, collectively, may contribute to successful health innovation? The existing literature on 
innovation leadership includes frameworks developed to measure leadership styles, such as those applying the 
‘Full Range Leadership Model’ and those more narrowly focused on one of the four phases (e.g., ‘Implementation’ 
phase as described in Figure 2) of the innovation process, using the ‘Innovation Implementation Framework’ 
(Aarons, Ehrhart, Farahnak, & Hurlburt, 2015; Antonakis, Avolio, & Sivasubramaniam, 2003; Avolio, 2010; 
Kirkbride, 2006). Another example is the ‘Learning and Innovation’ model approach proposed by Deng et al.  
(2010). This builds upon the ‘Full Range Leadership Model’ and has been tested by Yan et al. (2014). Deng et 
al. (2010) aligns each of the five leadership styles, described in Table 1 (page 16), ranging from positive 
leadership styles (Authentic, Transformational and Transactional styles) to negative leadership styles (including 
Laissez-faire and Aversive styles) with the leadership theory that addresses Employee Mindset  (i.e., a growth 
versus fixed  orientation, which will be described in Chapter 2, which presents the review of the literature 
undertaken for this thesis).  
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Consequently, there are established survey questionnaires developed to test for leadership 
styles among leaders/managers which may incorporate , as noted previously, selected  leadership 
theories and concepts that drive innovation (e.g., Bass and Avolio’s Multifactor Leadership 
Questionnaire [MLQ-Form 5X]) , Antonakis et al. (2003). However, I have been unable to find any survey 
questionnaire that has been developed specifically to test for the alignment of leadership styles adopted 
by health organisation leaders/managers with empirically supported leadership theories and concepts 
which, collectively, as will be described in my literature review, may contribute to successful health 
innovations. This required me to develop a survey questionnaire, based on a range of theories and 
concepts to accomplish the aim and objectives of this study. 
The NHS has developed  its own leadership model, now being taught in its ‘Leadership 
Academy’, which is focused on improving the NHS’ customer service and meeting community needs by: 
1.) providing and justifying purpose and contribution3; 2.) team  motivation; and 3.) improving system 
performance (Storey & Holti, 2013).  However, it is not apparent that its leadership model explicitly seeks to 
align the leadership of health leaders/managers with empirically supported leadership theories and 
concepts shown to be favourable to health innovation.  
 
 
 
 
 
 
 
 
 
 
 
 
                                                          
3 As described by Storey and Holti (2013) leaders in the NHS should “focus explicitly on the needs and 
experiences of service users, continually reinforcing an inspiring vision of the mission and social 
contribution of the organisation or unit…” 
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Table 1: The Continuum of Leadership Style 
 
Leadership Style Description Citations
Authentic
Authentic leadership is a positive form of leadership 
by example. An authentic leader possesses a high-
degree of confidence and self-awareness. The 
authentic leader believes every person has something 
positive to deliver and can be developed to reach 
their full potential by modeling the behavior of the 
leader. For example, authentic leaders/managers may 
be more tolerant of employee errors and consider it 
part of the self-development process. The 
Transformation style of leadership may incorporate 
many of the attributes of this style.
(Deng et al. , 2010; Yan et al., 
2014)
Transformational
Transformational leadership is a positive form of 
leadership which is distinctive because it is inspiring 
and motivational. It encourages followers to achieve 
the mission/vision/values set by the leader by going 
above and beyond achievement of their job 
description. 
(Caridi-Zahavi et al. , 2015; 
Deng et al. , 2010;2; Jung et al., 
2003; Schermuly, et al., 2013; 
Weng, Huang, Chen & Chang 
,2013; Yan et al., 2014)
Transactional
Transactional leadership is defined by a focus on 
following organizational policies and procedures. 
However, this is a positive form of leadership 
especially when it accompanies a Transformational 
leadership style.  This form of leadership is focused 
on organisational process and can turn the 
Transformational leaders inspiration into corporate 
actions. There is little emphasis on innovation under 
this leadership style singly rather a focus on 
goverance and process. This leadership style is 
commonly found in industries that view themselves 
as stable and not changing.
(Deng et al. , 2010; Yan et al., 
2014)
Aversive
Aversive leadership is a negative form of leadership 
and is intolerant of errors promoting a risk-averse 
culture. Under this negative form of leadership, the 
follower faces harsh treatment for not achieving the 
dictates from the leader. 
(Deng et al. , 2010; Tidd & 
Bessant, 2013; Yan et al., 2014)
Laissez-faire
The Laissez-faire style of leadership is a negative and 
delegated style of leadership (i.e., can be described 
as passive-aggressive) where organization members 
may be given considerable latitude to make 
decisions, but with little support. Leaders/managers 
with a Laissez-faire style of leadership generally have 
a callous disregard for developing followers or setting 
themselves as a role model.
(Deng et al. , 2010; Yan et al., 
2014)
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1.1.3 Innovation in the NHS 
Innovation and entrepreneurism became prominent in the lexicon of the NHS following the 
publication of Best Research for Best Health, which included the goal to “establish the NHS as an 
internationally recognized centre of research and excellence”. This was followed by High quality care for 
all: NHS next stage review final report which recommended the formation of “Academic Health Science 
Centres … to bring together a small number of health and academic partners to focus on world-class 
research, teaching and patient care” (Directorate, 2006, p. 2), and (Darzi, 2008, p. 57). In 2009, the first 
AHSCs were created “to foster medical innovation and high-quality care throughout hospitals” (Ovseiko 
et al., 2014, p.4).  In 2011, expenditure on health research in the UK amounted to approximately £8 
billion annually with the government providing approximately 24% of this amount, with its share 
growing (Walshe & Davies, 2013).  
Beginning in October 2008, the National Institute for Health Research (NIHR) funded nine 
CLAHRCs as pilots for five years. A second wave followed and, at present, there are 13 CLAHRCs which 
are “collaborative partnerships between a university and the surrounding NHS organisations, focused on 
improving patient outcomes through the conduct and application of applied health research” (CLAHRC 
Partnership Programme, 2014), p.1. The “CLAHRCs have three key interlinked functions: conducting high-
quality applied health research; implementing the findings from research in clinical practice; and 
increasing the capacity of NHS organizations to engage with and apply research. CLAHRCs are regional 
with their agendas determined by the partnering organizations and tailored to health care needs in their 
areas”  (Currie et al., 2013, p 28). 
The NHS recognizes the importance of the diffusion and spread of research innovation as a 
means to improve health outcomes. This is considered key to meeting the health challenges posed by, 
among other factors, an aging UK population. In 2012, this recognition led to the invitation to form 
AHSNs as organisations to network with the AHSCs, CLAHRCs and all parts of the NHS and the local 
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community to improve health and wealth (NHS England, 2011, December 5, 2012, June 20, 2015). 
Walshe & Davies (2013) described the primary mission of the AHSNs as “knowledge mobilization” (p.7) 
while Fish (2013) commented that the success of the AHSNs, “depends on shared values, strong working 
partnerships, local leadership and energy…” (e18).  
 Concurrently, with the preceding developments in research in the UK, the NHS was 
substantially reorganized following the Health and Social Care Act 2012. The resulting complex 
structure, which is still evolving. As described by Alderwick, Dunn, McKenna, Walsh, and Ham (2016 ), 
since the passage of the Health and Social Care Act 2012, the NHS has abolished Strategic Health 
Authorities and, after several other changes, have given rise to Sustainability and Transformation Plans 
(STPs).The current STP plans completed in 2016 were located in 44 local areas throughout England with 
responsibility for all areas of NHS spending “from 2016/17 to 2020/21” (Alderwick et al., 2016 , p 7).  
While the Health and Social Care Act 2012 “sought to strengthen the role of competition within the 
health system, NHS organisations are now being told to dampen the competition and collaborate to plan 
and provide local services. This strategy is being called place based-planning… The introduction of STPs 
reflects a growing consensus that more co-ordinated action is needed to meet the challenges facing the 
NHS and social services (Alderwick et al., 2016 pp., p 7-16).  
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 1.2 Research Questions 
 
In this research study, I am asking one main question and one subsidiary question. 
1. Do the styles of leadership adopted by leaders/managers in organisations charged with 
innovation in the health sector in the UK align with leadership theories and concepts 
empirically shown to encourage innovation? 
2. How do the leadership styles adopted by leaders/managers in these UK organisations compare 
with those seen in an organisation adopting similar roles in the US that many of them aspire to 
emulate? 
1.3 Aim and Objectives 
 
Following from these research questions, the overarching aim of my study is to ascertain the 
leadership styles of health leaders/managers of organisations charged with driving innovation in the UK 
and a selected high-performing comparator in the US and assess how these adopted styles align with 
empirically supported leadership theories and concepts considered most likely to drive much needed 
health innovation.4  When culture and other differences are taken into account, comparative 
international research studies, as in this instance, provide valuable global insights regarding health 
leadership (Ardichvili & Kuchinke, 2002). 
The objectives that flow from this aim and the methods used are set out in Table 2. As can be 
seen from Table 2, a single research design (i.e., either quantitative or qualitative approach) will not singly 
achieve the objectives of this research study.  As explained by Greene and colleagues  “if the research 
purpose requires development, or using the results from the first method to inform the use of the second 
                                                          
4 In connection with the survey questionnaire described in Appendix A, the Authentic and 
Transformational leadership styles have been combined in the statements to each question. As 
described by Ardichvili and Kuchinke (2002), Transformational leaders incorporate many of the 
attributes of Authentic leaders. 
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method; or expansion, adding breath and scope to a study (Greene, Caracelli, & Graham, 1989) as cited 
in Onwuegbuzie & Collins (2007), and the research question” (p.284) then the time line of the study will 
require a Mixed-Methods (Explanatory) Sequential research design (Creswell, 2014b). As described in this 
thesis, this research design will allow qualitative methods (e.g., qualitative interviews) to explain the 
quantitative (e.g., survey) results. In addition, the qualitative methods will enable assessment of the reliability 
and validity of the survey results. 
Although it is common in qualitative research to indicate certain characteristics of those individuals 
that are quoted, such as their role in an organisation, this was not done in this thesis. This was because of the 
small number of organisations from which the sample was drawn and the small number of people they each 
employ.  Consequently, it would be very difficult to prevent their identification. This issue was raised as a 
concern when the protocol was presented within LSHTM for approval and, consequently, it was included 
when the ethical approval was being sought. It soon became clear that the guarantee of anonymity was 
considered important by interviewees as they were willing to discuss quite sensitive issues with me, 
something that I believe would have been unlikely if they felt they could be identified. However, I do 
recognise that this makes it more difficult for the reader to interpret the data.  
 
 
 
 
 
 
 
 
 
DRPH THESIS                                                                                                                     26 
 
Table 2: Objectives of the Research 
 
In the following chapter, I present my review of the literature on leadership and innovation, 
seeking to identify relevant concepts and theories.  
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Chapter 2 Literature Review 
 
 I conducted a literature review to identify studies that had examined leadership and innovation in 
the health and other sectors and to identify empirically supported concepts and theories that should 
promote health innovation. The studies identified in my literature review were consistent with the focus 
of this study on specific health organisations with respect to leadership of health innovation including 
CLAHRCs, AHSCs, and AHSNs which were formed as a solution to the translation gap in health research.  
The results of the literature review were also used to gain a better understanding of the 
‘Context’ with respect to leadership of health-related research and development activities within the UK 
and US. In addition, the literature review was instrumental in structuring the survey questionnaire and 
initial interview questions.  
I extracted information from the papers reviewed by applying the PEO/PIO (Population, 
Exposure [Issue], Outcome) or PICO (Population, Patient, Problem, Intervention, Comparison, Outcome) 
structure as appropriate for the type of study, in four phases (described in Chapter 2.2: Results of the 
Literature Review) to identify studies of the leadership styles of health leaders/managers that are most 
likely to drive much needed health innovation.  
A keyword search string was prepared using a selection of electronic databases, including 
MEDLINE, PsycEXTRA, Econlit, and Embase. A full description of the databases, years searched, and 
search strategy, is provided in Appendix G. 
In addition, an Internet search using the Google search engine was performed to identify any 
documents published online by a government agency or other organisations providing relevant 
information and to update the results of earlier searches. Also, I performed extensive hand searching of 
references in papers identified in the searches described above (articles/studies) even if those source 
papers were subsequently excluded from this review. The specific inclusion and exclusion criteria used 
in the review are summarized in Table 3. 
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Table 3: Specific Inclusion and Exclusion Criteria 
Inclusion Exclusion 
1. Published articles/books/studies 
providing information and evidence 
relevant to leadership styles and 
characteristics of leaders/managers 
most likely to drive health innovation. 
 
 
2. Articles/studies/documents published 
solely online by a government agency 
or other organisation providing 
information and relevant evidence. 
 
3. Published articles/books/studies or 
government/other organisation 
documents that are not specifically 
addressing the leadership/management 
of innovation that were consistent with 
the focus of this study on specific 
health organisations with respect to 
leadership of health innovation 
including CLAHRCs, AHSCs, and AHSNs 
which were formed as a solution to the 
translation gap in health research. 
 
 
4. Published articles/books/studies or 
government/other organisation 
documents that are not specifically 
addressing a subject relevant to the 
leadership of innovation or excluding 
mention of innovation altogether. 
 
No published or other articles/studies were excluded from the three searches based upon the 
methodology, published date, geographical location or language of journal publication.  Quality 
assessment of the papers included was performed using a standardized tool (Center for Evidence Based 
Management, n.d.). This is similar to other widely recognized tools for the assessment of qualitative and 
other studies.  
2.1 Synthesis of Extracted Evidence 
 
To perform the literature review , I applied the Matrix Method adapted from Garrard (2014).  As 
used in this thesis, this has four components, including a: 
1.) Paper Trail Folder-to document the process of undertaking the literature review; 
2.) Documents Folder-for retaining documents for review; 
3.) Review Matrix Folder-a spreadsheet format used to abstract each document included in the 
thesis; and a 
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4.) Synthesis Folder- this folder is an expansion of the preceding spreadsheet where I 
commented on each reference. As described previously, the quality of references in this 
thesis was assessed using a standardized tool (Center for Evidence Based Management, 
n.d.). The headings of this spreadsheet are illustrated in Table 4. 
Table 4: Illustration of Matrix Method Spreadsheet 
Author, 
Title, 
Journal 
Year 
Published Purpose 
Type of 
Study 
Study 
Themes 
Study 
Questions-
Theory 
Literature 
Review 
Comments-
Narrative 
Synthesis 
Hypothesis 
Tested-
Including 
sample 
framework 
 
Source: Adapted from Garrard (2014). 
As described by Popay et al. (2006), a narrative synthesis approach was used to synthesize the 
data extracted from the selected studies. The objective of this approach was to give more weight to the 
collective synthesis of the selected studies than would be achieved with an analysis solely based on a 
singular view of each study (i.e., the sum of the parts [of the individual studies selected] would 
contribute more, collectively, to the questions posed than the studies read and analysed singly). 
2.2 Results of the Literature Review 
 
As depicted in Figure 3, a total of 3,643 results were obtained in the four phases of electronic 
data searches using the Ovid search engine. The first phase used the search string of innovation* and 
health* and networks* and United Kingdom. It was based upon the experience I had gained during my 
work on the OPA report. This yielded 840 results, net of 19 duplicates. The second search phase used 
the search string of innovation* and health* and networks* and leadership*.  This phase yielded 2,660 
results, net of 38 duplicates. The third search phase used the search string combining innovation* and 
health* and leadership* and the search string of health* and leadership styles* and characteristics*. 
This yielded 64 results. The final and fourth phase used the search string of Social Capital* and health 
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leaders* and yielded 17 results, net of 5 duplicates. An additional 115 books/articles/publications were 
obtained from hand/Google Internet engine searching of references to the studies where the full text 
was assessed. After reviewing the abstract of the records or summary of the records, a total of 3,467 
records were excluded as not relevant to this research study.  A total of 229 full-text records were read 
and analysed and 109 of these records were excluded based on the criteria in Table 3. This resulted in 
120 records that were included in the reference list. 
Figure 3: PRISMA Flow Diagram 
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2.3 Relevant Literature 
 
Throughout the study, follow-up literature searches were performed, focusing on the results 
emerging from the analysis of the survey questionnaire and the themes5 identified in interviews. The 
documents identified are cited throughout my thesis and listed in the References.  
Based upon the application of the Matrix Method described in Table 4, the literature review 
identified the following leadership theories and concepts favourable to health innovation: 
1. Creating a Psychological Climate for Innovation 
2. Leader-Member Exchange (LM X) 
3. Social Capital Promotes Innovation 
4. Leadership Clarity  
5. Supporting Team Reflectivity 
6. An Appropriate Employee Mindset 
7. Organisational Culture and Innovation 
8. Role of the Chief Executive Officer (CEO) (i.e., A Chief Executive Officer who is a leader) 
 
I included only those leadership theories and concepts proposed as drivers of health innovation 
if they were supported by empirical research. Others, which were more speculative, proposing but not 
testing theories and concepts, were excluded.  
In the following sections, I describe these leadership theories and concepts in more detail, 
setting out their potential applicability to leadership for innovation. 
 
2.3.1 Leadership Theories and Concepts Relevant to Health Innovation 
1). Creating a Psychological Climate for Innovation 
 
The Psychological Climate of an organisation includes the: 1.) level of leadership support; 2.) 
extent to which innovation is championed; 3.) setting of expectations for innovation and 4.) use of rewards.  
These elements of the Psychological Climate have, as described below, been shown to be directly related 
to the organisation’s effectiveness in implementing innovation (Jacobs et al., 2015; Wisdom, Chor, Hoagwood, 
                                                          
5 The themes are based upon the Methods (Qualitative Data Collection and Analysis) described in my 
thesis (Creswell, 2014b; Green & Thorogood, 2013). 
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& Horwitz, 2014). R.-H. Weng, Huang, Chen, and Chang (2015) believed that a supportive organisation 
encouraged employees to turn “creative ideas into innovative outputs” (p.428). As described by  R. H. 
Weng, Huang, Huang, and Wang (2012), in a quantitative study of 439 Taiwanese nurses in four 
hospitals, a supportive organisational climate encouraged creativity of the nurses studied and led to 
innovative behaviour. 
Jacobs et al. (2015) described how the Psychological Climate influenced innovation and 
implementation by individual physicians participating in the US National Cancer Institute’s Community 
Clinical Oncology Program. In this study, the physicians’ perception of the Psychological Climate had a 
positive effect on the ‘Implementation’ phase as depicted in Figure 2. Jacobs et al. (2015) describe “the 
direct relationship between implementation climate and implementation effectiveness” as one of the most 
important findings from their study (p.12). However, this cross- sectional study was limited to oncologists 
participating in the program, was focused solely at the individual level, and did not consider a wider 
organisational perspective. 
Helfrich, Weiner, McKinney, and Minasian (2007) describe a framework for the adoption of 
complex innovations to be used in health organisations based on one first studied in a manufacturing 
environment. Helfrich et al. (2007) concluded that the successful implementation of complex 
innovations was dependent on “management support and innovation-values fit, which contribute to an 
organizational ‘climate’ for implementation” (p.279). 
A supportive Psychological Climate is not, on its own, a guarantee of success in innovation and 
requires that the attention of leaders/managers is devoted to both organisational and individual 
concerns (i.e., ‘Context’ and ‘Group Cohesiveness’). James et al.  (1990) as cited in Scott and Bruce (1994, 
p. 582), examined Psychological Climate in a mixed methods study of engineers, scientists and technicians 
in a research and development facility of a major US manufacturing company. The researchers 
hypothesized that success at the ‘Implementation’ phase as depicted in Figure 2 was dependent on 
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individual cognitive interpretation of an organisation’s Psychological Climate.   
2). Leader Member-Exchange (LM X) 
 
LMX refers to the quality of a leader/manager’s relationship with employees, especially when it is 
accompanied by employee psychological empowerment. In other words, the quality of the LMX relationship is 
the extent to which employees perceive their leadership is “acting in their best interest, caring, supportive, 
loyal and reliable” (Schermuly et al., 2013), (p.133)  . These LMX relationships have been identified as a driver 
of organisational innovation (Scott & Bruce, 1994).  
Quality LMX, when it is accompanied by psychological empowerment and leadership support, has 
also been found to be associated with greater effectiveness in all phases of the innovation process 
depicted in Figure 2 (Bucciarelli, 2015; Schermuly et al., 2013; Wisdom et al., 2014). Leadership support 
for LMX and innovation, according to West and Anderson’s  (1996) quantitative study of 27  hospital senior 
management teams in the United Kingdom, was the main predictor of innovation. Resources provided to the 
senior management teams beyond a minimum to accomplish a task did not predict innovation. Ultimately, it 
was the relationship between the leaders/managers and members of the organisations studied which was critical to 
health innovation. 
3). Social Capital Promotes Innovation 
 
It is beyond the scope of this review to cover the now extensive literature on Social Capital, the 
networks of relationships among people who live and work in a particular society, enabling that society to 
function effectively, which has been reviewed in detail elsewhere (Grootaert & Van Bastelaer, 2002). Here, I 
focus on the Social Capital that links leaders/managers through relational and network assets such 
academic organisations, clinical commissioning groups, governmental and related agencies, non-
governmental organisations, and industry and professional groups. The strength of these relationships 
has been identified as an important contributor to effective innovation in an organisation.  
For example, in a quantitative study in the US, Baker et al. (2015)  surveyed 1,978 respondents from a 
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cross-section of manufacturing and service companies regarding their use of external network assets. This study 
provided empirical support for the proposition that learning through external networks 
disproportionately benefits conservative, risk-averse firms, findings that may be especially applicable to 
the NHS and the health sector (Weintraub, 2016). 
Landry, Amara, and Lamari (2002) performed a quantitative study of 440 respondents from the 
manufacturing sector, evaluating the impact of Social Capital on innovation. Included in the study were 
explanatory variables  such as “business network assets, information network assets, research network assets, 
participation assets  and relational assets  and one form of cognitive Social Capital (reciprocal trust)” (p.2). Landry 
et al. (2002) concluded that these forms of Social Capital “contribute to a larger extent to explain both the 
decision to innovate or not and the decision to undertake more or less radical innovations” (p.15). 
In the 21st century, there has been an exponential expansion of information available to organisations 
through multiple channels (e.g., the Internet). Local knowledge that exists in such networks, which is especially 
likely to be contextually relevant, can help leaders/managers to interpret and use information from all sources to 
innovate. This may be especially true in conservative sectors, such as the health sector, where professional 
hierarchies can impede the transfer of knowledge (Baker et al., 2015; Balkundi & Kilduff, 2006; Currie & White, 
2012; Kyratsis, Ahmad, & Holmes, 2012; Landry et al., 2002; Lewis & Ricard, 2014; Phillips, Johnsen, Caldwell, & 
Lewis, 2006; Rowley, 1997; Scarbrough et al., 2014; Wisdom et al., 2014; Zachariadis, Oborn, Barrett, & Zollinger-
Read, 2013) . 
As concluded by Baker et al. (2015), “breakthrough innovation has long been associated with an 
Entrepreneurial Orientation (EO)” (p.13). Few organisations have “the culture, capabilities, human resources, or 
financial resources to morph themselves into a strong EO culture. This research demonstrates …the ability to 
utilize market knowledge, ideas, and interpretations from external networks, provides a means for firms …to 
successfully innovate” (p.13). 
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4). Leadership Clarity 
 
Leadership Clarity (defined in terms of the roles of team members) was found to foster organisational 
innovation in a study of 3,147 respondents in health care teams in the UK (M.A. West et al., 2003).  This 
quantitative study was narrowly focused on three types of health care teams: 98 primary health care teams 
(PHCTs), 113 community mental health teams (CMHTs), and 72 breast cancer care teams (BCTs). Self-report 
questionnaires were completed by 1,156 respondents from 98 PHCTs, 1,443 respondents from 113 CMHTs, and 
548 respondents from the 72 BCTs. The survey questionnaires sought respondents’ perceptions of team 
functioning, innovation, leadership, and effectiveness. The study pointed to the importance of not just a single 
leader, but also to managers showing leadership at all levels of the organisation. Innovation was more likely to 
result when the organisation’s leaders/managers understood its objectives and where high levels of team 
participation and commitment to excellence was present (M.A. West et al., 2003). 
5). Supporting Team Reflectivity 
 
Innovative organisations have identified the importance of measures that facilitate reflection by 
team members as encouraging innovation, especially in a high-pressure environment where there is a heavy 
workload, tight deadlines, high expectations and a less than an optimum working environment. These innovative 
organisations believe that leaders/managers should be encouraged to create opportunities for team members to 
reflect inside and outside the traditional work environment (Schippers, West, & Dawson, 2015). For example, 
since the 1940s, the 3M Company has encouraged its thousands of technical employees, regardless of 
their roles, to use 15% of their paid weekly hours (i.e., the 3M 15% Rule) to reflect/work on independent 
ideas.  Since 1951, it has sponsored the annual 3M Technical Forum (3M Company, n.d.), a global event, 
where 3M employees from a wide range of backgrounds and experience, ranging from marketing and 
sales to scientists, meet to exchange ideas and information.  The 3M Company argues that many of its 
health and other innovations emerged from the ideas generated as a result of this approach (3M 
Company, 2002). As described by Jung et al. (2003), organisations such as the 3M Company, have 
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outperformed their competitors because the innovative ideas generated by all employees are valued, 
leading to better business outcomes. 
As described by Schippers et al. (2015), leaders/managers that encourage team Reflectivity can 
promote innovation in less than optimum working conditions. This cross- sectional quantitative study 
included 1,156 members of 98 primary health teams in the UK. However, the researchers were not privy to 
the content of the reflective process, including: if and how often reflexive sessions took place; what was 
discussed; and how the discussions resulted in innovations. In addition, it is unknown whether prior 
innovation successes may have influenced the results observed.  
6). An Appropriate Employee Mindset 
 
An Employee Mindset, with a willingness (i.e., growth versus fixed orientation) to learn from errors, 
supports innovation. For example, an employee with a growth mindset generally believes it is beneficial to their 
career development to learn from their mistakes. In contrast, an employee with a fixed mindset is more interested 
in ‘looking good ‘and may avoid changing situations which may cause them to possibly make a mistake (Yan et al., 
2014).  When this employee growth mindset is combined with a leadership style where the leader believes in 
“facilitating learning and developing employees” a less risk-averse environment is created which further supports 
organisational innovation. 
 In a quantitative study of 268 members of California colleges, a fixed Employee Mindset was found to 
stifle innovation despite a Transformational leadership style (Yan et al., 2014). The ‘Learning and Innovation’ 
model approach proposed by Deng et al. (2010), which is built upon the ‘Full Range Leadership Model’ and 
tested by Yan et al. (2014) aligns management styles with the management theory addressing Employee 
Mindset. 
7). Organisation Culture and Innovation  
 
As described by Herbig and Dunphy (1998), certain aspects of culture can facilitate transmission of 
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messages of leaders/managers to an organisation and make them more clearly understood. Such an 
organisational culture facilitates transmission and comprehension of messages from leaders and rewards for risk 
taking. Hogan and Coote (2014), in  a quantitative study of 658 participants from Australian law firms, explain 
that leaders/managers can effectively use Schein’s three cultural layers (i.e., cultural values, norms and 
artefacts as described in Figure 4 ) to have greater certainty that their communications will be accepted 
and lead to innovative behaviours (Schein, 2010).  
Figure 4: Layers of an Organisational Culture that Supports Innovation 
 
Source: Hogan and Coote (2014), p.2.  
 
An organisation with a culture that emphasizes success or encourages and rewards risk taking is thus 
more likely to be successful (i.e., a higher innovation capacity) especially in the first two phases of the innovation 
process depicted in Figure 2 [i.e., the ‘Search’ for and ‘Selection’ of new ideas leading to innovations] (Herbig & 
Dunphy, 1998; Hogan & Coote, 2014; Wisdom et al., 2014). As shown in Figure 4, a study by Hogan and Coote 
(2014) of 658 principals of Australian law firms, empirically demonstrated the links of Schein’s multi-layered 
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model of organisation culture to risking-taking and a firm’s innovation capacity. 
8). A Chief Executive Officer (CEO) who is a leader 
 
Mintzberg (2011) explains, that “leadership is a necessary component of management” (p. 66). 
However, the enthusiasm, opinion leadership and vision of the CEO are critical determinants of an 
organisation’s success at innovating. For example, CEO leadership drives innovation by creating an 
environment with high quality work relationships. An enthusiastic and visionary CEO (i.e., a 
Transformational leadership style) creates an organisational culture that encourages open knowledge 
integration and learning essential for innovation (Bucciarelli, 2015; Caridi-Zahavi, Carmeli, & Arazy, 
2015; Wisdom et al., 2014). Caridi-Zahavi et al. (2015) in a survey of senior executives of randomly 
selected small to medium-sized technological ventures (SMVs) in Israel, found CEO leadership was a key 
driver of innovation, encouraging organisational connectivity and knowledge integration. However, the 
study included only 267 CEOs and had a 27.7% response rate. 
Elenkov et al. (2005), performed an empirical study of 1,340 presidents, managing directors and 
CEOs from 227 professional firms and business units in six countries (including the UK and the USA), with 
respondents from 223 of the selected firms and units. The study encompassed the ‘Full Range Leadership 
Model’ discussed previously and the ‘Upper Echelons Perspective’ (i.e., a focus on the influence of senior 
leadership in fostering innovation) and ‘Visionary Leadership’ framework (i.e., the importance of senior leadership 
to influence innovation by articulating a credible vision-Transformational Leadership Style). The principal aim of 
the study was to determine whether strategic leadership influenced product or administrative 
innovation. The study found that strategic leadership influences innovation exclusive of the effects of 
organisation size and culture, among other factors. 
Each of these eight leadership theories and concepts has empirically been shown to have a 
positive impact on an organisation’s innovation capacity and the innovation process described in Figure 
2. However, the absence of any particular one does not necessarily mean that an organisation will fail to 
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achieve its innovation objectives. Therefore, I will examine the collective relationship of these eight 
leadership theories and concepts to leadership styles and innovation while I will also analyse (i.e., 
operationalise) how participants in my survey perform against these individual leadership theories and 
concepts. 
2.3.2 Leadership Styles and Innovation 
While these eight empirically supported leadership theories and concepts have found support, 
albeit in a disparate manner in research in various economic sectors, they have not collectively been applied 
to organisations responsible for health innovation and related to specific styles of leadership. These leadership 
styles lie on a continuum from positive to negative leadership styles including Authentic, Transformational, 
Transactional, Aversive or Laissez-faire organisational leadership styles  (Deng et al., 2010; Jung et al., 
2003; Yan et al., 2014). For example, leadership styles that positively impact an organisation’s innovation 
capacity (e.g., Transformational Style of Leadership) are more likely to inspire leaders/managers to bring  forth 
new opportunities for innovation as depicted in the ‘Search ‘phase of the innovation process and to take risks of 
possible failure which affects all the innovation phases shown in Figure 2 (reproduced again here).  
Figure 2:  The Innovation Process 
 
Source: Tidd and Bessant (2013), p.60. 
Further, under a positive leadership style such as Transformational leadership, leaders/managers are 
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more motivated to invite additional risks through collaborations with outside venture capitalists, 
commercialization institutes and others and ‘Select’ projects which have more uncertainty, but also more 
benefit. This is despite increasing the possibility that the confidentiality of innovations will be leaked to 
competitors and the media. However, collaborations with outside groups may also introduce additional 
resources to improve the prospect of the organisation successfully implementing an opportunity (i.e., the 
‘Implementation’ phase in Figure 2) and also capturing the benefits of each innovation opportunity, as depicted 
in the fourth phase or ‘Capture’ phase of the innovation process in Figure 2. When a positive leadership style is 
combined with effective use of these eight leadership theories and concepts, it is to be expected that the 
capacity to innovate will be enhanced.  
In Figure 5, the leadership styles (i.e., Transformational, Transactional, Aversive or Laissez-faire 
leadership styles) are operationalised with the eight leadership theories and concepts that have empirically 
been shown to have a positive impact on an organisation’s innovation capacity and then related to the 
four phases of the innovation process described in Figure 2. As previously suggested, the absence of any 
particular one of these leadership theories and concepts does not necessarily mean that the innovation 
process will not succeed. However, I have listed the leading leadership theories and concepts with 
respect to each phase of the innovation process based upon the literature review performed.  
For example, creating a Psychological Climate for innovation is more likely to make 
leaders/managers feel safe to introduce new opportunities in the ‘Search’ phase for new 
ideas/opportunities as depicted in Figure 2. This is because innovation is expected and rewarded. 
Leaders/managers therefore have less cause to fear causing internal jealousies because they are introducing 
an idea that others in the organisation may have overlooked in the past. The Role of the CEO, in embedding 
the drivers of health innovation in the organisation, is recognized for its critical importance in each of the 
four phases of the innovation process depicted in Figure 2. 
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Figure 5: Leadership Styles and the Innovation Process Phases Operationalised with Eight 
Empirically Supported Leadership Theories and Concepts 
 
 Note: Figure 5 depicts that the styles of leadership described in Table 1 envelop each of the four phases 
of the innovation process described in Figure 2 (i.e., the ‘Search’ for ideas/opportunities followed by the 
‘Selection’ and ‘Implementation’ of the idea/opportunity; culminating in the ‘Capture’ of the benefits of 
the innovation idea/opportunity). The leadership theories and concepts corresponding to each of the 
innovation process phases employed by leaders/managers will likely vary depending upon the ‘Context’ 
of the situation. However, the leadership theories and concepts depicted in Figure 5 were related (i.e., 
ranked) by the researcher to each of the innovation process phases based upon an analysis of the 
present literature review. 
 
These eight theories and concepts provide the basis for the research in this thesis and inform the 
methods used to undertake it, as described in the following chapter. 
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Chapter 3 Methods 
3.1 Research Design 
 
I will use a pragmatic worldview (Creswell, 2014b). This focuses attention on the research 
problem and uses “pluralistic approaches to derive knowledge about the problem” (Creswell, 2014b), 
p.11). As described by Creswell (2014b), “there are many forms of this philosophy, but for many, 
pragmatism as a worldview arises out of actions, situations, and consequences…There is a concern with 
applications—what works—and solutions to problems” (p.10).  While a single quantitative study may 
offer insights into what a leader/manager is doing, it does not necessarily allow those leaders/managers 
to say why a particular leadership style has been adopted. As described by Antonakis et al.  (2003), 
combining qualitative and quantitative approaches, as will be done in this thesis, makes it possible to 
explain what a leader/manager is doing and why. Therefore, Antonakis et al. (2003) recommended that 
future leadership studies use a mixed-methods approach. 
This pragmatic worldview can best be achieved by an Explanatory Sequential Mixed-Methods 
approach, combining quantitative and qualitative approaches. In particular, it makes it possible to use 
one set of data “to check the accuracy (validity) of the other database” and more clearly explain the 
results obtained than is possible when each approach is viewed singly (Creswell, 2014b, p. 15).  I also 
considered the Convergent and Exploratory Sequential Mixed-Methods design approaches. However, 
the strength of the Explanatory Sequential Mixed-Methods approach is that each distinct phase, as 
depicted in Figure 6, is clearly identifiable and, most importantly, each phase of the approach builds 
upon the other (Creswell, 2014a). 
Figure 6:  Explanatory Sequential Mixed Methods Approach 
 
Source: Creswell (2014b), p. 220. 
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3.1.1 Mixed Methods 
The Explanatory Sequential Mixed-Methods includes a:  
a.) literature review6; 
b.) survey of leadership styles among leaders of organisations in the UK and US engaged in 
innovation in the health sector; and a 
c.) qualitative interviews among a sub-set of participants to the survey. A nested sampling 
design as described by Onwuegbuzie and Collins (2007). 
The combined results are used to develop a s a m p l i n g  framework that is feasible, as described 
in Figure 7, which will allow me to access appropriate health leaders/managers involved in health 
innovation and assess their leadership styles.  
3.1.2 Survey of Leadership Styles 
As stated previously, the overarching aim of this research is to ascertain the leadership styles of 
health leaders/managers of organisations charged with driving innovation in the UK and a selected high-
performing comparator in the US. Then the study will assess how these adopted leadership styles align 
with the leadership theories and concepts identified in the literature review. To accomplish this aim, I 
will undertake a survey among leaders/managers of UK health organisations responsible for driving 
health innovation (CLAHRCs; AHSCs; AHSNs) and a selected high-performing comparator in the US.  
The survey will involve  a questionnaire administered to individuals within these health 
organisations, from which I will derive a leadership profile (i.e., pattern or map of leadership styles) of 
each of these health organisations in the UK and USA (Appendix E), looking both at the perception of the 
organisation by those in leadership roles and how those individuals view themselves, as described by 
Handy (1996). I will use the findings from a leading comparator in the USA (which precedes the founding 
                                                          
6 The literature review is an expanded version of the material presented earlier in this thesis so will not be 
described further here. 
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of the AHSNs, CLAHRCS and AHSCs listed in Appendix E) as a benchmark against which to compare the 
results from the UK health organisations. The comparative analysis will take account of differences in 
health systems and national culture, as described by Hofstede (1980) and how this may impact the 
results of the survey questionnaire. 
 The Sampling Framework described in Figure 7, was developed as follows: 
1.) I initially set a target of 150 study participants with consideration of the minimum 
sample size recommendations depicted in Table 5. 
2.) Although the focus was on health organisations in the UK charged with driving 
innovation while contemporaneously deriving data from a US comparator organisation, I sought to 
identify an organisation in the USA known for its reputation as a health innovator that was comparable 
in size and scope to those in the UK. The US comparator health organisation, as one of the largest 
organisations of its kind in the US, encompassed a sufficient staff size/student enrolment, scope of 
activities and functions to align with the collective UK health organisations charged with driving health 
innovation (CLAHRCs; AHSCs; AHSNs)7 participating in this study.   
3.) Senior leadership of the US health organisation agreed to serve as a pilot test site for 
the methods used in the UK.   
4.) Selection of the UK health organisations was undertaken to provide a range of types of 
organisations. It was not intended to provide a representative sample of them as this would have been 
far beyond the scope of a DrPH thesis and the resources available. Hence, the sample was a convenience 
                                                          
7 As discussed, this study purposely chose to focus on CLAHRCs, AHSCs, and AHSNs which were formed 
by the UK government with the intent to drive health innovation and work together and with other 
stakeholders in the UK. As described by the participants included in this study, there are many other 
public and private organisations in the UK who have important roles to improve the health and 
wellbeing of the UK population which were not included within the scope of this study. These 
organisations could be considered for future research with respect to the leadership of health 
innovation (e.g., NHS Genomic Medicine Centres; MedCity; NIHR CRN). However, certain of the study 
participants, because of their standing in their fields of research, may also have roles with these other 
organisations. 
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one, facilitated by the unsolicited support of representatives of the National Institute of Health Research 
(NIHR) which supports the activities and funding of the CLAHRCS as depicted in Figure 1. Learning of my 
study from an officer of one the CLAHRCs I had approached, representatives of the NIHR unilaterally 
contacted four of the remaining 12 CLAHRCS in the UK encouraging their participation in my study. As a 
result, these four additional CLAHRCS joined the study. To complete the sampling framework, a London-
based AHSC and its related AHSN agreed to participate in the study.  Upon reaching a possible 155 study 
participants, I decided to cease recruitment of UK and US health organisations. However, relationships 
were established with other health organisations for future studies of health innovation leadership. 
5.) The distribution of questionnaires was preceded by a letter from a senior officer or 
his/her representative as described in Box 1. 
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Box 1:  Letter from a Senior Officer or His/her Representative to Colleagues to Participate in the 
Study 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
6.) Then two stage sampling was undertaken (i.e., multi-stage purposeful sampling) as 
described by Onwuegbuzie & Collins, (2007). The first stage involves sampling organisations to 
participate in the study. As noted, in the USA a single organisation was selected, primarily to pilot the 
approach, but also to provide some comparative benchmarking. This was an organisation whose duties 
closely approximate the responsibilities of the AHSNs, CLAHRCS and AHSCs in the UK.  
7.) In the UK, the first stage sampling frame initially comprises the entire set of AHSCs, 
 
 
 
Dear Colleagues: 
 
I am asking for your help on a research project being conducted by Philip Weintraub from 
the London School of Hygiene and Tropical Medicine. Philip’s research focuses on leadership and 
innovations within healthcare organisations and systems.  He is developing a tool that gauges the 
innovation potential of a healthcare organisation/system. The tool can also be used to 
attract/retain senior leaders and managers in the hopes of maximizing innovation and improve 
patient care and outcomes, similar to our efforts related to shortening the time it takes to get 
research from the bench to the bedside.  
 
Philip will be contacting you each directly with a Qualtrics LLC web-based anonymous survey.  I 
hope you will each take a few minutes to aid this important research. I have attached an 
Information Note from Philip Weintraub which provides more information.  If you have any 
detailed questions, feel free to reach out to him directly. His contact information is included 
below.  
 
Thank you. 
 
Kind regards, 
 
[Signature] 
 
Contact Information: 
Philip Weintraub 
DrPH Candidate, London School of Hygiene and Tropical Medicine, 
Faculty of Public Health and Policy 
Department of Health Services Research and Policy 
LSHTM Email: Philip.Weintraub@lshtm.AC.UK 
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AHSNs and CLAHRCs as described in Appendix E. I contacted the leadership of these organisations 
individually and through the collective leadership of the AHSNs and CLAHRCS. Representatives of the 
leadership of one leading AHSC agreed to participate in the study, including its affiliated CLAHRC and 
AHSN. In addition, a CLAHRC affiliated with another leading AHSC agreed to participate as did three 
other unaffiliated CLAHRCs. As discussed, with respect to the CLAHRC organisations, my research 
attracted the (unsolicited) attention of representatives of NIHR. These NIHR representatives encouraged 
CLAHRC organisations to participate in the study, for which I am appreciative.  
8.) Because of the strong UK receptivity to participating in the study, my sampling frame 
exceeded my initial estimate of 150 study participants. Also, I identified considerable overlap of 
organisational responsibilities for study participants within the UK organisations. For example, several 
leaders/mangers in the AHSC had clinical responsibilities as well as involvement with the AHSC’s 
affiliated CLAHRC and AHSN in different research roles. Therefore, the contact listing prepared for the 
survey questionnaire had to be reviewed to identify study participants that may have leader/manager 
roles in multiple organisations. 
9.) In the second stage, I created a sampling frame for each UK organisation participating 
in the study, to the extent feasible and practicable, comprising all employees holding 
leadership/managerial roles. I used the organisation’s organogram, organisational directory or web-site 
descriptions to create a matrix with axes based on tiers within the organisation and functions.  
Generally, a total of 3-5 individuals, depending on the size of the organisation and availability of 
participants8, were sampled from within each cell, at random. If available, the managing director of each 
organisation was invited to participate.  
10.)  Each tentative contact list of study participants was submitted to a representative of 
                                                          
8 For example, in one organisation, three of the leaders/managers were on leave and were excluded 
from the study. 
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the organisation for review. The purpose of this review was to ensure that participants, who may have 
recently left the organisation, were out of the country on assignment, or on an extended leave of 
absence, were not included in the study. I sought to attain saturation of leaders/managers from each 
organisation. I used the Qualtrics LLC web-based system to distribute the survey questionnaires and, 
prior to sending them, I drafted a letter that the organisation could edit and send to potential 
participants, as described in Box 1, in advance. It was accompanied with an ‘Information Note’ 
(Appendix B), providing more information about the study.  
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Box 2:  Example of Electronic Letter Inviting Study Participants to Complete a Survey 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
11.) The Qualtrics web-based survey software tool was selected to send the survey 
questionnaires as described in Box 2 because of its robust functionality and the excellent customer 
technical support provided. Competing web-based survey tools are offered by Survey Monkey, Google 
Forms, and the University of Bristol (BOS) among others. I have tested these applications and found the 
Dear Survey Participant:  
 
I am Philip Weintraub and I am inviting you to join with your colleague’s 
at_________________________ in a research study which focuses on leadership of health innovation. 
 
Thank you in advance for your participation. 
 
Please follow this link to consent to participate in the study: 
  
 
Or copy and paste the URL below into your internet browser: 
 
Instructions to Anonymously Submit the Survey: 
Please click the 'Submit' button to complete the survey located after the last survey question. 
 
The survey questionnaire is mailed to you through the Qualtrics LLC web-based software system 
ensuring all participant responses will remain anonymous and secure. It is estimated it will take you 
approximately 15 minutes to complete. 
 
Please do not hesitate to contact me if you have any questions or concerns.  
 
Again, thank you for your time. Your contribution is appreciated. 
 
Kind regards, 
 
Philip 
 
Philip Weintraub 
Public Health & Policy, DrPH Candidate 
Department of Health Services Research and Policy 
London School of Hygiene and Tropical Medicine 
LSHTM Email: Philip.Weintraub@lshtm.AC.UK 
 
Follow the link to opt out of future emails: 
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Qualtrics LLC web-based survey tool a superior product in terms of ease of use, survey analysis functions 
and customer technical support. In addition, Qualtrics LLC is used by over 7,000 organisations in 75 
countries including over 1,600 colleges/universities (LLC, 2015)9. The functions within the Qualtrics LLC 
web-based survey software tool allowed me to determine whether all those invited had responded, while 
preserving anonymity. It allowed me to send multiple gentle reminders to non-responders as depicted in Box 3. 
In addition, it allows for the downloading of survey results in PDF, Word, Excel, or SPSS format.   
Box 3: Example of a Reminder Letter to Study Participant 
                                                          
9 Security Statement 
Qualtrics, LLC (2015) “uses Transport Layer Security (TLS) encryption (also known as HTTPS) for all 
transmitted data. We also protect surveys with passwords and HTTP referrer checking. Our data is 
hosted by third party data centers that are SSAE-16 SOC II certified. All data at rest are encrypted, and 
data on deprecated hard drives are destroyed by U.S. DOD methods and delivered to a third-party data 
destruction service. 
Qualtrics deploys the general requirements set forth by many Federal Acts including the FISMA Act of 
2002. We meet or exceed the minimum requirements as outlined in FIPS Publication 200. 
HIPAA Statement: With some restrictions, Qualtrics may be designated as a Business Associate when the 
Qualtrics BA Agreement is signed with a Covered Entity—those organizations that are required to comply 
with HIPAA privacy rules. All client data are considered confidential, and treated as such, with no specific 
designation (such as medical (PHI), PII, or public). Therefore there is a duty of care that Qualtrics must 
have with PII data. 
Related to HIPAA, HITECH (Health Information Technology for Economic and Clinical Health Act) are 
updated assessment rules to ensure that data are properly protected and best security practices 
followed. By using secure and certified data centers, Qualtrics ensures the highest protection and testing 
as per HITECH requirements.” 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dear Survey Participant:  
 
I am sending this gentle reminder inviting you to join your colleague’s at_________________________ in a 
research stu y which focuses on leadership of he lth innovation. Please follow the link below to consent to 
take the survey or continue a su vey you already started. If you have already star ed the Qualtrics’ survey, 
you may return online to complet  the partiall  completed survey. The informati n you ente ed is saved.  
 
Please note this survey requires you to singly rank the four statements. Please put a "1" by the statement 
that is the ‘best fit', "2" by the next best, and so forth (e.g., 1 = Best Fit; 4 = Lowest Fit) in the 'Organisation' 
and 'Self' columns.  
 
Follow this link to the Survey:  
 
 
Or copy and paste the URL below into your internet browser: 
https://kent.qualtrics.com/jfe/preview/SV_57vK33R6PtUx6Ad?Q_CHL=preview 
 
Instructions to Anonymously Submit the Survey: 
Please click the 'Submit' button to complete the survey located after the last survey question. 
 
The survey questionnaire is mailed to you through the Qualtrics LLC web-based software system ensuring all 
participant responses will remain anonymous and secure. It is estimated it will take you approximately 15 
minutes to complete. 
 
Please do not hesitate to contact me if you have any questions or concerns. Thank you for your participation. 
 
 Kind regards, 
 
Philip 
 
Philip Weintraub 
Public Health & Policy, DrPH Candidate 
Department of Health Services Research and Policy 
London School of Hygiene and Tropical Medicine 
LSHTM Email: Philip.Weintraub@lshtm.AC.UK 
 
Follow the link to opt out of future emails: 
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As depicted in Figure 7, the final sample framework includes 155 participants from 8 health 
organisations in the UK and the US. As described in Chapter 4.2: UK Health Organisations, the AHSC 
selected for this study is affiliated with an AHSN. For purposes of clarity in this thesis, the AHSN is 
grouped with the AHSC and the AHSC is then referred to, on a combined basis, as a single UK healthcare 
organisation. Then this thesis reflects six UK health organisations were included in this study rather than 
seven. 
Figure 7: Research Study Sampling Framework 
                    
The questionnaire (instrument) includes basic sociodemographic and organisational variables. Thus, 
data on the respondent included: age; sex; organisational role; tenure with organisation; and education level 
UK 
1/15 AHSNs 
Included within 
AHSC sample 
Included within AHSC 
sample 
5/13 CLAHRCs 
Up to  25 surveyed 
in each (n=107) 
Interviewees 
(n=24) 
1/9 AHSCs 
25 surveyed  in 
total (n=  25 ) 
Interviewees 
(n=5) 
US-Pilot 
Test 
University/ 
Medical School 
AHSC 
23 surveyed in 
total  (n=23) 
Interviewees 
(n=5) 
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achieved. Data on their organisation included: number of  employees as described by  Mumford, Scott, Gaddis, 
and Strange (2002) , and (Hitt, Hoskisson, & Kim, 1997)  as cited in (Jung et al., 2003). To maximize response 
rates, I used the reminder functionality built into Qualtrics LLC. This sampling framework will result in a sample 
size that exceeds the minimum size recommendations most common in quantitative and qualitative research 
designs as described by Onwuegbuzie & Collins (2007) and summarised in Table 5. 
 
Table 5: Selected Minimum Sample Size Recommendations 
 For Most Common Quantitative and Qualitative Research Designs 
Research 
Design/Method   Minimum Sample Size Suggestion 
Correlational   64 participants for one-tailed hypotheses; 82 participants 
    for two-tailed hypotheses 
      
Causal-Comparative   64 participants for one-tailed hypotheses; 82 participants 
    for two-tailed hypotheses 
      
Phenomenological   ≤ 10 interviews 
      
      
Grounded Theory   20-30 
      
Sampling Design     
      
Subgroup Sampling   ≥ 3 participants per subgroup 
Design     
      
      
Nested Sampling Design   ≥ 3 participants per subgroup 
      
Data Collection 
Procedure     
Interview   12 participants 
      
    Note: 
 
  
For correlational and causal-comparative research designs, 
the recommended sample sizes represent those needed to 
detect a medium using J. Cohen (1988) criteria, one-tailed 
statistically significant relationship or difference with .80 
power at the 5% level of significance. 
Source: Onwuegbuzie and Collins (2007), pp.288-289. 
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Next, the survey questionnaire contains questions that pertain to each of the eight leadership 
theories and concepts (Appendix A: Questions 7-14) identified in the literature review. The survey 
instrument’s instructions to each respondent are excerpted in Box 4. 
Box 4: Survey Instructions 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The questions 7-14 are presented in Appendix A. Each refers to one of the eight empirically 
supported leadership theories and concepts identified in the literature review. For each, a set of four 
responses (a-d) is offered, which map onto four leadership styles, as shown in Table 1 (i.e., 
Transformational, Transactional, Aversive, and Laissez-faire). The respondent then indicates which of 
 
Research Study- Leadership of Health Innovation: Building an Innovative Health Organisation   
 
Thank you for taking part in this research study.      
 
To complete the survey questionnaire:            
 
A.) Please complete questions 1-6 regarding your organisational role and the number of people 
who work in your organisation.           
 
B.) For questions 7-14 you will be asked to rank the four statements in order of 'best fit' to the 
leadership styles that characterise your organisation, as a whole (i.e., Organisation Column) and 
'best fit" reflecting your personal leadership style (i.e., Self Column). To rank the four statements, 
put a "1" by the statement that is the ‘best fit', "2" by the next best, and so forth (e.g., 1 = Best 
Fit; 4 = Lowest Fit) in the 'Organisation' and 'Self' columns.  Please indicate a single response for 
each of the statements (a.-d.) for the ‘Organisation’ and ‘Self’. Thereby, completing a single 
ranking of each statement for the ‘Organisation’ and ‘Self’. From your organisation and personal 
perspectives, please consider the main drivers which provide impetus or motivation and drive 
innovation which are typical, respectively, of your organisation and then your personal leadership 
style.  
 
For purposes of this survey, leaders include senior leadership and managers unless otherwise 
noted. Innovation is defined as the multi-stage process of creating, selection, implementation and 
capture of the value of new concepts, processes and/or products.   When you have completed the 
survey press the 'Submit' button located after Question 14 as described in the email 
instructions. Again, your responses will remain anonymous.               
 
Thank you for your participation.            
 
Kind regards,           
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these responses most accurately reflects the leadership style that characterises the overall organisation 
as well as the style adopted by the individual themselves. They then rank the remaining styles in order 
of approximation to the style of the organisation and the individual. (Appendix A). The questions relate 
to the theories and concepts as follows: 
Question 7:  Creating a Psychological Climate for Innovation 
Question 8:  Leader-Member Exchange (LM X) 
Question 9:  Social Capital Promotes Innovation 
Question 10: Leadership Clarity Essential for Health Innovation 
Question 11: Supporting Team Reflectivity 
Question 12: An Appropriate Employee Mindset 
Question 13: Organisational Culture and Innovation 
Question 14: Role of the Chief Executive Officer (CEO) (i.e., A Chief Executive Officer who is a leader) 
 
For example, as shown in Table 6, Question 7 concerns creating a Psychological Climate for 
innovation. Ranking Question 7, response a., as the best fit (rank as number 1 or first) from an 
‘Organisation’ perspective indicates that senior leadership and management sets high expectations for 
innovation with commensurate rewards for success and would signify a Transformational leadership 
style. The choice of statement b. indicates that the respondent believes health innovation is solely 
represented in standard policies and procedures, implying a Transactional style. Statement c.  suggests 
that health innovation ideas, if any at all, flow down from the top of the organisation while failure to 
implement an assigned idea is not an option and would signify an Aversive leadership style. Finally, 
statement d. shows a belief that the leader(s) offer freedom to staff to pursue health innovation, but 
proponents of innovative ideas are completely on their own to succeed or fail and would indicate a 
Laissez-faire Style of Leadership. Then the preceding process would be repeated from a ‘Self’ (i.e., your 
personal leadership style) perspective. 
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Table 6:  Operationalised Responses to Survey Questions 
 
Note: I developed Table 6 to operationalise the survey questions (i.e., questions 7-14, Appendix A) used 
in the questionnaire. The survey questions describe a leadership style that is then related to each of the 
eight empirically supported leadership theories and concepts in this thesis. This is based upon an 
analysis of the survey data from Qualtrics LLC. The Qualtrics LLC’s survey data is downloaded into SPSS 
and the descriptive statistics for each survey response are calculated and analysed. Based upon an 
analysis of the measures of central tendency (i.e., Median, Mode and Mean), selected leadership styles 
are colour coded and rankings shown. 
 
This survey instrument was adapted from that used by Handy (1996) in terms of structure and 
the style of questions/statements posed. It was piloted with selected representatives of the 
administrative leadership and/or translational medicine departments of two US universities, one of 
which served as the pilot test for this study. As described by Rea & Parker (2014), Cronbach’s Alpha was 
calculated, in Table 7, using ‘Statistical Package for the Social Sciences’ (SPSS) to test the scale reliability 
(internal consistency) of the responses based upon the results described in Chapter 4.1:US Pilot Study. 
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Table 7: Cronbach’s Alpha 
 
Note: Cronbach’s Alpha of 92.6% was calculated excluding Survey Question 13: Organisational Culture 
(n= 8), which had a Cronbach Alpha of approximately 50%.  This result, with regards to the respondent’s 
understanding of Question 13, was addressed in subsequent changes to the survey questionnaire 
(Appendix B) and interviews with study participants. Source: SPSS  
 
As described in Chapter 3.1.6, the qualitative interviews subsequently provided insight as to the 
reliability and validity of the survey. In addition, the questionnaire was shared and discussed in advance 
with: 1.) representatives of the University’s10 senior administrative leadership; 2.) representatives of the 
NHS and AHSN/CLAHRCs; 3.) senior executives in Healthcare11, a publicly-held stock organisation traded 
on the New York Stock Exchange recognised for its health innovation; 4.) colleagues at Kent State 
University, Kent, Ohio; and 5.) members of a start-up technology company in the US. These discussions, 
involving colleagues in both the UK and US, resulted in improvements in the content and clarity of the 
survey instrument, especially with regards to the language differences (e.g., spelling of certain words) 
between the UK and US.  
This extensive piloting ensured that the questionnaire was easily understood by those 
                                                          
10 The name of the organisation was changed in the interests of confidentiality. 
11 The name of the organisation was changed in the interests of confidentiality. 
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responding to it and the questions posed reliably captured the leadership styles seen, mapping onto the 
eight empirically supported leadership theories and concepts from the literature review. Based upon 
this work, I made appropriate edits and modifications of the survey instrument’s wording. However, the 
overall structure of the survey was generally well received by respondents.  For example, as described 
by Harzing et al. (2009), survey instruments, such as in this instance, using rankings performed best in 
reducing response and language bias in international studies. 
As described in Chapter 3.1.5: Qualitative Data Collection and Analysis, the intent of this Explanatory 
Sequential Mixed-Method approach, as shown in Figure 6, is to use the qualitative phase to explain the 
quantitative results more fully. However, the quantitative results in this approach can inform the qualitative 
questions posed (Creswell, 2014b, p 224). 
3.1.3 Conduct of the Survey  
a. In accord with the continuum of leadership styles and objectives of this research study 
described in Tables 1 and 2, respectively, this questionnaire seeks to determine 
patterns of leadership style(s) found in health organisations engaged in health 
innovation. Individuals in each organisation are asked a series of questions, each 
relating to one of the leadership theories and concepts identified in the literature 
review. Each has four possible responses, corresponding to a different leadership 
style (Transformational, Transactional, Aversive, and Laissez-faire) (Appendix A). They 
are asked to provide responses about the leadership style of the organisation in which they 
work and the style they, personally, adopt. Responses are then aggregated within these 
two perspectives and compared.  
b. This design was chosen for several reasons, including: 1.) the ability to look at all of the 
eight leadership theories and concepts identified in the literature review but not, to my 
knowledge, looked at together; and 2.) for pragmatic reasons, recognising that the 
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respondents are busy health leaders/managers who operate with finite resources and 
under time pressures.  
c. The number of potential respondents (leaders/managers) in any of these organisations is 
limited, although the precise number will vary according to the size/structure of the 
organisation. However, they will include both members of senior leadership and lower 
levels of management reporting to senior and successive levels of leadership. Pihlainen et 
al.  (2016) and Oshagbemi & Gill (2004) describe the importance of taking a broader 
perspective when analysing  an organisation’s senior leadership and management 
rather than placing a singular focus on a specific organisational level (e.g., first-
level management).  
d. The Qualtrics LLC web-based software allows for the survey questionnaire to: 1.) be 
communicated by email; 2.) protect identities of the respondents, who will remain 
anonymous; 3.) include pre-set email reminder notices and 4.) export the results of the 
survey to perform further analysis.  
e. As noted, the survey questionnaire described in Appendix  A is adapted from Handy 
(1996). As he described, “the questionnaire…provides one way of analysing and 
codifying… your organisation and yourself (i.e. the respondent). Questionnaires, of 
course, are fallible, particularly when one fills them in for oneself about oneself. Add to 
that the fact that organisations are not hard objective realities, like chairs, which can be 
objectively measured and described, or is your character or personality.…So it is clear that 
the scores that you arrive at can only be your view, from where you stand at this point in 
time, of the organisation and yourself” (pp.63-64). 
f. Survey respondents received an electronic ‘Information Note’, as described in Appendix 
B, introducing the researcher and describing the aim and objectives of the research, 
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among other matters. It was estimated that it will take survey respondents 
approximately 15 minutes to complete and submit the survey electronically using 
the Qualtrics web-based software. The Qualtrics LLC web-based software assures 
that each respondent’s completed survey questionnaire will remain anonymous 
and secure. 
g. The data from the survey were stored anonymously on a dedicated personal 
computer hard disk under my control. I performed all data analysis, reviewed by 
my supervisor.  
3.1.4 Quantitative Data Analysis 
a. A table was prepared with the numbers and percentages of respondents and non-
respondents.  Non-response bias was evaluated using a Wave Analysis. That is, I 
performed a weekly analysis to determine if later responses differ materially from 
earlier survey responses. Some researchers assume late responders are more 
typical of non-responders (Creswell, 2014b, p. 162; Rea & Parker, 2014, pp. 197-8). 
In addition, to the extent feasible, I monitored, among successive waves, the pre-
determined categorical nominal, ordinal and numerical variables (i.e., 1.) Individual 
Respondent: age; sex; organisational role; tenure with organisation; and education level 
achieved; and 2.) Organisation: number of employees influences the respondent and 
non-respondents for each health organisation (Mumford et al., 2002 & Hitt et al., 
1997, as cited in Jung, 2003). 
b. The analysis depicts the profile of leadership style for each health organisation, 
both overall and relating it to each of the eight leadership theories and concepts. 
As noted, the analysis includes a comparison of the results of the survey 
questionnaires from UK health organisations with one US health organisation 
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known for its innovative approach. In addition, a descriptive analysis of the survey 
results was developed by categorical nominal, ordinal and numerical variable 
categories for UK and the US comparator health organisations (Creswell, 2014b, 
pp.161-166; Rea & Parker, 2014). As described by Rea & Parker (2014), SPSS was 
used to: 1.) analyse cross-tabulated data; and 2.) perform other statistical analyses. 
The plan of analysis includes an assessment of the eight leadership theories and concepts identified 
in the literature review and collection of data concurrently from respondents’ organisations and personal 
perspectives. Zampieron et al. (2013) used a similar approach in a study to compare leadership styles of 
nurse managers and their staff. That study gathered information based upon perceived (i.e., an 
‘Organisation’ perspective) versus preferred (personal [‘Self’] perspective) leadership styles.  
To illustrate the approach, Figures 8 and 9 show the ranking given to different leadership styles, as 
seen from the ‘Organisation’ and ‘Self’ perspective, are summarised, based on answers to the question 
on the ‘Psychological Climate’ (question 7 in the survey) for a hypothetical organisation.  Individuals 
had been asked to state: 
 a. Leaders set high expectations for health innovation with commensurate rewards for 
success. 
b. Health innovation is included in standard policies and procedures. 
c. Health innovation ideas, if any at all, flow down from the top of the organisation and failure 
to implement an idea is not an option. 
d. Leaders offer freedom to pursue health innovation, but proponents of ideas are on their own 
to succeed or fail. 
Thus, Figure 8 shows the ranking (1-4) of the ‘Organisation’ in terms of ‘Psychological Climate’. 
The responses referred to: a.) level of leadership support; b.) championing of innovation; c.) innovation 
expectations; and d.) rewards, or in other words, the extent to which organisation members believe 
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health innovation is expected, supported, and rewarded. In this illustration, approximately 50% of the 
collective survey respondents stated the organisation demonstrated (ranked as 1 or first-red line12) a 
Transformational Style of Leadership and approximately 43% of respondents ranked as 2 or second (blue 
line) an Aversive Style of Leadership.  
In contrast, Figure 9, which looks at how respondents rank their own leadership style, in terms 
of: a.) level of leadership support; b.) championing of innovation; c.) innovation expectations; and d.) 
rewards, or the extent to which respondents view their own style, finds that approximately 29% (ranked 
#1-red and purple lines) had either Transformational or Transactional Styles of Leadership, while 
approximately 38% ranked 2 or second (purple line) reported a Transactional Style of Leadership. 
Figure 8: Ranking the ‘Psychological Climate’ from an ‘Organisation’ perspective  
 
Source: Qualtrics LLC 
 
                                                          
12 Respondents are requested to rank the statements from 1 to 4, putting a ‘1’ by the 
statement that best represents the organisation, ‘2’ by the next best, and so forth. 
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Figure 9: Ranking from a Personal (‘Self’) Perspective the ‘Psychological Climate’  
 
Source: Qualtrics LLC 
 
Thus, Figures 8 and 9 show a marked the lack of alignment suggesting that the organisation’s capacity for 
innovation may be failing to meet senior leadership’s expectations. This recognition of a misalignment between 
‘Organisation’ and ‘Self’ perspectives affords the organisation an opportunity to take remedial steps to address the 
‘Psychological Climate’ in a constructive and time-sensitive manner.   
A similar analysis, as depicted in Figures 8 and 9, was performed for each health organisation 
included in the study. As described in Table 6, I then identified a leadership style based on each of the eight 
leadership theories and concepts and then collectively, for the overall organisation.  Then the US comparator 
health organisation was analysed and compared to the collective results for the UK health organisations 
surveyed in Chapter 5.  
To illustrate the approach to combining the survey results, I use the responses to the eight 
leadership theories and concepts for the 11 respondents in the previously depicted hypothetical organisation 
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to generate Tables 8 and 9, from an ‘Organisation’ and ‘Self’ perspective, respectively. Upon a review of 
the collective results in Tables 8 and 9, it would appear that a majority of the respondents ranked the 
Transformational (36% of responses) and Transactional (32% of responses) Styles of Leadership as ‘1’ or 
first from an ‘Organisation’ and ‘Self’ perspectives, respectively. However, as discussed in Chapter 1: 
Introduction and Chapter: 4.1.2: Quantitative Data Collection, the ‘Organisation’ perspective would 
appear dependent on the ‘Context’ (i.e., operating environment) and ‘Group Cohesiveness’ that the 
leaders/managers function. This suggests a situational response in leadership style from/for 
leader/manager respondents also from a ‘Self’ perspective. As previously discussed, unlike in natural 
sciences, social science theories are rarely, or never, according to some, universally applicable (Gorton, 
2012).  To account for the implications of the different organisation Contexts and levels of Group 
Cohesiveness, a weighted score was calculated for each leadership style, allocating 4 points if ranked 
first, 3 if ranked second, and so on (missing values were coded as zero), with the total divided by the 
number of respondents.  
Table 8: ‘Organisation’ Perspective-Collective Results 
   
 
      ‘Organisation’ Perspective 1 2 3 4 Weighted Score Total 
Transformational 32 16 22 18 21.6 88 
Transactional 17 32 22 17 20.5 88 
Aversive 13 29 19 27 18.5 88 
Laissez faire 25 20 25 18 20.7 88 
Total 87 97 88 80   352 
Note: Rankings 1-4 showing a collective best fit to least from an ‘Organisation’ perspective depicting 
responses from eleven participants to eight questions (7-14), each with four possible responses: (i.e., a.) 
Transformational Leadership Style; b.) Transactional Leadership Style; c.) Aversive Leadership Style or d.) 
Laissez-faire Leadership style).  A total of 11 respondents and eight questions and four statements with 
each question were included [11 X 8 X 4=352 responses]). Then a weighted leadership style score was 
calculated as described. 
 
Source: Qualtrics LLC and Microsoft Excel analysis 
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Table 9: ‘Self’ Perspective-Collective Results 
 
‘Self ‘ Perspective 1 2 3 4 Weighted Score Total 
Transformational 20 25 19 24 19.7 88 
Transactional 27 29 19 13 22.4 88 
Aversive 17 21 27 23 18.9 88 
Laissez faire 21 18 31 18 19.8 88 
Total 85 93 96 78   352 
Note: Rankings 1-4 showing best fit to least from an ‘Organisation’ perspective depicting responses from 
eleven participants to eight questions (7-14), each with four possible responses: (i.e., a.) 
Transformational Leadership Style; b.) Transactional Leadership Style; c.) Aversive Leadership Style or d.) 
Laissez-faire Leadership style).  Then a weighted leadership style score was calculated as described. 
 
Source: Qualtrics LLC and Microsoft Excel analysis 
 
As depicted in Table 8, the eleven respondents show a weighted ‘Organisation’ score that is almost 
split among a Transformational, Transactional and Laissez -faire Styles of Leadership.  That is, an organisation 
with inspiring leadership, but little sincere interest in the members of the organisation as individuals. 
Innovation ideas, if any at all, are processed according to policies and procedures with pre-set awards.  
As described in Table 9, the 11 respondents show a weighted ‘Self’ perspective that favours a Transactional 
Leadership Style, but the other three leadership styles are still preferred by several their colleagues.   
I have presented the preceding analysis of a hypothetical health organisation to demonstrate 
the approach used throughout this thesis to analyse the results of the surveys performed. In this 
instance, there is a conflict between the ‘Organisation’ and ‘Self’ perspectives.  As will be discussed in 
Chapters 4 and 5 of this thesis, conflicts between survey respondents’ perspectives from an ‘Organisation’ 
versus a ‘Self’ leadership style will need to be addressed by senior leadership and management to improve 
the organisation’s innovation capacity and possibly reduce resulting employee turnover. It is emphasized that 
this thesis focuses on building innovative health organisations. Therefore, the ‘Organisation’ and ‘Self’ 
perspectives collectively presented are not merely the views of unrelated individuals, but individuals who 
collectively work for health organisations that are trying, as an organisation, to innovate to achieve its 
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strategic mission, vision and values and its duty to its stakeholders including patients. 
3.1.5 Qualitative Data Collection and Analysis 
The qualitative component began once the survey results were analysed. It involved semi-structured 
interviews with approximately twenty percent of the leaders/managers of the organisations included in 
the survey, in the UK and the USA, as depicted in Figure 7.  
As described by Onwuegbuzie & Collins (2007), this sampling framework  is referred to as a nested 
sequential sampling design.  An example is the study conducted by Way, Stauber, Nakkula, and London 
(1994) as cited in Onwuegbuzie and Collins (2007). “These researchers administered questionnaires that 
focused in the areas of depression and substance use/abuse to students in urban and suburban high 
schools (quantitative phase). On finding  a positive relationship between depression and substance use 
only in the suburban sample, the researchers undertook in-depth interviews of the most depressed urban 
and suburban students (qualitative phase)…”(p.296).  
Onwuegbuzie & Collins (2007) believed that this nested sampling framework was  the most flexible 
and enabled the “researcher … to fit a specific research context, as well as the research goal, research 
objective(s), research purpose, and research question(s)” (p.297). Contrary to popular belief, 
Onwuegbuzie & Collins (2007) explained that non-random sampling  was often used in quantitative and  
qualitative studies. As in this instance, nested sequential sampling designs can use a combination of sampling 
methods to best fit the aim and objectives of this study. 
The leaders/managers were randomly selected for interview. However, if a leader/manager was 
not available, an appropriate individual was substituted to the extent feasible. The interview schedule, 
the core of which was the same for all organisations to enable comparability, complemented the results 
of the survey questionnaires (e.g., offering insight into the operating environment of the organisation) and 
interviews were conducted either face-to-face   or   by telephone using Skype, depending on the locality 
and availability of key informants. These interviews lasted approximately 30 minutes each. The preference 
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was to perform in-person interviews in the offices of the participating organisations.  
Because of the anonymous nature of the responses to the survey and the nested approach used, 
participants selected at random for interviews may or may not have completed the questionnaire. As 
described in Appendix F, the interviews followed a semi-structured, open-ended format allowing the 
participant to offer further information and provide opinions for the interviewer to pursue other lines of 
questioning where relevant.  
The interviews had two objectives. The first was to identify the ways in which different leadership 
styles facilitate or inhibit innovation, assessing their influence on the four stages of the innovation model 
described in Figure 2. The second, subsidiary objective was to assess the extent to which the questions in 
the survey accurately and reliably capture the leadership styles in the organisation, thereby contributing to 
the validation of the survey instrument.  
The interview schedule initially explored in depth the questions asked in the survey, ensuring that 
meanings were clear, before obtaining concrete examples of how leadership characteristics impact on the 
work of the organisation and, in particular, its ability to innovate. A second element focused on situations in 
which health innovation has been facilitated or impeded and why. These stories were interrogated to 
identify aspects of leadership styles that gave rise to these facilitating or impeding factors. This information 
was subsequently related back to the findings from the survey in the particular organisation.  
The interview schedule was piloted in both countries. In the US, the piloting took place during 
the collection of data from the quantitative survey and was informed by emerging results. In the UK, 
piloting of the survey instrument was undertaken with colleagues in several UK health organisations, as 
described previously. The approach to piloting is as set out in the Box 5 below. 
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Box 5: Piloting of interview schedule 
A draft interview schedule was piloted among a group of at least 5 people working in health 
organisations in each country. The piloting addressed the following issues: 
1. Will each question measure what it is supposed to measure? 
2. Are all the words used understood? 
3. Do all respondents interpret the interview question in the same way? 
4. Does the interview process create a positive impression that motivates people to respond to the 
questions posed? 
5. How long does it take to complete the interview? 
6. Is the information you want collected? 
 
3.1.6 Qualitative Data Analysis 
Green & Thorogood (2013) describe qualitative reliability as relating to “issues such as accuracy 
of reporting, consistency of coding, and thoroughness of analysis” (p.324). Creswell (Creswell, 2014b) 
describes qualitative validity “meaning that the researcher checks for the accuracy of the findings” 
(p.201). Given the limitation of this research study being performed by a single researcher, the 
strategies used to ensure the reliability and validity of the data analysis will include, but not limited to: 
a. Interviews, with the exception of parties who do not wish to be recorded and the 
extent practicable, will be recorded on two different devices (i.e., Livescribe Echo 
smartpen and the Voice Record Pro App on an IPhone 6). 
b. I arranged for the interviews to be transcribed shortly after completing them, using 
a reliable third party.  The transcriber had access to a shared file of each interview 
in Microsoft’s OneDrive without any reference to the party’s name or the survey 
questionnaire, if completed. 
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c. This research employed an interactive approach adapted from that described by 
(Maxwell, 2012) rather than a cyclical or a linear structure (Creswell, 2014b; Green 
& Thorogood, 2013).  
d. As noted, the quality (and accordingly the weight given) of identified documents 
listed as references in this thesis was assessed using a standardized tool (Center for 
Evidence Based Management, n.d.). 
e. Triangulation of data sources was performed throughout the study.  
f. The coded interviews were summarized into themes for further analysis, as 
depicted in Figure 10. 
g. The collected interview data were stored anonymously on a dedicated password 
protected personal computer hard disk under my control. I performed all data 
analysis, with review by my supervisor.  
To summarize, the ongoing data collection and analysis is an iterative process. As noted above, 
survey data were solicited from 155 persons while interviews were conducted with 34 individuals as 
depicted in Figure 7. This is not a hypothesis testing study, but rather one to identify emerging themes, so 
formal sample size testing is not appropriate. As noted previously, and as explained by Onwuegbuzie & 
Collins (2007), the sample sizes in this research study exceed the minimum size for a study of this sort.  
I reflect specifically on my role as a researcher in Chapter 5.4, Contributions of the Study. 
This includes reflecting on the survey data, documentary sources, audio files, transcripts, and my 
interview technique throughout the data collection phase, revising the interview schedule as 
appropriate. The documentary sources and transcripts of audio-taped interviews were coded using 
thematic analysis to identify emergent themes. I used NiVivo software to manage the coding process 
and within the analysis of the data. I maximized validity of the analysis by identifying negative cases, 
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ensuring my interpretations of the data were sufficiently contextualized and by triangulating findings 
across the different sources.  
Figure 10: Validating the Accuracy of the Qualitative Information 
 
Source: Creswell (2014b), p.197. 
 
3.1.7 Explanatory Sequential Mixed Method 
To accomplish the aim and objectives, data collection was performed “in two distinct phases” 
(Creswell, 2014b, p. 224).  As previously noted, the intent of this method, as was shown in Figure 6, was to 
use the qualitative phase to explain the quantitative results more fully. However, the quantitative results in 
this approach can inform the qualitative questions posed. 
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3.1.8 Data Analysis, Interpretation and Validity 
In this approach, the analyses of data from the quantitative and qualitative phases are first 
considered separately. However, the sample for the qualitative phase is drawn from the population 
used in the quantitative phase to enhance the validity of this approach. Therefore, in the interpretation 
of this research, the results of the two phases are first discussed separately and then the quantitative 
results are illuminated by the qualitative results. In this way, the results from each phase can be 
triangulated with each other to strengthen their validity. The approach to triangulation will be based 
on the method of triangulation by Patton (1999) whereby quantitative and qualitative data elucidate 
complementary aspects of the same phenomenon. This approach points the researcher to where these 
data sources diverge, which is of most interest as it offers the most valuable insights. 
3.2 How my background enables me to conduct mixed methods research  
 
I am a DrPH student with experience in health organisations in both the public and private 
sectors in the UK and the US. My prior business experience includes working in computer information 
services, healthcare consulting, investment banking, and the financial services industry as well as an 
audit partner with the international public accounting firm of Deloitte LLP. My US government service 
includes serving as the Special Assistant to the Vice-Chairman of the Board of Governors of the Federal 
Reserve System which included both domestic and international banking oversight responsibilities. In 
addition, I served (pro bono basis) as the Treasurer of a not-for-profit Florida-US regional medical centre 
and served as a trustee and member of its executive and finance committees. I subsequently served as a 
member of a county’s healthcare district’s finance committee and as a member of selected task groups. In 
2015, I undertook an OPA of an AHSN in the United Kingdom as part of my DrPH degree.  
Given my experience, it will be important to address the issue of reflectivity.  In Chapter 5.4, 
Contributions of the Study, this will be facilitated by keeping a field diary, recording the progress of the 
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research and reflecting on the role of a researcher in the interactions with subjects.  
3.3 Ethical Issues 
 
Prior to the commencement of the research, the senior leadership/governance representatives 
of each organisation in this study were informed of my background and were provided with my 
curriculum vitae. I spoke with the senior leadership/governance representatives of each organisation 
prior to commencing this study and discussed its aim and objectives, responding to any questions 
regarding the ‘Information Note’ (Appendix B). Their agreement to commence the research was 
obtained.  In addition, the ‘Information Note’ will be provided to leaders/managers selected to receive 
survey questionnaires or participating in an interview.  An ‘Informed Consent Form’ (Appendix C) was 
provided to leaders/managers selected for interviews. This research protocol was approved by the 
London School of Hygiene and Tropical Medicine Ethics Committee on 18 February 2016. In each 
instance, when interviewees are anonymously quoted in this thesis, a signed Consent Form as described 
in Appendix C was obtained in advance which states:  I understand that any quotations used in writing 
up the study findings will be used anonymously and I consent to this. 
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Chapter 4 Results 
 
4.1 US Pilot Study 
 
4.1.1 Introduction 
After being granted permission by the Vice Provost for Academic and Strategic Planning, I 
piloted a study at one of the largest US Universities13, a not-for-profit organisation, which includes a 
highly regarded medical school and hospitals including speciality hospitals (e.g., treatment of cancer); 
and an AHSC (collectively referred to in this thesis as the ‘University’, ‘US health organisation’ or ‘US 
Pilot Study’). With a student body of over 50,000 students, the University is one the leading educational 
and health organisations in the United States and among the largest as measured by size of the student 
body (Vice Provost for Academic and Strategic Planning of the University, Personal Communications, 6 
October 2016). 
As described in Chapter 3.1.1, a sample of 26 department leaders/managers was selected within 
the US University whose duties closely approximate the responsibilities of the AHSNs, CLAHRCS and 
AHSCs in the UK.  In this instance, the study participants had responsibilities within: the Division of 
Clinical and Translational Informatics; Division of Computational Biology and Bioinformatics; or the 
Division of Data Science. In addition, certain study participants may be on a temporary assignment to 
these and /or other departments at the University from other highly regarded research organisations 
throughout the US. 
4.1.2 Quantitative Data Collection 
As described by Rea and Parker (2014), Cronbach’s Alpha was used to test the reliability of the 
respondent results to the survey questionnaire as depicted in Table 7. The response rate to the US Pilot 
                                                          
13 The name and certain descriptive data of the organisation has been changed to ensure the confidentiality of the 
information shared with the researcher. 
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Study is depicted in Table 10. 
Table 10: Survey Questionnaire Response Analysis 
All Responses:      
Distribution 
Channel 
Audience Size-
Initial 
Surveys 
Started  
Responses Response 
rate 
Completion 
Rate (of those 
starting survey) 
Invitation by 
Qualtrics LLC 
Email 
26 14 8 31% 57% 
Source: Qualtrics LLC.-29 June to 30 September 2016 
 
Of the initial sample of 26, three participants left the University within a short time after the 
survey process started (including the head of the Division of Clinical and Translational Informatics) and 
these three surveys were not completed.  Therefore, the response rate was adjusted to approximately 
34.8% (i.e., 8 out of 23). This response percentage exceeds that obtained by the RAND Corporation 
(2016) in a report on Innovation, Health and Wealth - a formative and summative evaluation which 
sampled a similar professional population in the UK. The RAND Corporation report represented 
independent research commissioned and funded by the UK Department of Health, Policy Research 
Programme. As described by the RAND Corporation, “survey responses overwhelmingly came from 
people already interested in innovation. After excluding initial contacts where emails were not 
deliverable, and alternative email addresses could not be found, the overall response rate was 16 per 
cent (typical for online surveys)…” (p.25).  
Non-response bias of the survey sample was also evaluated using a Wave Analysis. Based upon 
the Wave Analysis performed over the survey period, no significant differences were noted between 
respondents and non-respondents. However, minor differences were noted as to age and sex. Non-
respondents tended to be somewhat younger (35-44) and more likely to be male. The results are 
summarized in Appendix I. 
Cronbach’s Alpha was calculated using SPSS to test the reliability of the survey questionnaire 
(Appendix A), giving a value of 92.6%. As noted previously, this result excluded Survey Question 13; 
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Organisational Culture (n= 8), which had a Cronbach Alpha of approximately 50%.  Consequently, this 
question was reworded to ensure greater clarity, based on interviews with study participants (Appendix 
A). 
As stated previously, the overarching aim of the study was to ascertain the leadership styles of 
health leaders/managers of organisations charged with driving innovation in the UK and a selected high-
performing comparator in the US. Then the study assessed how these adopted leadership styles align 
with the leadership theories and concepts identified in the literature review. As noted in the previous 
chapter, each of these theories and concepts was operationalised as one question, with four statements 
a-d, relating to the following leadership styles, including: a.) Transformational Leadership Style; b.) 
Transactional Leadership Style; c.) Aversive Leadership Style; or d.) Laissez-faire Leadership style. They 
were then asked to describe the leadership style in their organisation and their own leadership style. A 
summary of their responses from each perspective is presented in Table 11. A weighted score was 
calculated for each style, allocating 4 points if ranked first, 3 if ranked second, and so on (missing values 
were coded as zero), with the total divided by the number of respondents. As this shows, based on the 
highest weighted score, the US organisation was considered to have a mainly Transactional Leadership 
Style, although with elements that were Aversive and Laissez-faire Styles of Leadership. A 
Transformational style attracted the lowest rankings. In marked contrast, the most prevalent leadership 
style adopted by respondents (‘Self’ perspective) was a Transformational Style of Leadership, indicating 
a mismatch between the respondents and their organisation. 
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Table 11: ‘Organisation’ and ‘Self’ Perspective Collective Results-Pilot Test-US Health 
Organisation 
‘Organisation’ Perspective 1 2 3 4 Weighted Score Total 
Transformational 11 7 16 26 15.4 60 
Transactional 18 26 12 4 22.3 60 
Aversive 18 16 16 10 20.3 60 
Laissez faire 16 14 17 13 19.1 60 
Total 63 63 61 53 77.0 240 
‘Self’ Perspective 1 2 3 4 
 
Total 
Transformational 32 8 9 4 21.8 53 
Transactional 3 25 15 10 15.9 53 
Aversive 9 11 14 18 14.4 52 
Laissez faire 10 12 9 20 14.3 51 
Total 54 56 47 52 
 
209 
Note: Rankings 1-4 showing best to least fit from an ‘Organisation’ and ‘Self ‘ perspectives  depicting the 
responses of eight respondents to eight questions (7-14)  A total of 8 respondents and eight questions 
and four statements with each question were included in the survey questionnaire (8 X 8 X 4=256 
possible responses). However, in certain instances participants did not respond to each question 
resulting in a lower collective count out of the 256 possible responses as was noted in Table 7 in the 
calculation of Cronbach’s Alpha.  
Source: Qualtrics LLC Survey Reponses and Microsoft Excel analysis. 
Table 12 examines the most commonly reported leadership styles associated with the different 
questions, and thus, the leadership theories and concepts.  
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Table 12: Responses to Survey Questions-US Health Organisation-Leadership Style Ranked as #1-
Best Fit 
 
Note: Table 12 depicts the operationalised responses to the US Pilot Study survey question responses 
(i.e., questions 7-14, Appendix A) from an ‘Organisation’ and ‘Self’ perspectives based upon the 
methodology described in Table 6. This approach includes an analysis of the survey response data from 
Qualtrics LLC. The Qualtrics LLC’s survey data was downloaded into SPSS and the descriptive statistics for 
each survey response were calculated and analysed. Based upon an analysis of the measures of central 
tendency of the data, the selected leadership styles were colour coded and ranked as the best fit (i.e., 
ranked as number 1 or first) to the survey question posed.14  
 
The striking finding is the consistency of responses in relation to ‘Self’, where respondents were 
most likely to opt for a Transformational style in relation to all the theories and concepts. In other 
words, they are people who prefer to work together to achieve a shared vision. However, their 
assessment of the organisation was extremely varied, although dominated by Transactional and 
Aversive styles, with a Laissez faire approach to creating a psychological climate for innovation. Taken 
together, these findings paint a picture of an organisation staffed by people who recognise the need for 
                                                          
14 As described by Rea & Parker (2014), the Mode can be best used to describe the most common 
responses for ranked scale data. The Median is the most appropriate measure for categorical ordinal 
data. However, the Mean should also be considered when there are numerical responses to questions.  
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innovation and the means to pursue it but are trapped within an organisation where the focus is on 
process, with blame for those who err, but with some elements of a hands-off approach.  This does not 
suggest a well-functioning organisation, despite its previous history of achievement. Crucially, the 
problem seemed to lie with the organisation rather than the staff, so it would seem unlikely that 
measures such as leadership training would help. It was thus unsurprising that members of the senior 
leadership of this University later resigned under pressure from the leaders/managers and staff from 
University departments that were included in this research. 
 I then explored the data in terms of the characteristics of respondents: age; sex; organisational role; 
tenure with organisation; and education level achieved.  While the Transactional and Aversive Styles of 
Leadership dominated the responses to the survey questions, certain respondents preferred a Laissez-faire 
Style of Leadership. At first glance, this seemed to be associated with their length of time with the organisation, 
so this variable was selected for further investigation.  
There were other reasons why this may be of interest. First, as described by Cohen and Bailey (1997), 
“‘Group Cohesiveness’ [Emphasis added] is positively related to performance. Three meta analyses and 
several empirical studies found a slight to moderate positive relationship between ‘Group Cohesiveness’ 
and performance. This is a robust finding in an area that has long been studied.” Second, 43% of the 
respondents (Appendix I) had spent over 10 years with the organisation and a further 29% had spent 5-
10 years with the University, so 72% had been with the University over 5 years. For comparison, the 
median tenure of management, professional and related occupations in the US is 5.1 years (Bureau Of 
Labor Statistics, 2016). 
Table 13 shows the ‘Organisation’ and ‘Self’ Perspective Organisation for US Pilot Study 
participants with 10 years or more tenure and weighted scores for this group  and those participants with less 
than 10 years tenure, adjusted for the number of respondents. Table 13 shows that those with shorter tenure 
are slightly more likely to report that they have a Transformational style from a ‘Self’ perspective while 
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presenting a Transactional Style of Leadership from an ‘Organisation’ perspective. In contrast, those who have 
been with the University longer are slightly more likely to view the organisation as demonstrating a 
Transformational style from both perspectives. 
Table 13: ‘Organisation’ and ‘Self’ Perspective Collective Results-Pilot Test-US Health 
Organisation Participants with more than 10 years Tenure and Weighted Scores for each 
Leadership Style among Those with Differing Levels of Tenure 
Tenure > 10 years (n=3) < 10 years (n=5) 
‘Organisation’ Perspective 
Transformational 18 13.8 
Transactional 17.6 25 
Aversive 17 22.2 
Laissez faire 15 21.6 
   ‘Self’ Perspective 
 Transformational 17.3 24.4 
Transactional 16.3 15.6 
Aversive 16.3 13.2 
Laissez faire 13.7 14.6 
Source: Qualtrics LLC & Microsoft Excel Analysis 
In Figure 11, I was interested in how those with over ten years in tenure viewed the CEO of the 
University. Upon further examination of the data, these leaders/managers ranked as 1 or first (from an 
‘Organisation’ or ‘Self’ perspective) either the Transformational (i.e., Senior leadership combines 
leadership by example with inspiring and motivating organisation members to experiment with new 
ideas) or the Laissez-faire Style of Leadership (i.e., senior leadership delegates most organisational 
responsibilities and duties to leaders/managers giving them considerable latitude to make decisions. 
Senior leadership does not lead by example and refrains from motivational efforts) as depicted in Figure 
11. This is followed by ranking as second the Transactional Style of Leadership. 
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Figure 11 : Organisation’ Perspective-Question 14-Role of the CEO 
 
Source: Qualtrics LLC Survey Reponses and Microsoft Excel analysis 
 
To summarize, as illustrated in Tables 11 and 12, there is a collective lack of alignment, among 
leaders/managers (e.g., mainly a Transactional Leadership Style, although with elements that were 
Aversive and Laissez faire Styles of Leadership from an ‘Organisation’ perspective) versus a Transformational 
form of leadership from a “Self’ perspective as aligned with the eight leadership theories and concepts 
favourable to health innovation. However, this collective misalignment was not noted among those who 
had over 10 years tenure with the organisation (Appendix I) described in Table 13. In Table 13, this 
group consistently ranked the Transformational, Transactional and Aversive Styles of Leadership highly 
both from the ‘Organisation and ‘Self’ perspectives. As this group also included the executive leadership, 
it indicated a difference in the perspectives of leadership style at different organisation levels.  
This lack of consistency among leaders/managers may also partially explain the high turnover that I 
observed among the University’s senior administrative leadership and the high ranking of a Laissez-faire Style of 
Leadership in this sample (Survey Question 14, Appendix A) by respondents with over ten years in 
tenure in the organisation (Figure 11). For example, the University had 5 interim and full-time presidents since 
2007 as well as recent turnover in other senior administrative and division/department leadership. Based upon 
the researcher’s observations and responses from survey respondents with over ten years of tenure in the 
organisation, described in Figure 11, the organisation’s board of directors and senior administrative leadership 
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project a top down corporate view without giving a great deal of attention to knowledge worker buy-in (i.e., 
Laissez-faire Style of Leadership).  
4.1.3 Qualitative Data Collection 
As described in Chapter 3.1.5-Qualitative Data Collection and Analysis, in October 2016, five of 
the twenty-three participants (approximately twenty percent) in the sample were randomly selected for 
a semi-structured interview (Appendix F). Of the five interview participants, three submitted survey 
questionnaires. This nested sequential sampling design is referred by Onwuegbuzie and Collins (2007) as 
a “random  purposeful technique” that “selected random cases from the sampling frame and randomly 
choosing a desired number of individuals to participate” (p.286). This approach enabled the selection of 
individuals covering each level of leadership and management. In this instance, one of the individuals 
selected was assigned to a project in China and a substitute participant was identified. After my arrival at the 
interview location, one individual became unavailable due to illness and the Vice Provost for Academic and 
Strategic Planning agreed to be interviewed. While he was not among the twenty-three survey 
participants, he had reviewed the survey questionnaire, research protocol and participated in prior 
discussions with me. 
The qualitative procedures facilitated the evaluation of non-response bias to the survey (i.e., views of 
non- respondents can be compared to survey respondents) manifested by any meaningful differences 
between the views of these two groups. During the interviews, those who had responded to the survey 
disclosed that they had more training and/or interest in leadership and health innovation, specifically. This 
observation is similar to that found by  RAND Corporation (2016). 
As previously explained, the interviews had two objectives.  The first was to identify the ways in 
which different leadership styles facilitate or inhibit innovation, assessing their influence on the four 
phases of the innovation process described in Figure 2(reproduced again here).   
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Figure 2: The Innovation Process
 
Source: Tidd and Bessant (2013), p.60. 
Consistent with the results reported in Chapter 4.1.2: Quantitative Data Collection, the 
interviewees collectively described an organisation with a Transactional Style of Leadership where short-
term return on investment (ROI) was the main criterion for deciding the amount of funding, 
administrative and other support a research project would receive. Concurrently, the interviewees 
described an organisation that demonstrated an Aversive Style of Leadership (i.e., top-down) where 
there was little consideration by senior administrative leadership (i.e., Laissez- faire Style of Leadership) 
of buy-in by leaders/managers at lower levels (divisions/departments). However, as emphasized by 
several interviewees, buy-in may be needed to generate a high level of collaboration to achieve the 
success of a research project. The following interviewees’ quotes are representative of these views: 
Answer: “We are in a situation now where it is more difficult to fund a research group, and so you’ve 
seen a shift from this more altruistic knowledge-based motivation to a much more financially driven, 
bring in money.” 
 
Answer: “I think it does relate to the fact that the funding for all the colleges and the health system is not 
all centralized, and I can’t begin to tell you how it’s actually done, but some colleges have more support 
and some have less support.” 
 
Question:  “Could we get buy in…?” 
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Answer:  “They don’t.  Their buy in is at the top level as you kind of go down, there’s executive 
committees, but once you get below a certain level, where you have brought faculty or the staff, there’s 
not really a buy in there.  It’s more like a forum saying “Hey look, we want to talk about these….” 
 
Answer: “That takes a lot of institutional will, but a lot of institutional will isn’t difficult if you have the 
vision for it.  All I’m saying is that change (i.e., innovation) is only hard when you are asking people to do 
something that they haven’t bought into.” 
 
 
The perceptions of interviewees of their ‘Self’ leadership style was primarily Transformational 
was especially strong among participants with over ten years tenure with the organisation as described 
in Figure 16. The following interviewees’ quotes are representative of these views: 
Answer: “When these organisations think outside of the box, yes there are going to be mistakes, there 
are going to be errors, but leaders learn from those mistakes and adapt.  I think adaptation has to be 
beautiful.  Okay, fine.  That was a mistake, that’s okay, move on, learn from it and adapt.  To me I think 
that is what I need.  Those are my role models.  Those are people whom I say I want to be like them.  I 
want to be able to be a critical thinker; you know, my mistake, my bad, learn from it, adapt and move 
on.”  
 
Answer: “You can’t be innovative if you are risk averse.” 
 
Answer: “The one challenge that I have in the conversation that we had and I just alluded to it, is you 
could do what worked for us again and fail.  It’s not that these are the ingredients, not a recipe, and I 
think that really it’s about getting the right people before they come in, and setting expectations…” 
 
Answer: “So the question is, if I can lead you, if I can give a vision of what we are trying to do, when I 
walk away you think that my idea is your idea.  So you are still working towards that common goal.” 
 
As described in Chapter 2.3.2 and Table 11, the Transactional leadership style with elements 
that were Aversive and Laissez faire Styles of Leadership attributed to the ‘Organisation’ would present 
a barrier to success through all four stages of the innovation process depicted in Figure 2. This is 
especially true if this Transactional leadership style is coupled with an Aversive leadership Style of 
Leadership, which could lead leaders/managers to be risk-averse rather than innovative.  
Given the predominant ‘Self’ perspective of a Transformational Style of Leadership shown in 
Table 12; this could inspire the innovation process. Therefore, this misalignment of the ‘Organisation’ 
and ‘Self’ perspectives (Tables 11 and 12) may lead to conflicts between a senior leadership not 
interested in achieving buy-in to an idea and Transformational leaders/managers at lower levels of 
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responsibility. Again, this misalignment of leadership styles may also partially explain the high 
leader/manager turnover seen in this organisation. 
Overall, the perceived Transformational Style of Leadership described by study participants with 
over ten year’s tenure (Table 13), from both the ‘Organisation’ and ‘Self’ perspectives, should not be 
surprising. These more experienced participants generally comprise the senior members of the 
organisation’s (executive) leadership at the division/department level who are the recognized experts in 
their field and may also aspire to senior administrative leadership.  
With the organisation’s senior administrative leadership’s Transactional Leadership Style with 
elements that were Aversive and Laissez-faire Styles of Leadership of leadership (Table 11) and their 
focus on ROI, it is incumbent on the study participants with over ten year’s tenure to present a strong 
business case to the senior administrative leadership of the University to generate and select ideas that 
represent a combination of their project team’s views (Figure 2-Phases 1 and 2, Search and Select, 
respectively). These individuals perceive the senior administrative leadership of the University as having 
a combination of Transformational and Laissez-faire Styles of Leadership (Figure 11). Accordingly, it is 
likely that these expert researchers see an opportunity to present a business case for their research 
proposals that blends the senior administrative leadership’s focus on ROI with their (‘Self’) collaborative 
Transformational Style of Leadership. 
The second objective of the interviews is to assess the extent to which the questions in the survey 
accurately and reliably capture the leadership styles in the organisation, thereby contributing to the 
validation of the survey instrument.  After transcription, which took place shortly after each interview, I 
coded the interviews line-by-line using NiVivo 11 and summarized the content into themes. The themes 
identified (i.e., listed as Questions 7-14 of the survey questionnaire in Appendix A) in the interviews 
were consistent with the prior literature searches used to structure the survey instrument and the initial 
interview questions.  
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The interviewees confirmed the organisation’s degree of alignment with the eight empirically 
supported leadership theories and concepts favourable to health innovation included in the 
questionnaire (Appendix A-Questions 7 to 14), individually and collectively. The following interviewees’ 
quotes are representative of these views: 
Question 7: ‘Psychological Climate’ 
Answer: “They created a safe environment, supportive culture for you to do this.  And if they were not 
willing to have the right climate and the right culture, and you instead were told, like at the GM 
manufacturing plant, we stamp this metal in the middle with a big X, and then you are going to stamp it 
with big X’s.” 
 
Question 8: ’Leader Member-Exchange’ (LMX) 
Answer: “I can’t speak to the organisation; we are not a monolith, not even from the top down.  I would 
tell you that my research success is entirely dependent on the infrastructure in relationships we built.” 
 
Question 9: ‘Social Capital’ 
 
Answer: “…And I might actually have networks of interdependence and my organisation then becomes a 
constellation of networks.  That’s what holds everything together, but in the end, there were a bunch of 
networks here, and there are going to be loose connections between the networks; but this one is doing 
this kind of work and that one is doing that kind of work, and no one is expected to do everything.  
People are expected to collaborate to come up with that.” 
 
Question 10: ‘Leadership Clarity’ 
 
Answer: “… it’s about getting the right people before they come in, and setting expectations.  We spend 
an awful lot of energy about setting expectations in our group so that you know….” 
 
Question 11: ‘Organisational Reflectivity' 
Question:  “In your Programme, is there an opportunity for the people to just exchange ideas with each 
other? I mean, is there a reflectivity time?” 
 
Answer: “Yes, there is. They have quite a lot of time to do so. So they follow the group, the whole cohort, 
and the same cohort meets up at every time, every month for ten or twelve months. And they do form a 
sort of cohesive Group during that time, and do have quite a bit of time reflecting. There’s one main sort 
of Course Programme Director who is with them every Session, even if he’s not formally teaching. They 
become very attached to him, and he sort of facilitates the group sessions. It’s very successful in doing 
that and they have quite a little time within each day actually just reflecting and talking to each other.” 
 
Answer:  “…We function like a think tank.  We function like a research incubator.  That’s the language 
people have when they talk about it.  For example, our group spends no less than 12 hours [weekly] 
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sitting together around a table of coffee…”  
 
Question 12: ‘Growth versus Fixed Mindset’ 
 
Question: “You had a growth Mindset.  You were open to change.” 
 
Answer: “That’s what collaboration is.” 
 
Question 13: Organisation 'Culture' refers to the values and beliefs which set the expectations for 
innovative behaviour 
 
Answer: “We should be supporting interdependent researchers, because they can do science that 
independent researchers can’t do.  That’s the part that’s missing.  There is a culture associated with it.  
There’s a mentality associated with it, and I think that you’ve got to buy into this idea that we are 
interdependent.  That may mean you need to clear out everything and start again and say, we are going 
to build an interdependent organisation… “ 
 
Question 14: ‘Senior leadership’s impact’ (Role of the CEO) 
Answer:  “No,  that wouldn’t work.  I was very fortunate.  The only reason I came here was that I was 
told I could create this environment.  So one of the dynamics that we have is we interview candidates for 
jobs.  One of the things that we tell them is when you come here; your prior research is gone.  You can do 
it off the side of your desk, but we can’t support you doing that research and this tent is big enough.  
What we are trying to do are train people to do this work, because this is what’s needed.  Not what 
interests you, but in ways needed by the Institution.  It is what is needed by the country.  This is what is 
needed.  That’s how we are driving our research.  What value are we adding to the world?  Not, well, I’m 
interested in this….that’s me-search.  I don’t understand how we can be funding so much of it.  I mean, I 
do - I understand the way it’s set up and everything, traditionally.  But that is not the team science 
approach that is going to get us to solve the big problems.  So, if we are going to do that, then you have 
to create an environment where people come in and what has happened, is that they have been 
transformed by the process.  We at times call it drinking the Kool Aid.  They get transformed by the 
process.  They change their world view and then they scaffold onto where we are, where their interests 
were.” 
 
 
4.1.4 Mixed-Methods Analysis & Discussion 
The overarching aim of this study is to ascertain the leadership styles of health 
leaders/managers of organisations charged with driving innovation in the UK and in a selected high-
performing comparator in the US and assess how the styles adopted align with the eight theories and 
concepts identified in the literature review as favourable to health innovation. To achieve this aim, an 
Explanatory Sequential Mixed Methods approach was used. The combined results of this approach were 
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then used to develop a feasible and practicable ‘ L e a de r s h i p  Framework’ that a health organisation can 
use to determine the  leadership styles of health leaders/managers aligned with eight empirically 
supported theories and concepts, thereby to drive much needed health innovation.  
The integration of the results of quantitative and qualitative approaches used in this US Pilot 
Study are depicted in Table 14; “a follow-up results joint display” as described by Creswell (2014a, p. 84). 
This summary of the results of the pilot test of the US health organisation provides a baseline for 
comparative purposes to the UK health organisations subject to the limitations discussed in Chapter 5.5 
of this study. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DRPH THESIS                                                                                                                     87 
 
Table 14: A Follow-Up Joint Display of Mixed-Methods Result- US Health Organisation 
Quantitative 
Results 
Qualitative Follow-Up 
Interviews Explaining 
Quantitative Results 
How Qualitative Findings 
Helped to Explain 
Quantitative Results 
1.) There is a collective lack 
of alignment, among 
leaders/managers (i.e., 
Transactional with elements 
that were Aversive and 
Laissez faire Styles of 
Leadership from an 
‘Organisation’ perspective 
versus a Transformational form 
of leadership from a “Self’ 
perspective) as aligned with 
the eight empirically 
supported leadership 
theories and concepts 
(themes) described in this 
thesis and shown favourable 
to health innovation. 
 
 
2.) This collective lack of 
alignment was not noted 
among the largest population 
group by tenure (i.e., over 10 
years with the organisation). 
This group consistently 
ranked the Transformational 
and Aversive Styles of 
Leadership highly both from 
the ‘Organisation and ‘Self’ 
perspectives. However, this 
population group perceived 
the senior administrative 
leadership having a 
combination of a 
Transformational and a 
Laissez-faire Style of 
Leadership. 
 
1.) The interviewees 
collectively described an 
organisation with a 
Transactional Style of 
Leadership where short-term 
return on investment was a 
priority on the amount of 
funding, administrative and 
other support a research 
project would receive. Also, the 
interviewees’ confirmed the 
organisation’s degree of 
alignment with the eight 
leadership empirically 
supported theories and 
concepts included in the study 
questionnaire. 
 
 
2.) Concurrently, the 
interviewees’ described an 
organisation which also 
demonstrated an Aversive Style 
of Leadership (i.e., top-down) 
where there was little 
consideration for buy-in of 
leaders/managers at the 
different levels of the 
division/department that may 
be needed to collaborate to 
achieve the success of a 
project. 
 
 
 
 
3.) A perceived ‘Self’ 
Transformational Style of 
Leadership was described by 
participants especially those 
with over ten years tenure. 
1.) This perceived misalignment 
of leadership styles between the 
‘Organisation’ and ‘Self’ is 
understandable. As expressed by the 
interviewees, the health 
organisation’s senior administrative 
leadership focuses on project by 
project funding return on investment 
because the sources of public funding 
for research have decreased. That is, 
organisations (particularly not-for 
profit organisations) may present a 
Transactional and Aversive senior 
administrative leadership style if their 
focus and first goal is to maintain 
financial viability (Gapenski, 2016). 
 
 
 
2.) Therefore, it is incumbent on 
this health organisation to engage 
leaders/managers with a 
Transformational Style of Leadership 
that is coupled with the courage to 
make a business case for research 
projects that will most help the 
health of the population and bring 
together the collaboration necessary 
to attract funding.  
 
 
 
 
 
 
 
3.) Health organisations will 
need to ensure leaders/managers 
have the necessary leadership skill-
sets by offering training programmes 
throughout their careers. 
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Based upon the work performed, there are two additional salient matters that I must discuss 
regarding the mixed-methods analysis.  
First,  a Reporter (2017) disclosed that the CEO of the University’s Medical Center resigned 
following complaints by the faculty about his leadership. He also stepped down from his position as 
executive vice president of health sciences at the Medical Center. According to the Reporter (2017) , 
“Thirty …University College of Medicine physicians … signed a letter of "no confidence" regarding the 
CEO … 2017. The letter notes that more than 100 faculty members from the College of Medicine express 
the same sentiments as the letter; however, not all signed it due to fear of retaliation [emphasis added]. 
Soon after,  … senior members of the Medical Center's … also wrote a letter detailing concerns about the 
leadership team.” While the two letters included several strong complaints against the CEO, “both 
letters allege the CEO’s leadership was negatively [emphasis added] affecting the academic mission...” 
These events, affecting leadership of the University, are consistent with the quantitative findings 
from the survey instrument used in this study (i.e., there is a collective lack of alignment of leadership styles, 
among leaders/managers, from ‘Organisation’ and ‘Self ‘ perspectives as described in this thesis). Further, these 
events occurred approximately seven months after my research at the University was completed. While 
disturbing, these events suggest that the methods that I used may be able to identify potential problems.  
The findings describe a University that presents a collective dysfunctional set of leadership styles from 
an ‘Organisation’ perspective, ranging from Transactional to negatives styles of leadership including 
Aversive to Laissez-faire, which contrasts with the Transformational form of leadership style preferred by 
leaders/managers at different levels in the organisation from a ‘Self’ perspective; particularly among the more 
senior researchers at the University.  
These quantitative findings are also supported by the qualitative interviews performed. The qualitative 
interviews found that leaders/managers believed the senior leadership of the University held a Transactional and 
Aversive leadership style partially because of their intense focus on Return on Investment. 
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As described by Miller & Tsang (2010) “organizations are diverse, complex, and changing social 
phenomena, with multiple levels of analysis, as well as multiple and contingent causal processes”(p.140). 
At the time this study was performed, the University presented an operating ‘Context’ which demonstrated a 
collective Aversive, Laissez-faire, and Transactional form of leadership style from an ‘Organisation’ perspective. As 
described by Antonakis et al. (2003),  “ratings of leadership may be contextually sensitive in that the 
context in which ratings are collected… and can affect measurement and structural properties of 
leadership surveys, as well as one’s interpretation of the results”(p.268).  Antonakis et al. (2003) further 
described this contextually sensitivity as a validation of a survey instrument, when it can differentiate 
between the leadership styles of multiple organisations. However, because the behaviour of the 
leaders/managers of the University and the staff reporting to them likely modified their behaviour due 
to the operating ‘Context’, comparisons to UK organisations participating in this study which presented 
a different operating ‘Context’, must be undertaken with caution.  
To enable me to conduct this analysis, additional procedures were undertaken, including: 1.) 
detailed discussions concerning the operating environment with several representatives of the 
University’s senior administrative leadership; and 2.) a review of documents including operating and 
strategic information. Finally, the differences in “employee motivation, management styles , and 
organisational structures” between the US and UK health organisations described by Hofstede (1980) 
were considered. 
Second, from a policy perspective, UK policymakers should take particular note of the 
approximately 71% of the sample with over 5 years tenure, including approximately 43% of the sample 
with over 10 years of tenure with this leading US health organisation. This contrasts markedly with the 
figures of 49% and 13%, respectively in the UK health organisations sampled, as depicted in Table 15.  
Currently, approaches to health innovation in the UK appear to show a preference for evaluating 
organisations in five-year increments, leading to decisions to continue or abandon an organisation. For 
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example, beginning in October 2008, the NIHR funded nine CLAHRC pilots for five years. A second wave 
followed, and, at present, there are 13 CLAHRC which are also subject to a five-year review. Also, the 
first AHSNs in the UK were formed in 2012 and are also subject to a five-year review to decide their 
continuation.15 This form of government oversight could lead to uncertainty about employment among 
critical leaders/managers and knowledge staff workers in UK organisations responsible for health 
innovation. If this uncertainty about employment is allowed to become embedded in the culture of 
these organisations, this could present a barrier to them achieving the ‘Group Cohesiveness’ observed 
in the US health organisation. In other words, leaders/managers and knowledge staff workers may 
perceive these health organisations as short-term resume builders versus part of a long-term career 
strategy.  
Table 15: Sample Population by Tenure-US and UK Health Organisations 
 
Note:  Compiled from sample data described in Appendix I.  As described in connection with Table 16, 
there were 61 total survey questionnaires submitted versus the 44 survey responses included for 
complete analysis. The 17 questionnaires not included for complete analysis were improperly prepared 
                                                          
15 On 27 July 2017, The NHS Board voted to commence the relicensing process for all 15 AHSNs subject 
to approval of their plans beginning April 2018. Ian Dodge, National Director: Strategy and Innovation 
stated the “AHSNs  serve as vital ‘connective tissue’ between industry, universities, and the NHS…In the 
future, AHSNs will have two primary functions: innovation and service transformation” (NHS England, 
2017, 6 July) . 
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(i.e., did not comply with the instructions beyond answering the categorical questions 1-6 [e.g., 
Question 3: What is your tenure with the Organisation?], but omitted responding to the ranked survey 
questions 7-14). 
 
4.2 UK Health Organisations 
 
4.2.1 Introduction 
As described in Figure 7, six UK health organisations described below were included in this 
study. These have been described earlier, in Chapter 1. As previously noted, the names and certain 
descriptive data of the organisations have been changed to ensure the confidentiality of the information 
shared with the researcher. 
1). Academic Health Science Centre –England (AHSC-England): 
 
AHSC-England is one of the leading AHSCs in the United Kingdom with partners from the NHS, 
social care and academia located throughout England.  AHSC-England’s reputation for excellence in 
health delivery and research extends throughout the UK and globally. For example, AHSC-England 
supports translational medicine improvements including innovations affecting population health by 
partnering with the NHS, other AHSNs, and CLAHRCS to train clinical and other professionals in 
leadership and support their innovative initiatives.  
2). CLAHRCs 
 
Five CLAHRCS were included in the study; each focused on specific delivery themes (e.g., 
dementia; mental health; respiratory care) and cross cutting themes (e.g., patient and public 
engagement). These were responsible for meeting the research needs of more than 12 million people 
located in different parts of England. 
The quantitative and qualitative data for the UK health organisations included will be presented 
in section 4.2.2: Quantitative Data Collection. 
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4.2.2 Quantitative Findings  
In Table 16, I have summarized the responses to the survey questionnaire from the UK health 
organisations. While there were 61 survey questionnaires submitted (i.e., of the 77 surveys started or 
72%) by respondents, a total of 44 questionnaires were accepted for complete analysis. The deleted 17 
survey questionnaires were improperly prepared (i.e., did not comply with the survey instructions 
described in Box 4 beyond answering the categorical questions [e.g., Question 3: What is your tenure 
with the Organisation?], but omitted responding to the ranked survey questions 7-14 (Appendix A). 
While these 17 responses were not analysed fully, they were included in Appendix I to describe 
responses to socio-demographic and organisational questions. 
Table 16: Survey Questionnaire Response Analysis-UK Health Organisations 
All Responses: 
   
 
 Distribution 
Channel Sampling frame 
Surveys 
Started Responses 
Response 
rate 
Completion 
Rate % 
Initiation 
By 
Qualtrics LLC 
Email 132 77 44 
 
 
 
 
33% 57% 
Source: Qualtrics LLC-24 November 2016-10 June 2017 
The overall UK survey questionnaire completion rate and the response rate of 57% and 33.3% 
are similar to the experience of the US health organisation of 57% and 34.8%, respectively. As previously 
discussed, the response rate (i.e., based upon 44 responses to the survey questionnaire) was more than 
double the response rate incurred by the RAND Corporation in a survey of a similar UK population 
(RAND Corporation, 2016).  
Non-response bias of the survey sample was also evaluated using Wave Analysis. Based upon 
the Wave Analysis performed over the survey period 24 November 2016-10 June 2017, no significant 
differences were noted. The survey period for each UK health organisation was approximately two-three 
months and the solicitation period was staggered over the period 24 November-10 June to allow for 
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analysis of the collected data prior to commencing interviews of randomly selected study participants. 
As previously discussed, each survey questionnaire was accompanied by an invitation letter (Box 1) with 
an attached Information Note (Appendix B). Also, gentle reminders were sent as depicted in Box 3. 
As stated, the overarching aim of the study was to ascertain the leadership styles of health 
leaders/managers of organisations charged with driving innovation in the UK and a selected high-
performing comparator in the US. Then the study will assess how these adopted leadership styles align 
with the eight leadership theories and concepts identified in the literature review.  
Based upon the survey responses, the collective leadership styles depicted by UK health 
organisations on an ‘Organisation’ and ‘Self’ perspective are compiled in Table 17. As before, a weighted 
score was calculated for each style, allocating 4 points if ranked first, 3 if ranked second, and so on 
(missing values were coded as zero), with the total divided by the number of respondents. 
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Table 17: ‘Organisation’ and ‘Self’ Perspective Collective Results-UK Health Organisations 
Organisation perspective 1 2 3 4 Weighted score Total 
Transformational 181 50 31 36 22.1 298 
Transactional 51 173 40 42 19.2 306 
Aversive 29 27 119 129 12.8 304 
Laissez faire 39 49 105 104 14.0 297 
Total 300 299 295 311   1205 
`Self-perspective 1 2 3 4 Weighted score Total 
Transformational 213 52 20 18 24.2 303 
Transactional 33 184 41 42 18.4 300 
Aversive 15 17 125 142 11.4 299 
Laissez faire 24 43 107 125 12.8 299 
Total 285 296 293 327   1201 
Note: Rankings 1-4 showing best to least fit from an ‘Organisation’ and ‘Self ‘ perspectives  depicting 
respondent survey choices to eight questions (7-14) for each of the four statements a-d to each question 
representing four leadership styles, including:  a.) Transformational leadership style; b.) Transactional 
leadership style; c.) Aversive leadership style or d.) Laissez-faire leadership style.  There was a total of 44 
respondents with eight questions and four statements with each question (44 X 8 X 4=1408 possible 
responses). However, in certain instances participants did not respond to each question resulting in a 
lower collective count out of the 1408 possible responses. Then a weighted leadership style score was 
calculated as described. 
Source: Qualtrics LLC Survey Reponses and Microsoft Excel analysis 
 
To recall, in the US Pilot Study, the dominant assessment of the organisation was that it 
exhibited a Transactional Style of Leadership, with a dominant Transformational Style of Leadership 
being described by the fewest respondents, although most respondents described themselves (‘Self’) as 
predominantly Transformational in leadership style. In the UK sample, the Transformational Style of 
Leadership was the dominant view of both the ‘Organisation’ and ‘Self’ perspectives.  
Table 18 examines the most common styles identified in responses to the individual questions (which 
map to the eight theories and concepts). Respondents ranked the Transformational Style of Leadership first 
whether their perspective was from an ‘Organisation’ or ‘Self ‘.  In the same regard, the Transactional Style of 
Leadership was ranked second whether their perspective was from an ‘Organisation’ or ‘Self ‘except, with 
respect to Question 12: Employee Mindset  which survey respondents ranked the Laissez-faire Style of 
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Leadership as the second best fit.   
Table 18: Operationalised Responses to Survey Questions-UK Health Organisations-Ranked as 
#1 and #2 Leadership Style 
 
Note: Table 18 depicts the operationalised responses to the survey questions (i.e., questions 7-14) from 
an ‘Organisation’ and ‘Self’ perspective based upon the methodology described in Table 6. This 
approach includes an analysis of the survey data from Qualtrics LLC. The Qualtrics LLC’s survey data was 
downloaded into SPSS and the descriptive statistics for each survey response were calculated and 
analysed. Based upon an analysis of the measures of central tendency of the data, the selected 
leadership styles were colour coded (as depicted in Table 6) and ranked as the best fit (i.e., ranked as 
number 1) and the next best fit (ranked as number 2) to the survey question posed.16  
 
Figures 12 and 13   look in more detail at the distribution of responses to the question relating to the 
Employee Mindset.  
 
 
 
 
                                                          
16 As described by Rea & Parker (2014), the Mode can be best used to describe the most common responses for 
ranked scale data. The Median is the most appropriate measure for categorical ordinal data. However, the Mean 
should also be considered when there are numerical responses to questions. Also, due to the collective consistency 
in leadership styles between the ‘Organisation’ and ‘Self’ perspectives in the UK survey results versus the US Pilot 
Study, additional emphasis was placed on the second ranked perspectives in the analysis of the UK survey results. 
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Figure 12: Organisation’ Perspective-Question 12-Employee Mindset 
 
Note: In Figure 12, leadership styles are depicted aligned with Question 12 regarding Employee Mindset 
[i.e., fixed versus growth] (i.e., ranked 1 to 4 from best to worst fit for respondents. The survey 
respondents stated their ‘Organisation’ perspective (ranked #1-red line) was a Transformational Style of 
Leadership. The Laissez- faire Style of Leadership was favoured as second (ranked #2-green line). 
Source: Qualtrics LLC survey responses and Microsoft Excel analysis 
Figure 13: ‘Self’ Perspective-Question 12-Employee Mindset 
 
Note: In Figure 13, leadership styles are depicted aligned with Question 12 regarding Employee Mindset 
[i.e., fixed versus growth] (i.e., ranked 1 to 4 from best to worst fit for respondents. The survey 
respondents stated their ‘Self’ perspective (ranked #1-red line) was a Transformational Style of 
Leadership. The Laissez- faire Style of Leadership was favoured as second (ranked #2-green line) 
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Source: Qualtrics LLC survey responses and Microsoft Excel analysis 
Figure 14 was created by aggregating the responses by each individual across all leadership 
theories and concepts to identify the leadership style that the respondents placed most frequently in 
first position. It shows the distribution of respondents placing each leadership style in first position 
within each of the six UK health organisations (labelled A-F) included.  
Figure 14: Distribution of first ranked responses by organisation, from ‘Organisation’ and ‘Self’ 
Perspectives 
 
Source: Qualtrics LLC 
This reveals a quite different picture to that seen with the US health organisation. Thus, for 4 of 
the NHS bodies, all, or almost all, respondents reported a Transformational Style of Leadership as 
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dominant when describing the organisation. In contrast, in only one, organisation A, did all respondents 
describe their own style as predominantly Transformational, although in all cases, a Transformational 
Style of Leadership was the single most common style that dominated in their assessment of 
themselves, accounting for over 50% of respondents in all but one organisation, where it was exactly 
50%. 
Figure 15 examines how the entire sample of UK health respondents perceived the styles 
adopted by themselves and their organisations. The most common combination, by far, comprised 
individuals who viewed their own style and that of their organisation as predominantly 
Transformational. A few saw their organisation as Transformational, but themselves as a Transactional 
or laissez-faire Style of Leadership.  
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Figure 15: Comparison of perceptions of dominant styles of self and organisation 
 
Source: Qualtrics LLC 
The value for health innovation of having staff who have a Transformational Style of Leadership 
in an organisation with the same culture is clear. For example, a person with a growth mindset generally 
believes it is beneficial to their career development to learn from their mistakes. In contrast, an employee with a 
fixed mindset is more interested in ‘looking good ‘and may avoid changing situations which may cause them to 
possibly make a mistake (Yan et al., 2014). This has implications for both senior leadership in an organisation, who 
can shape its culture, and for human resource practices, which should seek to attract and retain those with a 
Transformational style.  
  I then explored the data by characteristics of the respondents, with a focus on the following variables 
because of their departure from the otherwise dominant styles of leadership (i.e., Transformational and 
Transactional Styles of Leadership ranked as number 1 and 2, respectively) including: 1.) organisation role; 2.) 
age of respondent; and 3.) tenure of respondents. 
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1.) Organisational Role: 
Table 19:  Operationalised Responses to Survey Questions-UK Health Organisation-Ranked as #1 and #2 
Leadership Style by Organisation Role of Survey Respondents  
 
Note: Table 19 depicts the operationalised responses to the survey questions (i.e., questions 7-14, 
Appendix A) from an ‘Organisation’ and ‘Self’ perspectives based upon an analysis of the survey data 
from Qualtrics filtered according to the organisation role of the survey respondents. The selected 
leadership styles were then colour coded (as depicted in Table 6) and ranked as the best fit (i.e., ranked 
as number 1) and the next best fit (ranked as number 2) to the survey question posed.  [Respondent 
groups by organisation role and related empirically supported leadership theories and concepts are 
not shown where the operationalised style of leadership according to the eight empirically supported 
leadership theories and concepts which are favourable health innovation were the same as the dominant 
leadership style preferences for the UK health organisations as a whole described in Table 18.] 
Source: Qualtrics LLC Survey Reponses and SPSS analysis 
Looking at the role of individuals within their organisation, the only area where the leadership style, 
from ‘Organisation’ and ‘Self ‘perspectives, materially differed from the dominant leadership styles shown 
overall by the UK health organisations (i.e., Transformational and Transactional Styles of Leadership ranked as 
number 1 and 2, respectively) was with regard to Question 12: Employee Mindset.  As discussed previously, this 
result is like the analysis depicted in Table 18 when the overall responses from UK organisations were mapped 
onto the leadership theories and concepts favourable to health innovation.  For example, respondents in a 
managerial leadership role ranked the Transactional and Aversive Styles of Leadership equally as their number 2 
preferences.  
 
Ranked Empirical Supported Drivers of Health Innovation: ...………………………..…..…...Rank Organisation …..………….……….………. ……………………...…..………Rank Self………………………………………..
a.) b.) c.) d.) a.) b.) c.) d.) 
Leadership Style………………………………………………………………… Transformational Transactional Aversive Laissez-faire Transformational Transactional Aversive Laissez-faire
Organisation Role-Executive Leadership:
Question 12: Employee Mindset………………………………………. Ranked As #1 Ranked As #2 Ranked As #1 Ranked As #2
Organisation Role-Managerial Leadership:
Question 12: Employee Mindset………………………………………. Ranked As #1 Ranked As #2 Ranked As #2 Ranked As #1 Ranked As #2
Organisation Role-Professional Specialists:
Question 12: Employee Mindset……………………………………… Ranked As #1 Ranked As #2 Ranked As #1 Ranked As #2
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2.) Age of Respondent: 
Table 20: Operationalised Responses to Survey Questions-UK Health Organisations-Ranked as 
#1 and #2 Leadership Style by Age of Survey Respondents  
 
Note: Table 20 depicts the responses to the survey questions (i.e., questions 7-14, Appendix A) from an 
‘Organisation’ and ‘Self’ perspectives based upon an analysis of the survey data from Qualtrics filtered 
according to the age of the survey respondents. The selected leadership styles were then colour coded 
(as depicted in Table 6) and ranked as the best fit (i.e., ranked as number 1) and the next best fit (ranked 
as number 2) to the survey question posed. [Respondent groups by age and related leadership theories 
and concepts are not shown where the operationalised style of leadership according to the management 
theories and concept s which drive health innovation were the same as the dominant leadership style 
preferences for the UK health organisations as a whole described in Table 18.] 
Source: Qualtrics LLC Survey Reponses and SPSS analysis 
An analysis of responses by age of respondents showed that those aged 45-54 showed a materially 
different leadership style when asked to Question 8: Leader-Member Exchange (LM X) from an ‘Organisation’ 
perspective than UK health organisations overall (i.e., Transformational and Transactional Styles of Leadership 
ranked as number 1 and 2, respectively).  Respondents aged under 35 present a materially different leadership 
style from an ‘Organisation’ and ‘Self ‘perspective from the leadership styles shown overall by the UK health 
organisations for survey Question 7: Psychological Climate; Question 13: Organisational Culture; and Question 
14: Role of the CEO (Appendix A).   
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3.) Tenure of Respondent: 
Table 21:  Operationalised Responses to Survey Questions-UK Health Organisations-Ranked as 
#1 and #2 Leadership Style by Tenure of Survey Respondents  
 
Note: Table 21 depicts the operationalised responses to the survey questions (i.e., questions 7-14 
Appendix A) from an ‘Organisation’ and ‘Self’ perspectives based upon an analysis of the survey data 
from Qualtrics filtered according to the tenure of the survey respondents. The selected leadership styles 
were then colour coded (as depicted in Table 6) and ranked as the best fit (i.e., ranked as number 1) and 
the next best fit (ranked as number 2) to the survey question posed. [Respondent groups by tenure and 
related empirically supported leadership theories and concepts are not shown where the 
operationalised style of leadership according to the empirically supported   theories and concept favourable 
to health innovation were the same as the dominant leadership style preferences for the UK health 
organisations as a whole described in Table 18.] 
Source: Qualtrics LLC Survey Reponses and SPSS analysis 
Looking at the role of duration of tenure at a UK health organisation, respondents who had been with 
the organisation for 1-2 years  differed from the overall picture in responses to Question 7: Psychological 
Climate; Question 8: Leader-Member Exchange (LM X); and Question 14: Role of the CEO  from an 
‘Organisation’ ‘and/or ‘Self’ perspective than the leadership styles shown overall by the UK health organisations 
(i.e., Transformational and Transactional Styles of Leadership ranked as number 1 and 2, respectively).  
Respondents with tenure of 2-5 years present a materially different leadership style from an ‘Organisation’ 
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perspective from the leadership styles shown overall by the UK health organisations for survey Question 7: 
Psychological Climate; and Question 11: Supporting Team Reflectivity. Finally, respondents with tenure of 10 
years or more present a materially different leadership style from an ‘Organisation’ perspective regarding 
Question 14: Role of the CEO.  
 
4.2.3 Qualitative Data Collection 
As described in Chapter 3.1.5: Qualitative Data Collection and Analysis, beginning in January 
2017 through May 2017, 30 interview participants (approximately 23 percent of the 132 UK survey 
participants described in Figure 7) in the sampling frame were randomly selected for a semi-structured 
interview (Appendix F).  
While I selected a slightly higher percentage of interviewees than initially planned, I was 
anticipating some last-minute cancellations because of professional or personal scheduling conflicts. 
When an interviewee could not appear, a representative of the health organisation assisted me to 
identify a suitable replacement often on very short notice. However, there was only one last minute 
cancellation due to a study participant being on-call for a medical matter where a replacement could not 
be identified. Consequently, the total interviews performed were 29 (approximately 22 percent of the 
132 UK survey participants), exceeding the 20 percent specified in Chapter 3.1.5: Qualitative Data 
Collection and Analysis. I am appreciative that the study received such strong receptivity in the UK. 
Of the 29 interview participants, a total of 21 submitted a survey questionnaire and seven 
others started a survey questionnaire and did not submit it. This nested sequential sampling design is 
referred by Onwuegbuzie and Collins (2007) as a “random  purposeful technique” that “selected random 
cases from the sampling frame and randomly choosing a desired number of individuals to participate” 
(p.286). This approach enabled the selection of individuals covering each level of leadership and 
management.  
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The qualitative procedures facilitated the evaluation of non-response bias to the survey (i.e., views of 
non- respondents can be compared to survey respondents) manifested by any meaningful differences 
between the views of these two populations can be analysed.  Based upon the interviews performed, I 
observed the following differences between survey respondents and non-respondents: 
1.) Respondents to the survey instrument disclosed to me that they had more training and/or 
interest in leadership and health innovation. This observation is similar that found by the RAND Corporation 
(2016). This may explain why 17 survey participants just completed the categorical questions and then 
submitted their surveys. As discussed, these individuals did not respond to the leadership style questions (i.e., 
Survey Questions 7-14, Appendix A.).  The element of Leadership Training is described in Table 22. The 
following paraphrased communication and a quote, respectively, from health organisation 
leaders/managers, including; i.)  a non-respondent to the survey who was randomly selected for an 
interview, but did not participate in either; and ii.) a survey respondent who was also an interview 
participant, are representative of this view: 
i. Answer:  I regret, but in reviewing the ‘Information Note’ in preparation for our meeting I 
realize that I do not have the background or training to respond to your questions.  I do not 
want to waste your time or adversely affect your results, so I will decline the kind invitation 
to participate in an interview. Best Wishes (Paraphrased and not quoted). 
 
ii. Answer: “Currently, the University offers Research and Development Courses, particularly for 
the early career Researcher, which I still fall into… I define myself as an early career 
Researcher as I’m …five years post Ph.D., which seems a long time compared to how my 
career was planned…It’s still an early career in terms of what kind of work I’ve been doing; 
so of those Researcher Development Courses, one of those is an introduction to Leading and 
Managing others. This is in the University, and the NHS... has Leadership Programmes.” 
 
2.) Respondents had generally a more cohesive relationship with the organisation and its senior 
leadership. For example, in a CLAHRC with a lower than average response rate (i.e., 12.5% versus an average 
survey response rate of 33.3%), a participant stated that very few professionals were located at or near the 
organisation’s headquarters office but were “dotted about England”. 17These professionals had overlapping 
                                                          
17 Jony Ive was Steve Jobs, Chief Designer, beginning in 1997. He was the lead designer of Apple’s IPod, IPhone 
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responsibilities, as mentioned earlier, and gave attention to other organisations where they performed clinical 
and/or other research duties. As a result, this study participant reported having difficulty getting a timely 
response to letters or telephone calls made on behalf of the organisation. The importance of ‘Group 
Cohesiveness’ is discussed in Chapter 4.1.2: Quantitative Data Collection. 
As previously explained, the interviews performed had two objectives.  The first was to identify 
the ways in which different leadership styles facilitate or inhibit innovation, assessing their influence on 
the four stages of the innovation process described in Figure 2(reproduced again here).   
Figure 2: The Innovation Process 
 
Source: Tidd and Bessant (2013), p.60. 
Consistent with the results reported in Chapter 4.2.2: Quantitative Data Collection, Tables 17 
and 18, the majority of UK interviewees presented a collective Transformational Style of Leadership 
from an ‘Organisation’ and ‘Self’ perspective. This was followed by a collective Transactional Style of 
Leadership.  
The following three interviewee quotes are representative of these views: 
Question: “How would you describe the leadership style of the organisation …?”  
                                                                                                                                                                                           
and IPad and most recently Apple Park, Apple’s new corporate campus in Cupertino, California. He 
commented that “scattering of thousands of Apple employees across more than 100 sites in Silicon Valley had 
rendered more difficult the collaboration necessary for innovation.  ... We’ve done a really good job of working 
around it, but it’s not the way we want to be working nor does it represent our culture well (Passariello, n.d.). 
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Answer: “It’s a mixture because of the numbers of people and the different types of background they are 
involved in in the organisation. So trying to lead Academic Researchers, University Researchers, is a very 
different proposition than trying to lead Senior Managers in the Health Care Organisation. They are just 
used to very different structures in which they work. The … role is very much about leadership, and it’s 
one of the most challenging leadership roles that I have had [and] so very different from being … of the 
University Department... So it’s a set of much dispersed challenges. Some of it is offering …the prospect 
of transformation. For the academics, it’s sometimes setting out what could be, but then offering a 
supportive structure in which they can make the changes themselves…” 
 
Answer:  It’s all about, let’s learn from it and just move on. It’s all part of aspiring to excellence. I try and 
make an environment where I want people to feel safe, I want people to feel valued, I want people to feel 
understood and supported and cared for. Each one of the staff has different needs… inspiration for 
excellence, but within I hope is a caring supporting positive environment. Let people have fun as well…” 
 
Answer: “My staff would tend to be leadership by example. And that’s possible, because as a clinician, I 
worked in the NHS part of my time; I did research the other part of the time at … and so on. So the 
CLAHRC was bringing different disciplines and academia together in a way that I think was very 
powerful.” 
As described in Chapter 2.3.2: Leadership Styles and Innovation, from the ‘Organisation’ and 
‘Self’ perspectives, the Transformational Style of Leadership dominated the collective responses of the 
UK survey respondents. This leadership style would present an inspirational and motivating force to 
achieve success through all four phases of the innovation process as depicted in Figure 2. This is 
especially true if this style of inspirational leadership was accompanied by a pragmatic Transactional 
leadership style. This combination, based upon an empirical study of 267 Columbian workers from a 
variety of industries by Torres, Espinosa, Dornberger, and Acosta (2017) and my observations of the 
participant organisations, could offer an opportunity to more smoothly align the visionary 
Transformational leadership style of leaders/managers with an organisation’s corporate governance and 
regulatory environment (e.g., efficiently establish organisation award and fellowship training 
programmes).  
As described in Table 18, the survey responses, when matched to the eight empirically 
supported leadership theories and concepts included in the survey questionnaire (i.e., Survey Questions-
7-14, Appendix A), consistently presented the Transformational Style of Leadership from an 
‘Organisation’ and ‘Self’ perspectives as ranking first. However, the Transactional Style of Leadership 
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was ranked as second except with respect to the ‘Employee Mindset’, in which the Laissez-faire Style of 
Leadership prevailed from an ‘Organisation’ and ‘Self’ perspective. Further analysis was performed by 
filtering the survey responses by specific leadership theories and concepts according to pre-determined 
respondent categorical nominal variables [i.e., 1.) Individual Respondent: age; sex; organisational role; tenure 
with organisation; and education level achieved; and 2.) Organisation: number of employees] (Mumford et al., 
2002 & Hitt et al., 1997, as cited in Jung, 2003)].   
 The resulting analysis is described in Tables 19, 20 and 21, which noted certain material departures 
from the dominant styles of leadership (i.e., Transformational and Transactional Styles of Leadership ranked as 
number 1 and 2, respectively).  Respondent survey departures from the dominant styles of leadership 
were not noted for categories analysed by sex, education or an organisation’s number of employees and 
were therefore not depicted in the preceding tables. 
These exceptions to the dominant styles of leadership are analysed in Chapter 4.2.4:  Mixed-Methods 
Analysis & Discussion. However, this should not distract from the entrepreneurial terminology used by 
several interview participants in describing their organisation. The most serious departures described in 
Tables 19, 20 and 21, while important to comment upon, were principally among a small percentage 
(less than 10%-Appendix I) of under 35 participants in managerial roles with 1-2 years tenure in their 
organisations. The preceding interviewee quotes regarding the dominant Transformational leadership 
style from an ‘Organisation and ‘Self’ perspectives using entrepreneurial terminology are representative 
of this view: 
Answer: “I think we sort of talked a bit about before that this is sort of quite an entrepreneurial 
organisation… Whereas, I was thinking what you want to do is create an environment which rewards 
innovation and especially doesn’t hurt it….If they are trying their best to improve things, and something 
didn’t quite work, well then the question is what did we learn from this? And then how can we take that 
forward? So we know we don’t need to make those mistakes again, but it’s in hindsight learning and 
what you are trying to achieve. The problem is still there, so we need to do something else. So you 
want…people who try and innovate and overcome these sorts of challenges, and I think that’s the key for 
it. And then it becomes about having enablers which support those people…” 
 
Answer: “I think entrepreneurialism is about supporting and making improvements and innovations and 
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changes in whatever system you work in. Yes, I would say we are entrepreneurial…” 
 
As previously noted, the second objective of the interviews is to assess the extent to which the 
questions in the survey accurately and reliably capture the leadership styles in the organisation, thereby 
contributing to the validation of the survey instrument.  An interesting observation from two of the 
interviewees captured the intent of this objective: 
Answer:  “I thought the survey was very interesting. I had to read it a couple of times before I got the 
scale…I thought it was interesting because it made me start thinking about it before the interview. I 
thought I hadn’t ever thought about my own personal view of what I think it should be like, versus what 
it is, and on some of them, that’s okay. It’s similar, then I go, no, yes, this is not good…” 
 
Answer: “That’s an interesting question. Reflecting back to the actual survey… I was one of the three or 
four who had to click onto the video to help me, because I didn‘t quite get it at first, how you want me to 
write different things. I had to Figure it out, and that was helpful. Those things actually work. They 
impart the knowledge, and I was required to learn it. The video worked, because usually, based on my 
experiences……..”18 
 
Due to the large number of interviews, interview transcription for the UK health organisations 
was performed solely by a reliable third party whom I engaged, shortly after each interview. I then 
coded the transcribed interviews line-by-line using NiVivo 11 and summarized them into themes. The 
themes identified (i.e., listed as Questions 7-14 of the survey questionnaire in Appendix A) from the 
transcribed interviews were consistent with the results of the US Pilot Study (Chapter 4.1.3: Qualitative 
Data Collection), the prior literature searches used to structure the survey instrument, and the initial 
interview questions.  
The interviewees’ confirmed the organisation’s degree of alignment with the eight empirically 
supported leadership theories and concepts favourable to health innovation included in the survey 
questionnaire (Appendix A-Questions 7 to 14); they reliably affirmed the leadership styles associated 
with each of these supported leadership theories and concepts individually and collectively. The 
following interviewees’ quotes are representative of these views. Views of the different interviewees 
                                                          
18 The survey questionnaire included a link to an Internet video I prepared (i.e., screencast.com) to assist 
survey respondents if they encountered any error messages which prevented them from completing the 
survey.  
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are separated by the symbol *: 
Question 7: ‘Psychological Climate’ 
Answer:  “So I think that’s how we operate. So individually, there isn’t a standard thing where if you get 
X number of papers, you get something, if you see what I mean. If you are doing well, we would look to 
support you and give you things to keep you here.”  
Question: “Were his achievements publicized with people outside this room…” 
 
Answer: “Everybody in our team would know.” 
Question:  “Okay, so they saw that … was being pulled along and given opportunities, doors were 
opened for …, because of … achievements. They saw all that.” 
 
Answer:  “Yes, absolutely. I want it clear that I think the thing we have here, if you look at the NHS where 
it’s under so much stress, that sometimes the people in here don’t realize how supportive and how 
unique this environment is which gives them these opportunities…” 
 
************************************************************************************ 
 
Answer: “I don’t micromanage them, but then I’m going to say something contradictory. I mean I think 
the principle is that you’ve got to kind of say to people, the Harvard decent management in our world, is 
to say to people I hired you because I think you are bloody good. Go and do good things and tell me what 
support you need. So that’s the principle…” 
 
Question 8: ’Leader Member-Exchange’ (LMX) 
Answer: “I’m quite comfortable with unmanaged structures, so to some extent, I think that you kind of 
want to try to inspire people with a way of thinking, being fully aware that that sounds great, but with 
some people, it doesn’t work, it doesn’t take. But quite a lot of the time, I think if you can inspire people a 
bit, although some operations will turn into a complete disaster, the total is much more than the sum of 
its parts. So I believe that you can actually get a huge amount more by trusting people than by close 
management.” 
 
*********************************************************************************** 
 
Answer: “So at the moment, I have identified a couple of coaching needs for my staff in two  
areas. Then it’s really down to my initiative to locate those and do that. Sometimes, I think the 
Leadership is enabling people to do that. My Manager is very good at saying, think about what you are 
doing and what you take on; how does that fit for you? So I feel encouraged and supported in that way, 
which to me is good Management as well as Leadership. It’s really difficult…Then sometimes giving that 
room for people to take their initiative and develop their leadership skills on their own; self-Leadership, if 
you like, as well as other Leadership [styles]. So they are two different things to me as well. At least it’s 
very multifaceted.” 
 
Question 9: ‘Social Capital’ 
 
Question: “Interesting. Is there anything else that I have not brought up which you think is important to 
driving Innovation in your field?”  
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Answer: “Partnership. Being ready to partner. “ 
 
Question: “Are you referring to collaboration?”  
 
Answer: “Yes…”  
 
Question:  “When you say partner, give me a little bit more detail with that.” 
 
Answer:  “Being open to working with people or organisations that will have a very different 
perspective.” 
 
Question: “Private sector for instance? “ 
 
Answer:  “…So I think that’s one thing, bridging the gap, but that wasn’t actually what I was thinking 
about. I was thinking about wider learning, developing our learning and therefore, Innovation; by 
thinking about, listening to, struggling with ideas from other sectors.  It may be private, as I’m not just 
talking about the public private partnership; I’m talking about the mention before any disciplinary 
partnership. So it might be the time we need to be listening to ideas from engineers or accountants, and 
thinking about their methods. “ 
 
***************************************************************************** 
 
Question: “Do you reach out to the private sector much?” 
 
Answer: “We do, yes. That’s one of things actually the NIHR, our funding body, would like us to do. For 
example, at the moment I am working on collaboration with a potential client, nothing is fixed yet, 
around going to get some software that we are working on from a third party. It doesn’t make sense for 
us to become a third-party developer.” 
 
Question 10: ‘Leadership Clarity’ 
 
Question: “If you had to choose one management driver that motivates these people to give their best, 
would it be for instance just creating an environment that they feel safe in, that there is support for, that 
they know they are going to be rewarded for their efforts, or is it other things? Is it opening up 
opportunities for them to obtain conferences, meet other people…? “ 
 
Answer: “I think it’s a mixture of all of it. It’s to have a clear vision.” 
 
Question:  “Clarity of vision, you might say.”  
 
Answer:  “So I think it’s a clear vision about why we exist and a very clear vision about what this unit’s 
about. We can talk about my research or we can talk about the department; but in spite, why do we 
exist? Why do we think the work’s important? What’s the goal of the work? But we are going to be 
excellent. So that everything comes from that clarity. This is really important work and we are going to 
do it to the best of our possible ability…” 
 
 
************************************************************************************* 
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Answer: “Yes, that’s quite clear when our mentoring process stops and the minute it goes on for external 
funding, we’ve lost control over that, but we don’t lose sight of it…it’s about talking to clinicians, it’s 
about talking to service managers, in the NHS or in the private sector to ensure that we research the 
right question at the start; and that’s absolutely important, …But one of the things we will be looking 
right from the start is getting the patients involved; patients who are elderly, perhaps, who already 
experienced it and say, would you wear that device? Would you pay for that device? How much would 
you pay for it?’ All that kind of thing, because there’s no point us going any further if they turn around 
and say, ‘no we wouldn’t wear it,’ so what is the point?” 
 
Question 11: ‘Organisational Reflectivity' 
Questions: “Do they come back and share the results of an outside meeting?” 
 
Answer: “You mean like my visit to …, for example, did I share that with the team?” 
 
Question: “Yes…” 
 
Answer: Yes, we do that. So, again, probably not as consistently as would be ideal, but given the busy 
schedules that the team has, I think we have managed that quite well. So most of the time, when people 
go away on a conference or an organized study trip like the one last week, we do a brief item on our 
team meeting which is every …. Every … for an hour, we have a team meeting with the whole team which 
is about 35-40 people.  In that meeting, we will hear back from them…” 
 
Question 12: ‘Growth versus Fixed Mindset’ 
 
Answer: …”I suppose that’s one of the roles that I had in the processes of trying to switch the lights on for 
them in relation to what the groups are that you are going to have to get engaged... So anyway, in this 
pathway model, the getting everyone around the idea of mocking up a model, you know, arrows, and 
here, this is what it’s going to be, and the model is thinking, I’ve got to go away and get the data for 
these things, do we have it? All that stuff is going on. You have the emergency people in there and then 
you have the stroke physician people, and it outed the emergency physicians who just didn’t think … 
technique worked. The reason they didn’t think it, was because it was some years before that some much 
esteemed person had come and told them, oh, it doesn’t work. You’ll hear some stuff about this, but it’s 
nonsense. Nope, it’s clearly wrong. Now the really beautiful thing about this story is that because you 
had the stroke physician, now all those emergency people know him, but they don’t see him very much; 
the consultants.  But, they know him and respect him. He was able to understand that this barrier to the 
whole thing getting better was that these guys just don’t think it works. So he then addresses that. But 
my point is that if we hadn’t set out with the idea of building a model of the pathway in order to make it 
quicker, we wouldn’t have found that out. We wouldn’t have sorted that out. So here’s what we 
accomplished.” 
 
Question: “There was a fixed mindset locked into incorrect evidence…” 
 
 
 
Answer: “…I don’t think it’s that transparent of an organisation. We do have quite a hierarchical 
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leadership style where…. “ 
 
Question: “Let me ask you, and this is true in many research groups that I’ve worked at, there is a 
tendency to have what I call top down leadership… Then they wonder why there is a lot of turnover. One 
organisation I had studied had 5 presidents of this organisation in 9 years. You know something is wrong. 
The board, not the president, who are not clinical people for the most part, are running this organisation, 
saying which project you are going to work on. Everything was driven by return on investment. The 
clinical people were to fall line, march to this drummer, or leave; and what was going on, was like a 
revolving door, not just at the personal level, but the top leaders of the different groups. From … groups 
to medical groups, they were all going too soon, and their key people were going too soon. So there was 
this top down, forced; while this gets us the best return investment, therefore, you do this. How is this 
group different from that?”  
 
Answer: “So I think there is a lot of top down push here for sure. I think the big difference is actually that 
there is a lot of buy in into the top down push, because it’s almost…we jump when the director or the co-
director says something. Oh, we have to get this deliverable; okay, then we all have to do it. I think often 
that’s really detrimental because people are working on other things that are…..” [Emphasis added] 
 
Question: “They’ll drop what they are working on.” 
  
Answer:  “Exactly. So I think there’s a buy in almost; they do it, but I wouldn’t say there’s like almost an 
emotional buy in. That sounds weird, but…” [Emphasis added] 
 
 
Question 13: Organisation 'Culture' refers to the values and beliefs which set the expectations for 
innovative behaviour 
 
Answer: “I can’t say I’ve cracked it. I would say that the way I deal with it, is this incredibly micro Level; in 
that, for example, when I’m with interesting people literately at the individual level, you meet people 
whom you want to bring in because they are really impressive. It’s about a one to one conversation. 
Everybody’s view, politely or not… It will literally be one to one conversation with researchers whenever 
we have regular, probably quarterly, lunches for new staff. Then we have regular bi-annually socials for 
everyone...” 
 
Question: “That’s part of your Culture, you might say?” 
 
Answer: “Yes, that’s part of the Culture. To all of those, not only are the messages reinforced, but we use 
it very much as a listening exercises…” 
 
Question 14: ‘Senior Leadership’s Impact’ 
Answer: “…I found it a very interesting and persuasive business, and one of the things that most clearly 
resonated with me was that if you want to get evidence used, it seems to me a reasonable hypothesis 
that a close engagement with the people who might use the information might be a pretty good starting 
place for engagement while you generated the evidence. That was a bit of the conclusion of the 
Commission which says, look, what we need is a closer partnership between the people who know what 
the questions are, which would be the kind of people at the end delivering services, and the people who 
do the research who can’t know how to answer questions, but tend to go and answer questions that they 
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are interested in rather than which are important. So we decided that we would try to produce a model 
which actually took that seriously…” 
 
************************************************************************************* 
Answer: “They were already performing quite well; but actually, what they seemed to have wanted was 
stability of a leader, a stability of a team that had really built relationships across working, which again 
added complexity, I think when you start to have different departments that have to work together, to 
me that gets more complex. I think where it didn’t hold up so well is, and I’ve heard other stories, that 
this is where you have a Leader but they are not there; they are not going to be there necessarily for the 
long haul…” 
 
As described in Chapter 3.1.5: Qualitative Data Collection and Analysis, the interview schedule 
explored in more depth the questions asked in the survey, ensuring that meanings were clear, before 
obtaining concrete examples of how leadership characteristics impact on the work of the organisation and, 
in particular, its ability to innovate.  A second element of the interview process focused on situations in 
which innovation has been facilitated or impeded and why. The 29 UK health organisation interviewees 
(views of different interviewees are separated by the symbol *) discussed barriers and facilitating 
situations in connection with leadership of health innovation, including: 1.) Leadership Training; 2.) Role 
of Bureaucracy; 3.) ‘Capture’ Phase of the Innovation Process; 4.) Health Organisation Competition and 
Conflicting Incentives; and 5.) Recruitment and Retention of Millennials-Aged 35 and under. 
The following interviewee quotes are representative of the UK study participants’ views 
regarding the preceding barriers and facilitating situations: 
1.) Leadership Training: 
Question: “What role does training play in health innovation leadership…?”  
 
Answer: “Vitally important. It’s really integral. In fact, in all my major roles, whether it’s head of 
a department, officer of a CHALRC, or a Clinical Research Network (CRN), training is amazingly 
important for many reasons; to upscale the work force, to increase morale, to engage people, to 
stimulate people and to make people believe that they can be part of making the system that 
they are in better, also to stretch people. So we do again, where we’ve always been pretty 
innovative in our training to the extent that the courses which we offer immediately outstrip 
demand and supply. Actually, already within a year, often new courses found that we couldn’t 
meet the demand; because we first started off by going out and asking people what do they 
want, but no interest in replicating what is already out there.  
 
Over my career, there will be a continuum of different courses that fit into that framework. With 
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respect to leadership, I’ve received all kinds of different answers on this one. I’m not trying to 
surprise you with this, I’m just telling you. For instance, the Health Foundation has an 
outstanding Leadership programme because I’ve met some of the people, but that’s for a few 
good people. Eventually, you are going to ask researchers to lead something in their career 
which may include small leadership roles at first, but then maybe quite large, and maybe with a 
big budget attached to it. What Training do they receive over their careers that would prepare 
them for assuming that kind of responsibility? It’s incredibly ad hoc. There are loads of national 
bodies, but they are all different, whether or not you get NIHR to do a leadership programme or 
other health organisation... There are scores of leadership programmes. What’s ad hoc is 
whether or when you get on them, and that’s dependent on your own productivity and the 
productivity and interest of your line manager. However, I also need to say that I am skeptical 
about the value of some of these leadership programmes. I think they are incredibly diverse and I 
think that they do not, in my …experience, tailor the programme to the very different ways that 
people learn and respond. For example …lecture might be great for some people and role play 
might be great for others. Group learning might be great for some, one on one might be better 
for others. In my experience, they are not tailored. I think the amount of value you get out of it 
might amount to one or two little plums from a forest of information and guidance. …Anyway, 
it’s about the tailoring of them, so I’m not convinced at all [of the value of many of these 
courses]. For example, the reason I talked on a recent programme was actually doing a favour 
for a colleague who I really respected and didn’t want to let down. I would never block anyone 
going on one, but what I’ve said to people before …look at it really carefully and decide which 
one you want to go on; whether it would suit your individual needs and …your time. Anyway, I’ve 
said enough about my view of Leadership Programmes.” 
 
******************************************************************************** 
Answer: “…Okay, but if I was going to be radical…, I would say your completion shouldn’t be we 
need more training, or we need any training. If we are going to use lessons from a Deloitte, or 
whoever’s like them, not necessarily do we have to get rid of people, but you need to be more 
ruthless about appointing people into posts where they have the skills to do it. So forget the 
training, basically; all the good people I know are not necessarily trained, they just either have it 
or they don’t. I suppose that’s a belief I have made with my fixed mindset. But training can help a 
bit.” 
 
 
Question:  “In all your training to date, has anybody or any course ever tried to teach you how to 
lead or manage?”  
 
Answer:  “Oh yes, as a doctor, yes, but not as a researcher.” 
 
Question:  “Let’s go back to your role as a doctor. What kind of leadership training did you 
receive then? “ 
 
Answer: “In the UK, before you become a consultant, you have to go on healthcare management 
and leadership courses, two courses. “ 
 
Question: “They have an Academy through the NHS?” 
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Answer: “Yes, exactly.” 
Question: “That is a long term programme. There are courses that lead all the way to your senior 
role. Do you feel at this point if they would suddenly come to you and say “We want you to lead 
this organisation,” would you say you are prepared to do that? “ 
 
Answer: “No, not at all.” 
 
Question: “What additional training do you think you need in your career that would prepare 
you to do this?”  
 
Answer: “What we as doctors generally get is a week course here and a week course there. As 
[there] a lot of things they can teach you go through a whole programme for a year. Generally, I 
would find the time for that, but I think actually it is worthwhile. It’s not that these week courses 
aren’t good, they are good, but they are just too short to learn [leadership of health innovation] 
properly”. 
 
2.) Role of Bureaucracy: 
 
Question:  “Yes, it’s hard to deal with. The last thing I wanted to bring up is… the different layers 
within an organisation… you need to work your way through ….for instance, I was at a cancer 
institute in America with one of the leading researchers. I’m talking to this man who has worked 
in this field for 30 years. He’s trying to find a cure for Cancer, but I looked at his desk and he had 
all this paperwork, his desk looked like it belonged to an accountant. He had vouchers that he 
was signing for people for travel, he had all kinds of accounting stuff on his desk, and I asked him 
what he was doing. He said… this is 20-30% of what I do. He’s not working on a cure for Cancer; 
he’s working on something for the Accounting Department. “ 
 
Answer: “The operational day to day stuff. “ 
 
Question: “Yes. And the question is, is there a need in a research environment to construct the 
bureaucracy in a more user friendly way? …. “ 
 
Answer: “Is anyone going to say no to that?” 
 
Question: “I don’t know.”  
 
Answer: “We are desperate for it.”  
 
*************************************************************************** 
 
Question: “Now this is something I understand because I’ve worked a whole career with financial 
people, and they are usually intelligent, and you have to make them part of the mission. Then 
they have to redesign the processes, not around what’s convenient for them, but what’s 
convenient for the people who are actually doing the work. “ 
 
Answer: “Yes. I agree with that.” 
3.) Health Organisation Competition and Conflicting Incentives 
 
DRPH THESIS                                                                                                                     116 
 
Question:  “Do you find your activities… at this organisation overlap the AHSNs and AHSCs a 
bit?” 
 
Answer: “I think they can and they do often, because what we do is pulling from the evidence out 
there of what is needed to be done. I think other people do that too, and often our project ideas 
are from the ground up, so multiple groups of people will recognize if the service isn’t running 
properly. So I think yes, you will get lots of different people trying to work on the same problem 
with slightly different …approaches. “ 
 
Question: “Since there is an overlap, do you see yourself really collaborating with …group? If 
they had a group in …, would you be collaborating with them? “ 
 
Answer: “So to be completely honest, I think we want to appear as though we are collaborating, 
but there is still an element of feeling competitive. I think there are …other organisations…you 
want to help, but you actually want to maintain that you’ve made this change, because you are 
accountable to others for any of the improvement. So it’s great to say you’ve shared in some 
learning, or shared in some activity; but actually, ultimately you want the result to be yours. 
Anything in Academia, it’s a bit better known, because you know, intellectual property; you want 
to keep it within your organisation. I think it feels weird actually, because you want to be sharing 
all this and saying we are just doing this for the greater good, but that’s not the reality of what 
actually happens a lot of the time.”  
 
****************************************************************************** 
Answer: “… we have …different masters, maybe four if you Figure …. I kind of think my master is 
my patient generally… But obviously, directly, I have to account to NIHR for money.  I have to 
account to the … because this [organisation] is primarily employing people in the University… 
and …, I have to account to partner organisations who are mostly NHS Organisations.” 
 
 
Question:  “There is an AHSN so you collaborate with them because their job is to take it, scale it 
up and push it out the door [to the population]?” 
 
Answer:  “Yes, for better or for worse, the AHSNs, AHSCs and the CHALRCs across England 
coincide geographically. …If I’m honest, the way those …different organisations were set up 
could have been clearer. They come from different masters, as Dept. of Health. “ 
 
Question:” That’s true, different funding.”  
 
Answer:  “While they are not quite the same in their remit, they are pretty similar. So CLAHRCs, 
the emphasis is on, okay, here’s the knowledge we have; how do we get that out to benefit 
people? Whereas AHSCs [and AHSNs], I think is a bit more business.” 
 
 
4.) ‘Capture’ Phase of the Innovation Process (Figure 2-How are we going to Benefit from it) 
 
 
Answer: “I think it might be helpful to have a national organisation that picks the best of what 
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the CLAHRCs, [AHSCs and AHSNs] are doing, and then decides to roll that out nationally. I’m not 
sure all the preceding organisations collaborate on quite a lot of stuff; it doesn’t seem that [they 
are regularly] spreading each other’s Ideas and Innovations into other areas. My understanding 
through … is that we’ve had quite strained relations with certain AHSNs; as I’m not sure the top 
leadership got on quite well and I don’t think we have any particular collaboration. I’m not 
certain my Team has been working with these health organisations.” 
 
 
Answer:  “That’s the big thing, because the barrier you come across is exactly what you just said. 
So you have an idea, you go to one person in Contract, they send you to another person in IP 
[Intellectual Property], this units; and then they say well, where’s your money? And we go, well, 
we don’t have the money, because we have to bid for the money. So you go around in circles. I 
mean, there are now some of these Innovations Hubs; the AHSNs are now supporting some of 
these Innovation Hubs and this, that, and the other. They are great, and they’ve moved us on 
from where we have been. But they are for the people who are really… who are a bit savvier, and 
know what they are doing; but there are so many people out there who could have Innovations, 
who could have smaller Inventions, who could develop these, and those are the people who are 
struggling. So yes, it’s great to have these Innovation Funds that are out there, and that’s one 
avenue; but you have to spend a few months writing your bid for them again, and where do you 
get the capacity for that?...” 
 
Answer: “But we [in the UK] still are much siloed here; so it’s still, we are the medical model, we 
are the Social Scientists, we are the….and …Business School, it’s very rare to get everyone 
working together on the solution, and because of your measures as well. Who measures…who 
are we funded by, who measures our outputs, and who measures success?” 
 
Answer: “Well, again it’s this thing about collaboration. So you are funded by an 
AHSN, you are measured again on outputs of the AHSN. How do we collaborate with the other 
AHSNs? Again, that’s the part of the missing link. Individually, if we know about them, we may 
have a personal relationship with them; and there is no formal mechanism of say, let’s all come 
together for ... So, for example, there isn’t a formal mechanism that then says, we have done this 
in one AHSN; where are all the other people who have done …Health work? Let’s bring this all 
together. We developed that for the CLAHRC ourselves and we actually recognized the gap; and 
we said why are all the CLAHRCS doing different research around the country in …Health? We 
have no Forum to discuss what we are all doing…. Again, …we haven’t done this.” 
 
Question: “Well, you do have a Forum. If I go to the Web, there is a Forum that looks like all 15 
AHSNs are under the same umbrella.” 
 
Answer:  “They are all under the same umbrella, the Directors at the Top of the Chairs, or 
whatever, will go to a meeting, but that’s not the same as the people leading the projects. Like 
you said, bring everyone together who has been left out, and have them all in one room. We 
haven’t all, under our specialty area across the Country contacted….” 
 
 
 
Answer:  “Yes. This isn’t really my area. The financial, the industry side of things is  
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something I’ve not really had much contact... I mean the issues that we are running up against is 
that the University contracts people who we have to work through, and are not very familiar 
with dealing with that kind of….They are used to the concept of like a spin-off company from a 
pharmaceutical side of things which tends to be quite big. Most of the stuff the CLAHRC does is 
much smaller and is often not about a physical product, but it might be about a way of doing 
something.  It is often a process rather than a thing. And they seem to struggle getting their 
heads around it… At the moment, we’ve had our hold ups of being with getting contracts 
produced by them that we are then able to use, to work with. Our… has been asking them for a 
Standard Model Contract that we can then use. From where’ve I’m sitting, it feels like it’s  
something that ought to be done at a more central level by the NIHR for use by all of the groups 
that it funds, because they’ve got some really serious experts who work for them on some of this 
stuff. If they could produce a standard model that basically says if you are funded by us, you 
should be using….because there are about four or five different contracts that they use to fund 
various groups. They have a slightly different contract with the… than they do for Universities to 
other Groups. They could produce a similar sort of model for at least a template contract for 
taking …forward, and some guidance on what they would expect to get back out of it…” 
 
 
5.) Recruitment and Retention of Millennials-Aged 35 and under19 
 
Answer:  “I think that’s a massive problem for healthcare and because of the cultural change, a 
lot of these younger entrepreneurial people are leaving really quickly. They don’t even hang on 
for four or five years. They are out as soon as they are qualified within a year or so, you know 
which is a massive drain to the [health] System and loss of knowledge.”  
 
Each of the preceding five elements discussing barriers and facilitating situations ultimately 
impact upon ‘Group Cohesiveness’. The positive relationship of organisation performance to ‘Group 
Cohesiveness’ was discussed in Chapter 4.1.2: Quantitative Data Collection.  A complete study of the 
dimensions of ‘Group Cohesiveness’ is beyond the scope of this thesis. However, the matter of ‘Group 
Cohesiveness’ will be discussed again in Chapter 5: Discussion of Collective Results. Also, I believe the 
subject of ‘Group Cohesiveness’ is deserving of additional research to generate a full discussion of its 
likely implications to leadership of health innovation and an organisation’s innovation capacity.   
                                                          
19 While there are varying definitions of the term, Millennials, it is a widely- held belief this term applies 
to people born in the early 1980s to the mid-1990s. At the time this survey was performed, beginning 24 
November 2016 to 10 June 2017 in the UK (Figure 7), the oldest millennial survey respondent in this 
study would have likely been under 35. However, it is possible a participant may have turned 35 during 
the latter part of the survey period and was included with the 35-44 age respondent group. The US Pilot 
Study, which commenced in June 2016, had no survey respondents under 35 (Appendix I).  
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4.2.4 Mixed-Methods Analysis & Discussion 
The integration of the results of quantitative and qualitative approaches with respect to the UK 
Health Organisations included in this study is depicted in Table 22; “a follow-up results joint display” as 
described by Creswell (2014a, p. 84). This summary of the results of the UK health organisations in this 
study will then be further analysed and compared to the summary of results of the US health 
organisation subject to the limitations of this study and discussion in Chapter 5. 
Table 22: A Follow-Up Joint Display of Mixed-Methods Results-UK Health Organisations  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DRPH THESIS                                                                                                                     120 
 
 Table 22: A Follow-Up Joint Display of Mixed-Methods Results-UK Health Organisations 
(Cont’.d) 
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Table 22: A Follow-Up Joint Display of Mixed-Methods Results-UK Health Organisations (Cont’.d) 
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Chapter 5 Discussion  
 
5.1 Discussion of Findings 
 
At the outset, I posed one main question and one subsidiary question. 
1. Do the styles of leadership adopted by leaders/managers in organisations charged with 
innovation in the health sector in the UK align with leadership theories and concepts 
empirically shown to encourage innovation? 
2. How do the leadership styles adopted by leaders/managers in these UK organisations compare 
with those seen in an organisation adopting similar roles in the US that many of them aspire to 
emulate? 
The first research question, on the collective leadership styles of leaders/managers of the UK 
and US health organisations (ranked as ‘1’) and their alignment with the leadership theories and 
concepts empirically shown to encourage innovation is addressed in Tables 23 and 24. 
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Table 23: Operationalised Responses to Survey Questions-Comparison of UK and US Health 
Organisation Leadership Styles from an ‘Organisation’ Perspective 
 
Note: Table 23 depicts the comparative operationalised responses to the UK Health Organisation and US 
Pilot Study survey questions (i.e., questions 7-14, Appendix A) from an ‘Organisation’ perspective based 
upon the methodology outlined in Table 6. This approach includes an analysis of the survey data from 
Qualtrics LLC. The Qualtrics LLC’s survey data was downloaded into SPSS and the descriptive statistics for 
each survey response were calculated and analysed. Based upon an analysis of the measures of central 
tendency of the data, the selected leadership styles were colour coded (as depicted in Table 6) and 
ranked as the best fit (i.e., ranked as number 1) to the survey question posed.  
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Table 24 Operationalised Responses to Survey Questions-Comparison of UK and US Health 
Organisation Leadership Styles from a ‘Self’ Perspective 
 
Note: Table 24 depicts the comparative operationalised responses to the UK Health Organisation and US 
Pilot Study survey questions (i.e., questions 7-14, Appendix A) from a ‘Self’ perspective based upon the 
approach methodology outlined in Table 6. This approach includes an analysis of the survey data from 
Qualtrics. The Qualtrics LLC’s survey data was downloaded into SPSS and the descriptive statistics for 
each survey response were calculated and analysed. Based upon an analysis of the measures of central 
tendency of the data, the selected leadership styles were colour coded (as depicted in Table 6) and 
ranked as the best fit (i.e., ranked as number 1) to the survey question posed.  
 
As can be seen, the UK health organisations collectively present a Transformational Style of 
Leadership, from an ‘Organisation’ and a ’Self’ Perspective (ranked as ‘1’). With respect to the 
Innovation process described in Figure 2, this leadership style aligned with the eight empirically 
supported leadership theories and concepts discussed in this thesis (from an ‘Organisation’ and ‘Self’ 
perspectives) would present an opportunity to achieve success through all four phases of the innovation 
process  (i.e.,’ Search’, ‘Select’, ‘Implementation’ and ‘Capture’ phases) as discussed in Chapter: 1.1.2: 
The Innovation Process, Chapter 2.3.2: Leadership Styles and Innovation and Chapter 4.2.3:Qualitative 
Data Collection, respectively (Figure 2 is reproduced again here).  
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Figure 2: Innovation Process 
 
Source: Tidd and Bessant (2013), p.60 
The second research question is also addressed in Tables 23 and 24, which reveals the stark 
contrast in leadership styles presented by the US health organisation from an ‘Organisation’ perspective.  
It demonstrates a dysfunctional set of leadership styles from an ‘Organisation’ perspective, ranging from 
Transactional to Aversive to Laissez-faire.  As a consequence, the US health organisation appears to face 
more challenges than the UK health organisations to drive health innovation through the four phases of 
the innovation process depicted in Figure 2.  
As discussed in Chapter 1: Introduction and Chapter: 4.1.2: Quantitative Data Collection, the 
‘Organisation’ perspective would appear dependent on the ‘Context’ (i.e., operating environment) and 
‘Group Cohesiveness’ in which the leaders/managers function. Even in the event that the US health 
organisation had depicted a Transformational  ‘Organisation’ perspective, there is still no guarantee that 
adhering to the eight empirically supported leadership theories and concepts shown to be favourable to 
health innovation will lead to the predicted results under all circumstances.  That is, the ‘Context’ and 
‘Group Cohesiveness’ of the US health organisation must be taken into consideration as well as the ‘Self’ 
perspective of the leaders/managers (Figure 17). 
In this instance, the ‘Self’ perspective of the leaders/managers is critical to the innovation 
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process. Respondents to the US Pilot Study presented a Transformational Leadership Style from a ‘Self’ 
perspective identical to that in the UK health organisation participants depicted in Table 24.  As 
described in Chapter 4.1.3: Qualitative Data Collection, the participants from the US health organisation 
reported that they were able to overcome the barriers to innovation placed in their way by senior 
leadership. As previously discussed, I observed that the leaders/managers of the US health organisation 
and the staff reporting to them appeared to have modified their behaviour to adapt to its operating 
‘Context’. However, there was a cost to the organisation and the study participants possessing a 
Transformational Leadership Style from a ‘Self Perspective’ operating in a dysfunctional organisation 
‘Context’. One aspect was evidenced by my observations regarding employee turnover. As described in 
Chapter 4.1.2: Quantitative Data Collection, the US health organisation had 5 interim and full-time 
presidents since 2007, as well as recent turnover in other senior administrative and division/department 
leadership. This profound lack of alignment between the ‘Organisation’ and ‘Self’ perspectives presents an 
opportunity for intervention, but also a stressful environment to function, possibly contributing to the observed 
turnover. 
The stressful nature of the operating environment of the US health organisation and the lack of alignment 
in ‘Organisation’ and ‘Self’ leadership styles in ‘Context’ and ‘Group Cohesiveness’ may explain the 
resignation of its CEO approximately seven months after the study was completed. Of particular note, it 
was reported that the resignation was prompted by a petition signed by approximately 30 physicians. It 
was also reported that another 100 physicians or more within the organisation wanted to sign the 
petition, but were afraid to do so fearing harsh retribution (Reporter, 2017). This would seem to be a 
realistic concern, given that the organisation presented an Aversive leadership style from an 
‘Organisation’ perspective in Table 12 with respect to the role of the CEO. 
As discussed in in Chapter 4.1.2: Quantitative Data Collection, the responses to survey questions 
according to pre-determined characteristic variables (Appendix I) showed   that approximately 71% of the US 
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health organisation respondents had over 5 years tenure, including approximately 43% of the 
respondents with over 10 years of tenure versus 49% and 13%, respectively, in the UK health 
organisations as depicted in Table 15.  This finding suggests that the US organisation had greater ‘Group 
Cohesiveness’ than the UK organisations and, therefore, potential for higher innovation capacity as 
described in Chapter 4.1.2: Quantitative Data Collection. However, there also may be a negative side to 
this finding with respect to the US organisation.  
As described in Table 15, the US organisation had no survey respondents with less than two 
years tenure or under the age of 35 (Appendix I). In contrast, approximately 20% and 10%, of the UK 
health organisations’ respondents had tenure of two years or less and were aged under 35 years, 
respectively.  My discussions indicate that the University recognizes that these younger people 
represent the future, as potential leaders of innovation, as is also recognised in many similar 
organisations in the USA and the UK.  However, subject to the limitations of this study, the findings of 
this study show a range of leadership styles ranging from Transactional to Aversive and Laissez-faire 
from a collective ‘Organisation’ perspective, which appears to be an issue which goes beyond just the 
recruitment and retention of Millennials. These findings may pose challenges to the US health 
organisation’s senior leadership in the recruitment and retention of innovative leaders/managers and 
staff, while affecting the overall innovation capacity of the organisation today. 
A discussion of the many implications of the ‘Context’ of an organisation and ‘Group 
Cohesiveness’ to leadership of health innovation are beyond the scope of this study. However, certain 
barriers and facilitating situations of ‘Group Cohesiveness’ are described in Tables 14 and 22 of 
Chapters: 4.1.4 and 4.2.4 Mixed-Methods Analysis & Discussion, respectively. These barriers and 
facilitating situations are further discussed in Chapter 5.2: Barriers & Facilitating Situations, including: 1.) 
Leadership Training; 2.) Role of Bureaucracy; 3.) Health Organisation Competition and Conflicting 
Incentives; 4.) ‘Capture’ Phase of the Innovation Process; and 5.) Recruitment and Retention of 
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Millennials-Aged 35 and under.  
5.2  Barriers & Facilitating Situations 
 
1.)  Leadership Training 
 
UK and US interviewees described the need for leadership training to prepare leaders/managers 
to successfully navigate through the four phases of the innovation process (i.e., ‘Search’, ‘Select’, 
‘Implementation’ and ‘Capture’ phases) depicted in Figure 2. As described by Aarons et al. (2015), 
leadership  for “Organizational Change for Implementation(LOCI)” [training] was supported to be a 
feasible solution for preparing leaders/managers to efficiently lead an evidence based practice (p.1).  
Aarons et al. (2015) described a relatively small pilot mixed-methods study of first level mental 
health service team leaders/managers.  However, this rigorous study was intended, in addition to 
supporting the feasibility of LOCI, to establish interest in future research rather than be generalized as a 
‘one size fits all answer ‘to a larger population desiring to improve their leadership skills. As a result, the 
study helped contribute to the importance of leadership training as a strategy for improving the 
innovation capacity of a health organisation. 
Based upon the interviews performed, it was clear that there is a plethora of innovation 
leadership fellows’ programmes and courses/seminars sponsored singly or in joint ventures by the NHS, 
AHSCs, AHSNs and other private/public organisations (e.g., NHS Innovation Accelerator20 [NIA] fellows), 
although not necessarily known and/or available to all researchers I interviewed. However, a number of 
these programmes are relatively recent, although they do more than discuss leadership principles and 
leadership of health innovation and assist innovative individuals to ‘Implement ‘and ‘Capture’ the value 
of their ideas.  
                                                          
20 As part of the approval of the relicensing of the AHSNs in July 2017, the NHS Board  assigned the 15 
AHSNs the responsibility for coordinating the Innovation Exchange model in connection with the 
Accelerated Access Review(NHS England, 2017, 6 July). 
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These recent programmes were developed in response to the recognised need in the UK to 
drive health innovation to promote “Health & Wealth” as described by as described by NHS England 
(2011, December 5) . For example, “…the NIA supports exceptional individuals with a passion for learning 
and a commitment to share their learnings widely, scaling evidence-based innovations for greater 
patient benefit…”(England, n.d.).  According to the UK interviewees, the NHS ‘Leadership Academy’,  
performs its mission of  improving the NHS’ customer service and meeting community needs well 
(Storey & Holti, 2013). However, as also pointed out by my UK interviewees, people learn differently and 
at a different pace.  
To respond to the comments by the interviewees that leadership programmes should be more 
widely promoted, suitable and cost effective, I recommend the NHS establish (possibly with partner 
organisations), an online clearing house of leadership programmes accessible by cell phone or computer 
with a concise course description by experience level and grouped alphabetically according to category, 
including21: 
a.) Course ratings on a recognized ranking scale based upon a stated number of actual 
participants who have completed the courses and the period used including student 
testimonials (AHSC Interviewee, Personal Communication, June 16, 2017); 
 
b.)  Links to online demonstration videos of actual classes held which is common to many 
online graduate programmes in the US; 
 
c.) Documentation of a standardized curriculum development process. For example, the 
alignment of the individual course competencies, course outcomes and learning objectives 
should be developed for the course modules for each of the courses to be presented. 
Courses should be placed into a pathway in order for Leaders/managers/students to 
determine their appropriateness (College of Public Health, Department Chair, Department 
of Health Policy & Management, personal communication, July 21, 2014); 
 
d.) A syllabus should be developed and available online for each course that is based on the 
alignment of the individual course competencies, course outcomes and learning objectives 
                                                          
21 Based upon the interviews performed, I recognize that certain organisations may have individually 
implemented certain parts of the recommendation outlined herein (e.g., instructor ratings on a 
recognized ranking scale).  The name of the individual/organisation in the personal communications was 
changed in the interests of confidentiality. 
. 
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referred to above. The syllabus should also incorporate a course schedule and policies and 
procedures which will govern each course including how students will be assessed and 
grading rubrics, if applicable (College of Public Health, Department Chair, Department of 
Health Policy & Management, and Instructional Designer, personal communications, July 21, 
2014); 
 
e.) Individual (anonymous) student assessments (i.e., ratings) of the instructor(s) and the 
course material should be submitted at the conclusion of each course, collected and 
available to prospective students (Interviewee, Personal Communication, June 16, 2017); 
and 
 
f.) A helpline, FAQs and an application with instructions should be available online for each 
course. Also, financial and time commitments should be clearly stated (College of Public 
Health, Department Chair, Department of Health Policy & Management, and Instructional 
Designer, personal communications, July 21, 2014). 
 
 
2.) Role of Bureaucracy 
The interviewees in the US and UK recognized the necessity of a bureaucracy to deal with the 
process of documenting activities and various administrative actions. However, there was a general 
agreement that some, but not all the people tasked with these duties understood their role was to first 
make the organisation run effortlessly, while complying with good governance practices.  
Based upon my observations and experience, the role of bureaucracy in health organisations 
included in this study could be broadened and made more user friendly than observed, including: 
a.) Organisation members should be initially given an orientation course that they are to be of 
service to their customers (e.g., researchers) and then kept well-informed of changes in the 
organisation’s and related researchers’ mission, vision, values, and project time-lines. 
b.) Each health organisation’s bureaucracy cannot expect to have all the answers to every 
question posed, but a central location for answers should be established. Whether this is 
done at an individual organisation level or collaboration among health organisations. In 
particular, certain questions regarding expertise required can be anticipated based upon the 
innovation process depicted in Figure 2 (e.g., legal contracts and negotiation; sources of 
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funding and application process; stakeholder contacts and relationships; engineering and 
design).  
3.) Health Organisation Competition and Conflicting Incentives 
As discussed in Chapter: 1.1.3: Innovation in the NHS, while the Health and Social Care Act 2012 
“sought to strengthen the role of competition within the health system, NHS organisations are now being 
told to dampen the competition and collaborate to plan and provide local services…(Alderwick et al., 
2016 ), pp.7- 16.   This is an interesting comment as competition is often viewed positively. However, 
regarding innovative health organisations, the interviewees confirmed that this competition had led to 
health organisations researching the same health issues and duplicating efforts. The result of this 
practice is wasting time and resources and encouraging a lack of collaboration delaying the delivery of 
needed health innovations to the public. 
This competition appears partially motivated by the funding and regulatory measures that each 
organisation must adhere to in order to have their funding or license renewed. In other words, 
researchers find themselves trying to please multiple masters, each with a different set of reporting 
requirements. Also, some researchers confronted by these myriad measures and conflicting incentives 
simply give up and the health innovation process ends before beginning the ‘Capture’ phase of the 
innovation process depicted in Figure 2. 
The NHS comment regarding encouraging collaboration is not likely in itself to eliminate 
competition without addressing the core issues driving it. Nor will the NHS be able to influence all 
sources of competition.  For example, there will always be competition for funding sources that impose 
different conditions, such as those from foreign or private sources outside the NHS. However, I 
recommend the NHS should commission a study, as soon as practical, to identify and collect the many 
variables impeding collaboration among health organisations. Based upon an analysis of the study 
results, the NHS should host a meeting of representatives of health organisations and other 
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stakeholders to discuss the results, solicit their feedback and develop a plan of action.  
4.) ‘Capture’ Phase of the Innovation Process 
Based upon the analysis described in Table 26,to improve the ‘Capture’ of the organisational 
benefits of the health innovation strategy in the UK, including achieving  “Health & Wealth” as described 
by NHS England (2011, December 5); I suggest the NHS should address each of the preceding 
recommendations (i.e.,  Leadership Training; Role of Bureaucracy; and Health Organisation Competition 
and Conflicting Incentives). 
The NHS has recognized the need to improve the ‘Capture’ phase of the Innovation process 
depicted in Figure 1. In an independently chaired report supported by the Wellcome Trust (GOV.UK, 
2016, 24 October), a detailed ‘Framework’ for implementing Accelerated Access Review (the 
‘Framework’) was presented to the NHS for implementation .  For example, it recommends detailed 
pathways for each of three innovative product groups including: 1.) pharmaceuticals; 2.) medical 
technology and diagnostics; and 3.) digital health. In addition, an ‘Accelerated Access Partnership’ is 
recommended be established to bring together all the main organisations involved with healthcare in 
the UK, the Department of Health and other stakeholder groups to “improve the coordination across the 
innovation pathways” (p.20). The ‘Framework’ also makes high level recommendations regarding 
training of clinicians and addressing conflicting incentives.  
To facilitate the implementation of the Framework’s recommendations, the NHS published ‘The 
NHS England Innovation and Technology Tariff 2017 to 2019 Technical notes’. “It  sets out the innovation 
themes, specifications, reimbursement and reporting requirements” for product innovations under the 
Accelerated Access Review (NHS England, 2017, 9 May). Based upon discussions with interviewees, the 
implementation of the ‘Framework’ is continuing and will likely take considerable time and effort before 
the NHS receives the intended benefits of an improved ‘Capture’ phase.  
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The actions of the UK government in health research and innovation are consistent with the 
view expressed by Mazzucato (2015) regarding the State’s role in promoting innovation. As described by 
Mazzucato (2015), the UK government is doing more than creating a national system for innovation; it is 
leading the process. For example, the Department of Health and Department for Business, Energy & 
Industrial Strategy announced new funding of up to £86 million to “speed up access to new medicine and 
technology by supporting business to develop and test their innovations” thereby visibly putting the 
State and the public’s money and trust behind improving the ‘Capture’ phase of the innovation process 
(GOV.UK, 2017 14 July) . 
Mazzucato (2015) explains that the US government assumes most of the risk in the early stage 
of innovations with the private sector sitting on the side lines because of the risk of uncertainty (i.e., a 
high failure rate) involving early stage start-up ventures. She cited examples of companies, including 
Apple Inc., which integrated technologies into their products proven solely by government funding and 
created billions in wealth for its shareholders.  
In the private US healthcare system, such an approach may be acceptable and expected where 
the government takes the risk, but the large benefits fall on the private sector which adapts proven and 
therefore lower risk innovations. While it appears that the NHS may have the included the recovery of 
their investment in their commercial arrangements with early stage innovators, it is not apparent 
whether the NHS will share and to what extent, if any, in the later stage equity appreciation of the 
supported early stage innovations. While a complete discussion, of these often complex financial 
arrangements, is beyond the scope of this study, I recommend that this matter be researched further in 
connection with the implementation of ‘Accelerated Access Review.’ 
Finally, several the interviewees’ expressed to me that many of their innovations are small and 
involve improving specific health processes rather being identifiable products that would neatly fall into 
the ‘Framework’s’ three product review pathways. While the NHS’ recent initiatives discussed herein are 
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exciting and needed, a pathway for these more numerous smaller health innovations should be added 
to the added to the ‘Framework ‘to improve the ‘Capture’ phase of the innovation process for most 
health organisations. 
5.) Recruitment and Retention of Millennials-Aged 35 and under 
As discussed in Chapter 4.2.2:Quantitative Data Collection and Chapter 5.1:Discussion of 
Findings, the study’s findings regarding the recruitment and retention of Millennials-aged 35 and under, 
may pose serious challenges for the organisations in each country.  
As described by DePass (2016, 14 June), the 3M Company ranked first in the US, in a national 
survey ,as the most preferred workplace for Millennials.  Among, the top ten workplaces for Millennials 
in the National survey were St. Jude Children’s Research Hospital, Mayo Clinic and two major US 
government agencies. Thus, dispelling the view I learned from certain interviewees that health and 
especially public organisations cannot compete in the recruitment and retention of Millennials.  
Of particular interest, DePass (2016, 14 June) reported the remarks of 3M Company CEO Inge 
Thulin regarding his views why 3M Company, a $30 billion multi-national corporation, headquarters in 
Minneapolis, Minnesota, would be an attractive workplace for Millennials. Mr. Thulin’ s explanations 
included: 1.) 3M’s sustainability projects and its three-to-12 month leadership development program; 
2.) 3M’s commitment to geographic, linguistic and ethnic diversity; 3.) senior administrative leadership, 
‘represents many races and countries around the world”; and 4.) 3M’s 15% Rule as discussed in Chapter: 
2.3.1: Leadership Theories and Concepts Relevant to Health Innovation, “which allows scientists and 
product makers to spend 15 percent of their time on projects of their choosing”. Mr. Thulin summed up 
his remarks by stating: 
“Our 15 percent culture is fantastic for these individuals… That is what that this group is looking 
[for]. They want to go to a place where they can look and see diversity in the management, 
sustainability and environmental goals [up held], and freedom. Lastly, they want to know they 
can make a difference. And they can and do.” 
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While a complete study of the recruitment and retention of Millennials is beyond the scope of 
this study, I would recommend that the NHS and the other members of the ‘Accelerated Access 
Partnership’ begin a dialogue with the senior leadership of the 3M Company and the other organisations 
among the top 25 on this national survey as a starting point for a complete research study of this barrier 
to health innovation. 
5.3  ‘Leadership Framework’  
 
As discussed in Chapters: 4.1.4 and 4.2.4, Mixed-Methods Analysis & Discussion, the combined 
results of this study were used to develop a feasible and practical ‘Leadership Framework’ depicted in 
Figure 16. This ‘Leadership Framework’ can be used by an organisation to determine the leadership 
styles of health leaders/managers aligned with eight theories and concepts used in this thesis.  
 
Figure 16: Leadership Framework for Health Innovation 
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The components of the’ Leadership Framework’ for Health Innovation are referenced 
numerically in Figure 16 and explained below: 
1.) Senior administrative leadership’s support for health innovation is evidenced by their active 
participation in the ‘Leadership Framework’. As discussed in this thesis, the support of 
senior leadership of each organisation is deemed essential for the ‘Leadership Framework’ 
to be successful. For example, only where I could obtain the support of the senior leadership 
of an organisation was it included in this study (Box 1). I contend that such support is 
essential to focus attention of busy health organisation team members in participating and 
giving the survey their serious attention. Consistent with the proposed ‘Accelerated Access 
Partnership’ discussed in in connection with the ‘Capture’ phase of the innovation process, 
the possible participation of representatives of the governance and regulatory structure and 
associated stakeholders is also contemplated. 
2.) To execute the ‘Leadership Framework’ process, there is a strong argument for a 
‘Management Innovation Team’ to be formed. Serious thought needs to be given to the 
people assigned and the authority delegated to this team. This is critical if the ‘Leadership 
Framework’ is to be implemented efficiently while maintaining the confidence and trust of 
all participants. For example, the team should have a representative of the human relations 
area (HR) to ensure all ‘available’ organisation leaders/managers participate, including 
participants beyond first level executives. A representative of senior administrative 
leadership should also be included on the team with the delegated authority to engage 
third-party organisations to ensure individual survey results are anonymous. 
3.) The recruitment process of ‘New Hires’ should include the completion a confidential survey 
questionnaire to determine if their leadership style is aligned with the eight empirically 
supported leadership theories and concepts discussed in this thesis. For ease of use and to 
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avoid any inordinate delays in the recruitment process, it is recommended that the survey 
questionnaire be included in an APP. The building of an APP to host the ‘Leadership 
Framework’ (i.e., on a mobile device that could be downloaded by an organisation recruit 
and/or a web-site), is beyond the scope of this study. However, the APP should include: 
a. An application using iOS or other operating system could be developed for all 
common commercial products for downloading on all iPhone, iPad and other 
devices; 
b. An Android application for download on all android phones and devices; 
c. A proprietary web-site with identical functionality; 
d. An administrative portal where the organisation can assign the survey 
questionnaire, view the results and view the statistical data displayed in a table 
format and/or in multiple graphs; 
e. A portal for the survey questionnaire taker to complete/submit the survey 
questionnaire and later view the results, if permitted by HR; and  
f. The capability of comparing all survey results to a scoring grid and/or compare it to 
statistical data from prior survey participants anonymously. 
The use of Apps to access data and other information over the Internet has been shown to be an 
effective means of delivering certain elements of the information required to deliver appropriate 
healthcare.  For example, Bullock et al. (2015) described an intervention involving 125 newly qualified 
doctors in Wales. The doctors were asked to access medical textbooks using an App. The study results 
supported that the timely access to technical knowledge and data advanced the development of these 
doctors. In addition, the doctors demonstrated their ease of use of the App, particularly in front of their 
colleagues in the workplace, improving over the 12 month intervention period. As described by Canedo, 
Graen, Grace, and Johnson (2017), Millennials show a preference for the use of Apps versus traditional 
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paper based practices in the hiring process. Further, Millennials desire to work for organisations that 
align with their values and as a consequence would likely appreciate the introduction of what may 
termed by some as ‘cutting edge electronic technology’ as well as the purpose of the ‘Leadership 
Framework’ App in the hiring process.  
 
 
4.) – 7.) Existing Organisation Managers/Leaders; Anonymous Surveys; Analysis of Survey 
Results; and Intervention Programmes 
 
To ascertain the collective leadership styles of an organisation and operationalise the results by 
the eight theories and concepts used in this thesis, the ‘Management Innovation Team’ should provide 
the App described previously for ‘New Hires’ to each manager/leader in the organisation. However, in 
this instance, there should be no personal identifier associated with an individual’s survey results (i.e., 
an anonymous survey). If feasible and practicable to encourage the participation of all leaders/managers 
in the survey process, an independent third-party firm with an established reputation should be 
engaged to perform the survey and collect the data. The survey process should encompass the 
procedures described in Chapter 3.1.2: Survey of Leadership Styles; Chapter 3.1.3: Components of the 
Survey Plan; and Chapter: 3.1.4-Quantitiative Data Analysis. The aim of this survey process is to 
ascertain the leadership styles of leaders/managers of health organisations charged with driving 
innovation and assess how these adopted styles align with the eight theories and concepts. The 
objectives should include using the collective results to benchmark the innovation capacity of the 
organisation, identify areas for improvement, and monitor the ongoing innovation capacity of the 
organisation. 
5.4  Contributions of the Study 
 
I have reflected on the contributions of my research to the furtherance of improving leadership 
of health innovation and building innovative health organisations. As discussed, there has been a paucity 
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of research regarding leadership of health innovation.  
As reiterated by several the study participants in the UK, this is an exciting time to be working 
with the NHS. The UK government is doing more than creating the organisation structures necessary to 
drive health innovation, it is leading the process. This study showed, with respect to the participants in 
this study, the leaders/managers of UK health organisations presented a collective (i.e., ranked as first or 
best fit in the survey questionnaire, Appendix A) Transformational Style of Leadership from an 
‘Organisation’ and ‘Self’ perspective.  This positive leadership style was aligned with the eight leadership 
theories and concepts identified earlier. Consequently, it would appear the UK appears to have the right 
leaders/managers to lead health innovation.  However, this study also emphasized that the combination 
of a positive Transformational Leadership Style and the eight leadership theories and concepts alone is 
no guarantee of success in the leadership of health innovation.  
The study identified several issues which could derail this road to success in health innovation. 
First, it discussed the subject of ‘Group Cohesiveness’.  For example, the CLAHRC and AHSN 
organisations are subject to five year license renewals.  This repeated renewal process may help to 
explain why the US health organisation’s leaders/managers have worked together for a longer period 
(i.e., more years of tenure in their organisation positions) than the UK health organisations. This is 
concerning because ‘Group Cohesiveness’ has been shown to be related to organisation performance. 
Second, the study also identified departures from the dominant UK style of leadership shown in the 
surveys (i.e., the Transformational leadership style). This occurred when the leadership styles of 
participants from an ‘Organisation’ and ‘Self’ perspectives aligned with the eight leadership theories and 
concepts were operationalised according to the categorical variables tested in this study. Of particular 
note were the ‘Organisation’ and ‘Self’ perspectives of study participants aged under 35 years 
(Millennials). It is evident that this generation represents the future of health innovation in the UK and 
the US, but organisations in both countries showed they faced challenges in retaining and recruiting 
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Millennials. Third, the interviewees in the UK (some of whom mirrored the comments of interviewees in 
the US health organisation) identified five barriers and facilitating situations in connection with 
leadership of health innovation, including: 1.) Leadership Training; 2.) Role of Bureaucracy; 3.) ‘Capture’ 
Phase of the Innovation Process; 4.) Competition and Conflicting Incentives; and 5.) Recruitment and 
Retention of Millennials-Aged 35 and under. Fourth, the preceding issues culminated in seven 
contextually appropriate recommendations on the basis of theory and empirical evidence, if considered 
and acted upon by the NHS and individual health organisations, may contribute to keep the UK health 
organisations on the road to success in leadership of health innovation.  
Only limited comparisons were made with the US health organisation, because, contrary to 
what was expected when selecting it, it presented a dysfunctional set of leadership styles from an 
‘Organisation’ perspective, ranging from Transactional to negatives styles of leadership including 
Aversive to Laissez-faire.  I believe that, because the US study participants presented a collective 
Transformational ‘Self’ perspective and ‘Group Cohesiveness’, they were able to adapt their behaviour 
to this difficult organisational ‘Context’. Consequently, they were able to progress through the 
innovation process successfully, but under stress.   Their ‘Group Cohesiveness’   was later demonstrated 
when they joined together to remove the senior administrative leadership they felt was the cause of 
their dysfunctional ‘Organisation’ perspective. 
I feel that this study also showed the importance of considering both the ‘Organisation’ and 
‘Self’ leadership style perspectives of an organisation’s leaders/managers not just at the senior 
administrative leadership level, but through as many organisational levels as practical. Again, while the 
UK and US comparisons were limited for the reasons stated, the comparisons provided insight by 
showing that the ‘Self’ leadership style perspective may be able to overcome a dysfunctional 
‘Organisation’ leadership style perspective, at least in the short-run. Therefore, the leadership of health 
innovation and the building an innovative health organisation is an iterative process involving the 
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considerations as depicted in Figure 17, whereby , the organisational ‘Context’ (e.g., operating 
environment) and ‘Group Cohesiveness’ of an organisation’s leaders/managers charged with driving 
innovation must also be simultaneously taken into consideration with the leadership styles from the 
perspectives of the ‘Organisation’ and ‘Self as aligned with the eight theories and concepts. Finally, I was 
able to propose a ‘Leadership Framework’ that is a feasible, affordable, and practical tool that health 
organisations could use in-house to determine the leadership styles of health leaders/managers and 
their alignment with eight empirically supported theories and concepts will best drive much needed 
health innovation. 
5.5  Study Limitations 
 
This study should be interpreted considering its limitations, including the following: 
1.) As described in the Methods section, this study used a cross-sectional survey design by a single 
researcher to determine a  pattern of leadership style(s) from respondents’ answers to 
questions linked with the eight leadership theories and concepts. A longitudinal study performed 
over a number of years, by a research team, may have resulted in different quantitative and 
qualitative results due to changes in the ‘Context (e.g., a changing operating environment due to 
changes in economic, political and social conditions) leaders/managers experience and the 
added research team leadership perspectives. 
2.) There are a limited number of leadership studies within the healthcare sector, and even less 
on senior leadership and innovation   (Goffin & Mitchell, 2010; Ovseiko et al., 2014; Weberg, 
2009; M. West et al., 2015). Therefore, had more studies of health innovation leadership been 
performed in the past it is entirely possible additional leadership theories and concepts supporting 
health innovation leadership may have been identified.  
3.) There was a lack of existing survey questionnaires that could test the alignment of leadership 
styles adopted by health organisation leaders/managers with the eight leadership theories 
DRPH THESIS                                                                                                                     142 
 
and concepts. Accordingly, this required me to develop a survey questionnaire to 
accomplish the aim and objectives of the study. As described in this thesis, the reliability and 
validity of the survey results were tested. However, the survey questionnaire has not been 
be subject to exhaustive testing by different researchers over a lengthy period of time as 
have other survey questionnaires that are narrower in scope  [e.g., Bass and Avolio’s 
Multifactor Leadership Questionnaire [MLQ-Form 5X] as described by Antonakis et al. 
(2003)]. 
4.) In the quantitative phase of this mixed-methods study, a two-stage purposive sampling 
framework was used which affects and therefore limits the generalizability of the study 
results to other health organisations not included in the study. In the UK, the first stage 
sampling frame was purposive and initially comprised the entire set of AHSCs, AHSNs and 
CLAHRCs as described in Appendix E. In the second stage, for each organisation participating 
in the study, I created a sampling frame, to the extent feasible and practicable, comprising 
all employees holding leader/manager roles. I used the organisation’s organogram, 
organisation directory or web-site descriptions to create a matrix with axes based on tiers 
within the organisation and functions.  However, I selected organisations only where I could 
obtain the support of the senior leadership. As a result of the sampling frame used, the 
number of health organisations included in the study and the sample size of the resulting 
study participants, may have omitted organisations/participants. If other organisations were 
subject to testing, these organisations may have reported results that differed from those 
described in this study. As the survey instruments were sent electronically through the 
Qualtrics LLC web-based system, response rates were negatively affected as reported by 
Rand Corporation in a 2016 survey of similar health organisations in the UK(RAND 
Corporation, 2016).  
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5.) The qualitative phase of this mixed-methods study used a nested sequential sampling design.  
Approximately 20% of the study survey participants were selected for a semi-structured 
interview regardless if they responded to the survey instrument or not. While the study 
participants were selected at random, no statistical inference can be drawn from this 
approach. Selected interview participants declined the researcher’s invitation or were later 
unavailable to be interviewed after initially accepting. Substitute interview participants were 
purposefully selected, if feasible. However, in one instance, substitution was not possible 
(i.e., last minute cancellation due to a study participant being on-call for a medical matter). 
6.) The responses to survey questions were anonymous. I considered this approach necessary 
to encourage survey respondents to participate in the survey. However,  this has been 
known to lead to ‘socially acceptable’  responses (Bernard et al., 2007). I sought to explore 
this tendency in the qualitative phase of this study. However, there was no indication of a 
strong desire to be ‘socially acceptable’ despite the pressure felt by some study participants 
as continuation of the funding of certain organisations was approaching the end of a 5 year 
budget period as discussed in Chapter: 4.1.4 Mixed-Methods Analysis & Discussion. 
 
5.6  Further Research 
 
I have summarized, in Table 25, suggestions for further research arising from this thesis that 
may have implications to leadership of health innovation. 
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Table 25: Further Research 
Thesis Chapter(s) Areas for Further Research  
Chapter: 4.1.2 
Quantitative Data 
Collection; Chapter 
4.2.3: Qualitative 
Data Collection 
 
 
Chapter: 
1Introduction 
Chapter: 4.1.4 
Mixed-Methods 
Analysis & Chapter: 
Discussion; Chapter: 
6.1: Summary  
 
 
Chapter 5.2: 
Barriers & 
Facilitating 
Situations 
 
 
Chapter: 4.2.3 
Qualitative Data 
Collection; Chapter: 
4.2.4 Mixed-
Methods Analysis & 
Discussion; Chapter: 
5.1 Discussion of 
Findings; Chapter: 
5.2 Barriers & 
Facilitating 
Situations; Chapter: 
6.2 Study 
Recommendations 
 
Chapter:5.3‘Leader-
ship Framework’ 
1. Group Cohesiveness- As Group Cohesiveness is linked with organizational 
performance, I believe the subject of Group Cohesiveness is deserving of 
additional research to generate a full discussion of its likely implications to 
leadership of health innovation and an organisation’s innovation capacity. 
 
 
 
2. Organizational Context-A complete discussion of the implications to leadership 
of health innovation regarding the ‘Contexts’ of an organization are beyond the 
scope of this study. As discussed, leaders/managers need to consider the 
organizational ‘Contexts’ in which these leadership theories and concepts are 
applied. 
 
 
 
 
3. NHS Equity Participation in Early Stage Innovations-NHS may have included the 
recovery of their investment in their commercial arrangements with early stage 
innovators, however, it is not transparent whether the NHS will share and to 
what extent, if any, in the later stage equity appreciation of the supported early 
stage innovations.  
 
4. Recruitment and Retention of Millennials-While a complete study of the 
recruitment and retention of Millennials is beyond the scope of this study, I 
would recommend that this should be the subject of a major project to 
understand how their aspirations, expectations, and motivations differ from 
those of previous generations and thus how they can best be recruited and 
retained as they will be key to health innovation. Also, noted in Table 26: Study 
Recommendations for NHS policy consideration. 
 
 
 
 
 
 
 
5. ‘Leadership Framework’- A partial use of the ‘Leadership Framework’ is included 
in Table 26: Study Recommendations for NHS policy consideration, only with 
respect to the formation of a ‘Management Innovation Team’ and the use of a 
confidential survey questionnaire to determine the leadership styles of ‘New 
Hires’. It is suggested the full implementation of the ‘Leadership Framework’ 
and development of an App to support its complete organisational 
implementation be subject to further testing in a variety of research 
organisations and under different operational Contexts. 
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Chapter 6 Policy Implications 
 
6.1 Summary  
 
Subject to the limitations discussed in Chapter 5.5, and the need to draw on further research on 
certain issues, as set out in Chapter 5, the following tentative conclusions could be drawn regarding the 
collective leadership styles of leaders/managers of the UK and US health organisations participating in 
this study and their alignment with the eight leadership theories and concepts.   The UK organisations 
presented a collective Transformational Style of Leadership both from an ‘Organisation’ and ‘Self’ 
perspective (i.e., ranked as ‘1’).  As discussed, this bodes well for the successful completion of the four 
phases of the innovation process described in Figure 2. However, the US health organisation presented a 
collective dysfunctional ‘Organisation’ perspective ranging from ranging from Transactional to Aversive 
to Laissez-faire.   I formed the view that the US study participants presented a collective 
Transformational ‘Self’ perspective and demonstrated ‘Group Cohesiveness’ so that they were able to 
adapt their behaviour to the organisational situation. As a consequence, they were able to progress 
through the innovation process described in Figure 2 successfully, but under stress.    
The overall results of this study show that building an innovative health organisation requires 
attention to the leadership styles of an organisation’s leaders/managers, supported by leadership 
theories and concepts that have been shown to encourage health innovation. This study presents a 
‘Leadership Framework’ in Chapter 5.3: ‘Leadership Framework’, to enable leaders/managers to put the 
preceding discussion in this thesis into action.  However, as also discussed in this thesis, a focus solely on 
developing a positive leadership style and aligning the eight theories and concepts among an 
organisation’s leaders/managers is no guarantee of success in innovation. As I have also discussed, 
building an innovative health organisation is an iterative process as depicted in Figure 17, whereby the 
organisational ‘Context’ (e.g., operating environment) and ‘Group Cohesiveness’ of an organisation’s 
DRPH THESIS                                                                                                                     146 
 
leaders/managers and staff charged with driving innovation must also be simultaneously taken into 
consideration.  
Figure 17: Discussion of Research Study Collective Results: The Components of Building 
An Innovative Health Organisation 
  
 
6.2 Study Recommendations for Policy Consideration 
 
Contextually appropriate recommendations based on theory and empirical evidence are 
summarized in Table 26. 
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Table 26: Study Recommendations 
 
 
Recommendations and Researcher’s Comments 
Chapter 5.2 
Barriers & 
Facilitating 
Situations 
(Recommendations 
1-5 for the NHS) 
Recommendation 1: Develop an online clearing house of leadership training 
programmes accessible by cell phones or computers, including concise course 
descriptions and target audience, in terms of roles and experience. This should draw 
on the research on organisational ‘Context’ and ‘Group Cohesiveness’ mentioned in 
Chapter 5. 
Comment: There is a myriad of different leadership training programmes available in 
the UK, US and Europe. However, whether these courses clearly describe the 
competencies, learning outcomes and objectives that fit the career needs of each 
team member in different health organisation and their preferred manner of 
learning is not always clear. 
 
Recommendation 2: The NHS should commission a study, as soon as practical, to 
identify and analyse the many variables dampening collaboration among health 
organisations, including competition and conflicting Incentives. This too should draw 
on the research on organisational context proposed in Chapter 5. Once the findings 
are available the NHS should convene a meeting of representatives of different 
organisations and other stakeholders to solicit feedback and develop a plan of 
action.  
Comment: In this instance, the competition appears partially motivated by the 
funding and regulatory measures that each organisation must adhere to in order to 
have their funding or license renewed. In other words, researchers find themselves 
trying to please multiple masters each with a different set of measures. Also, some 
researchers confronted by this myriad of measures and conflicting incentives simply 
give up and the health innovation process ends before beginning the ‘Capture’ 
phase of the innovation process depicted in Figure 2. 
 
Recommendation 3: The role of bureaucracy in innovative health organisations 
should be subject to detailed scrutiny, with a focus on how it can support rather 
than impede innovation. This should be informed by the research mentioned in 
Chapter 5 on organisational ‘Context’ and, especially, given their growing role in the 
workforce, the expectations of Millennials, who use technology in a quite different 
way than their predecessors. 
Comment: The interviewees in the US and UK recognized the necessity of a 
bureaucracy to deal with the process of documenting activities and various 
administrative actions. However, there was a general agreement that some, but not 
all the people tasked with these duties understood their role was to first make the 
organisation run effortlessly as well as in accords with good governance practices. 
Also, there is a strong case for a central contact point for researchers to obtain 
answers to their questions especially regarding the scaling up of innovations, 
fulfilling the role of a “help desk”. 
Recommendation 4: I would recommend that the NHS and the other members of 
the ‘Accelerated Access Partnership’ begin a dialogue with the senior leadership of 
the 3M Company and the other organisations among the top 25 in a national survey 
in the recruitment and retention of Millennials-aged 35 and under, as a starting 
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point for a complete research study of this barrier to health innovation. Again, this 
should be informed by the research on Millennials proposed in Chapter 5. 
Comment: The study’s findings pointed to the recruitment and retention of 
Millennials-aged 35 and under as an issue for today and the future.  This issue may 
pose considerations for the US and UK health organisation’s senior administrative 
leadership regarding the improving innovation capacity of a health organisation. 
 
Recommendation 5: While the NHS’ recent initiatives discussed herein are exciting 
and needed, a pathway for these more numerous smaller health innovations should 
be added to the added to the ‘Framework ‘to improve the ‘Capture’ phase of the 
innovation process for the majority of health organisations. 
Comment: My interviewees repeatedly stated that many of their innovations were 
small and more than likely related to a quality process improvements which may 
directly affect the wellbeing of patients. It is important not to lose the ‘Capture’ of 
these innovations because they do not fit a predetermined pathway. 
 
Chapter 5.3 
‘Leadership 
Framework’ 
(Recommendations  
6-7 for UK Health 
Organisations) 
Recommendation 6: To ascertain the collective leadership styles of an organisation 
and operationalise the results by the eight theories and concepts favourable to 
driving innovation, organisations should consider creating a ‘Management 
Innovation Team’ as described in the ‘Leadership Framework’, with an evaluation 
built into its implementation. 
Comment: Of course, implementation of this recommendation may vary 
considerably depending on the size and complexity of the health organisation. The 
‘Management Innovation Team’ could be in an existing department in an 
organisation or a special task force. However, while the research in this thesis 
suggests that such a model could be effective, it will be essential to evaluate it in 
practice, and in particular to explore the role of Context, asking not just “does it 
work?” but “in what circumstances does it work?” 
 
Recommendation 7: The recruitment process of ‘New Hires’ should include the 
completion a confidential questionnaire to determine their leadership style aligned 
with the eight theories and concepts discussed in this thesis. For ease of use and to 
avoid any inordinate delays in the recruitment process, it is recommended that the 
survey questionnaire be included in an App. 
Comment: Building an innovative health organisation is not an overnight process. 
‘New Hires’ are the building blocks of an innovative organisation. 
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Chapter 7 Conclusion 
 
The overarching aim of my study has been to ascertain the leadership styles of health 
leaders/managers of organisations charged with driving innovation in the UK (the primary focus of this 
study) and a selected high-performing comparator in the US. I then sought to assess how these adopted 
styles align with empirically supported leadership theories and concepts considered most likely to drive 
much needed health innovation from an ‘Organisation’ and a ‘Self perspective of the study participants. 
With respect to the UK participants in this study, the leaders/managers, at multiple levels of 
responsibility in six health organisations, presented a collective Transformational Style of Leadership 
from an ‘Organisation’ and ‘Self’ perspective.   
This positive style of leadership inspires the accomplishment of the mission/vision/values in the 
health organisations studied and bodes well for the successful completion of all four phases of the 
innovation process (searching for opportunities, selecting, and implementing, and capturing benefits) 
within the NHS.  However, as also discussed in this thesis, a focus solely on the leadership style of health 
organisation leaders/managers and the alignment with the eight theories and concepts is no guarantee 
of success in health innovation. Building an innovative health organisation is an iterative process where 
the organisational ‘Context’ (e.g., operating environment) and ‘Group Cohesiveness’ of an 
organisation’s leaders/managers and staff charged with driving innovation must also be simultaneously 
taken into consideration.  The implications of organisational ‘Context’ and ‘Group Cohesiveness’ to 
successful health innovation was also noted for further research. 
Based upon the research performed, including a discussion of the barriers and facilitating 
situations in connection with leadership of health innovation, seven contextually appropriate 
recommendations were proposed for policy consideration to improve health innovation within the NHS 
including a ‘Leadership Framework.’ As described in this thesis, the ‘Leadership Framework’ is a practical 
tool that health organisations could use in-house to determine the leadership styles of health 
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leaders/managers and their alignment with eight empirically supported theories and concepts to best 
drive much needed health innovation.  
My hope is this study can lead to improving the leadership of health innovation and the building 
of innovative health organisations. Thereby, making a contribution to reducing the estimated 17 years 
required to translate scientific discoveries into health actions in the UK and US (Brownson et al., 2006; Morris 
et al., 2011).  
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Chapter 8 Integrating Statement 
 
In September 2014, I enrolled in LSHTM’s DrPH Programme (the “Programme”) with the 
principle objectives of: 1.) improving upon my prior experience, education and training in leadership and 
management; 2.) acquiring skills in applying the evidence base for public health outcomes to the 
formation of policy; 3.) learning effective techniques for communication of public health policies to 
health organisations and policymakers; and 4.) raising the level of my knowledge with respect to the 
preceding objectives so I could confidently assume a senior public health leadership role in an 
organisation in the private or public sectors. I believe I have achieved these objectives. As explained in 
this integrating statement, this achievement was due to a variety of factors including:  
a.) outstanding course instructors, instruction materials and opportunities to apply what I have 
learned;  
b.) the exceptional and timely guidance provided by my supervisor, Professor Martin McKee, 
and members of my advisory committee; and 
 c.) the knowledge gained from my fellow research degree students and research study 
participants. 
The Programme is divided into the following three components: 
1.) Taught Component. This part of my studies was critical to successfully completing the 
Organisational and Policy Analysis Project (OPA) and Research-based Thesis components of the 
Programme.  
The Taught Component included the ‘Evidence based Public Health Policy & Practice Module 
Session’ (EBPHP) and the ‘Understanding Leadership, Management & Organisations’ Module Session 
(ULMO).   
The EBPHP course was focused on getting research evidence into policy and practice. The 
course’s objectives included:  
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a.) developing an understanding of the relationship between research and policy/practice; 
 b.) critically evaluating published evidence; 
 c). viewing cost-effectiveness and cost-benefit studies;  
d.)  ethnography and interviewing techniques; and 
 e.) performing a systematic literature review.  
 For example, the skills acquired in my EBPHP course enabled me to perform a literature review 
for my thesis which identified leadership styles and their implications to health innovation.  I then 
related the leadership styles of senior leadership and management (leaders/managers) to eight 
empirically tested leadership theories and concepts favourable health innovation. This led to developing 
the overarching aim of my study which is to ascertain the leadership styles of health leaders/managers 
of organisations charged with driving innovation in the UK and in a selected high-performing comparator 
in the US. Going forward, I assessed how these adopted styles align with empirically supported 
leadership theories and concepts considered favourable to needed health innovation. 
The ULMO course of instruction included a discussion of:  
a.) comparative health systems; 
 b.) management theory;  
c.) management in the public sector; 
d.) leadership styles held in a residential setting outside of the classroom; 
e.) organisational culture; 
f.) strategic management, management skills and evaluating a public health programme;  
g.) working in networks and collaborating; and  
h.) managing change.  
The ULMO course prepared me to perform a strategic analysis of a health organisation in the 
United Kingdom (UK) as part of my OPA. 
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2.) OPA. The OPA component of my professional doctorate was undertaken in an 
Academic Health Science Network (AHSN); an organisation charged with fostering innovation in the 
English National Health Service (NHS) in which I was embedded in for approximately three months in 
2015. The objectives of the OPA as described in Weintraub (2016) included:  
a. “outlining the context and key influences on policy in relation to the specific public health issue 
and organisation chosen for the project; 
b. assessing the extent to which organisational factors and/or external relationships constrain or 
enhance the organization’s ability to deliver its mandate; 
c. developing a clear, actionable policy or practical recommendations to increase the 
effectiveness of the organization in influencing or delivering its public health goals; and 
d. gaining experience in applying policy science and/or organisational management theories to 
the critical analysis of a real world organisational case study (Jonathan Cox, Course Director of DrPH 
programme, personal communication, Introduction to the Organisational and Policy Analysis Project, 
presented 28 October 2014).” 
Consistent with the preceding course objectives, the aim of my OPA was to analyse how the 
AHSN could meet both local/member objectives and national policy, whilst transferring from centrally to 
locally funded over the next few years (P.Weintraub, personal communication to Joint EBPHP-ULMO 
OPA Session, 16 December 2014).  
The instruction in the Taught Component prepared me to achieve the aim of the OPA.  For 
example, a Strategic Analysis of the AHSN was performed to: 1.) develop clear, actionable policy and 
practical recommendations to increase the effectiveness of the AHSN in influencing and/or delivering its 
public health goals; and 2.) identify issues for further consideration by the AHSN arising from the 
analysis performed. This Strategic analysis included suggesting improvements to the AHSN’s value 
proposition to potentially attract independent funding (Weintraub, 2016).  
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In connection with my OPA, I gained experience in interview techniques by performing semi-
structured interviews of 1822 study participants.  Certain members of the Central Management Team 
were interviewed on multiple occasions to enhance triangulation of data sources over the course of the 
study.  The interviews were then transcribed and coded line-by-line using NiVivo 10 to identify recurring 
themes. These themes informed and underpinned the Strategic Analysis of the AHSN I performed 
(Weintraub, 2016). 
3.) Research-based Thesis. 
Following completion of my OPA, I prepared a DrPH Review Report in order to demonstrate that 
I should be allowed to proceed to data collection and fieldwork and complete my thesis. The DrPH 
Review Committee approved my DrPH Review Report on 5 August 2016. As discussed in my research-
based thesis, I asked one main question and one subsidiary question, including: 
a. Do the styles of leadership adopted by leaders/managers in organisations charged with 
innovation in the health sector in the UK align with leadership theories and concepts empirically shown 
to encourage innovation? and  
b. How do the leadership styles adopted by leaders/managers in these UK organisations 
compare with those seen in organisations adopting similar roles in the US that many of them aspire to 
emulate? 
These research questions were inspired by my experience performing my OPA. While the 
AHSN’s management and the wider NHS agreed that leadership was the key to health innovation, there 
was no practicable framework to guide leadership development. I developed a ‘Leadership Framework’ 
which aligned leadership styles of leaders/managers responsible for health innovation with empirically 
supported leadership theories and concepts shown favourable to health innovation (Weintraub (2016).  
                                                          
22 The AHSN had a total of 48 full-time and part-time management and staff including volunteers.  
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As part of my research-based thesis, I performed a literature review using skills gained in the 
Taught Component and experience gained in performing interviews in my OPA. The literature review 
convinced me that an Explanatory Sequential Mixed Methods approach would be a preferable method 
to accomplish the aim and objectives of my research-based thesis. For example, in an Explanatory 
Sequential Mixed Methods approach, data collection is performed “in two distinct phases…”  
The intent of this method is to use the qualitative phase to more fully explain the quantitative results. 
However, the quantitative results in this approach can inform the qualitative questions posed (Creswell, 
2014b, p. 224).  Antonakis et al. (2003) reached a similar conclusion and recommended that future 
leadership studies use a mixed-methods approach. 
A survey questionnaire was employed in the quantitative phase of the study.  There are 
established questionnaires developed to test for leadership styles among leaders/managers which may 
incorporate  selected  leadership theories and concepts that drive innovation (e.g., Bass and Avolio’s 
Multifactor Leadership Questionnaire [MLQ-Form 5X])  Antonakis et al. (2003). However, there is no 
questionnaire to test for the alignment of leadership styles adopted by health organisation 
leaders/managers covering the eight theories and concepts which, as described in my literature review, 
may contribute to successful health innovations. As a result, I developed a questionnaire for this 
research study to test for the relationship of different leadership styles and the eight leadership theories 
and concepts innovation to accomplish the aim and objectives of this study.  
The qualitative component of my research study began once an organisation’s survey results had been 
collected and analysed. It involved semi-structured interviews with approximately twenty percent of the 
leaders/managers of the organisations who were selected to receive survey questionnaires. The initial 
survey and interview questions were influenced by the literature review performed using skills learned 
in the Taught Component and refined in my OPA. 
I believe I achieved the objectives I set for myself in undertaking the Programme.  A strong 
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indication of the achievement of these objectives is based upon the positive receptivity shown by senior 
management representatives of leading health organisations to participate in my research study on 
leadership of health innovation. 
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Appendices 
 
Appendix A: Survey Questionnaire 
 
Research Study- Leadership of Health Innovation: Building an Innovative Health Organisation   
 
Thank you for taking part in this research study.      
 
To complete the survey questionnaire:            
 
A.) Please complete questions 1-6 regarding your organisational role and the number of people who 
work in your organisation.           
 
B.) For questions 7-14 you will be asked to rank the four statements in order of 'best fit' to the 
leadership styles that characterise your organisation, as a whole (i.e., Organisation Column) and 'best 
fit" reflecting your personal leadership style (i.e., Self Column). To rank the four statements, put a "1" by 
the statement that is the ‘best fit', "2" by the next best, and so forth (e.g., 1 = Best Fit; 4 = Lowest Fit) in 
the 'Organisation' and 'Self' columns.  Please indicate a single response for each of the statements (a.-d.) 
for the ‘Organisation’ and ‘Self’. Thereby, completing a single ranking of each statement for the 
‘Organisation’ and ‘Self’. From your organisation and personal perspectives, please consider the main 
drivers which provide impetus or motivation and drive innovation which are typical, respectively, of your 
organisation and then your personal leadership style. For purposes of this survey, leaders include senior 
leadership and managers unless otherwise noted. Innovation is defined as the multi-stage process 
of creating, selection, implementation and capture of the value of new concepts, processes and/or 
products.         When you have completed the survey press the 'Submit' button located after Question 14 
as described in the email instructions. Again, your responses will remain anonymous.               
 
Thank you for your participation.            
 
Kind regards,           
 
Philip           
 
Philip Weintraub    
Public Health & Policy, DrPH Candidate           
Contact Information:     
Faculty of Public Health and Policy    
Department of Health Services Research and Policy   
London School of Hygiene and Tropical Medicine    
15-17 Tavistock Place London, WC1H 9SH   
Email: Philip. Weintraub @lshtm.ac.uk 
© 2016 Philip Weintraub. All Rights Reserved.               
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Q1 What is your current role in the organisation? 
 Executive Leadership 
 Managerial leadership 
 Professional specialty 
 Technical support 
 Administrative support  or incl. clerical 
 
Q2 What is your age? 
 Under 35 
 35-44 
 45-54 
 55 and over 
 
Q3 What is your length of time with the Organisation? 
 Below 1 year 
 1-2 years 
 2-5 years 
 5 -10 years 
 Over ten years 
 
Q4 What is the highest level of education you have completed? 
 Degree 
 Master's Degree 
 Doctoral Degree 
 Professional Degree (JD, MD) 
 Other ____________________ 
 
Q5 What is your gender? 
 Other 
 Male 
 Female 
 
Q6 How many people work in your organisation including independent contractors and volunteers? 
 1–50 
 51–100 
 101–999 
 1000–4999 
 5000+ 
 
  
DRPH THESIS                                                                                                                     166 
 
For the following questions, 7-14, you will be asked to rank the four statements in order of 'best fit' to 
the leadership styles that characterize your organisation, as a whole (i.e., Organisation Column) and 
'best fit" reflecting your personal leadership style (i.e., Self Column). To rank the four statements, put 
a "1" by the statement that is the ‘best fit', "2" by the next best, and so forth (e.g., 1 = Best Fit; 4 = 
Lowest Fit) in the 'Organisation' and 'Self' columns.  Please indicate a single response for each of the 
statements (a.-d.) for the ‘Organisation’ and ‘Self’ with a single ranking for each of the four 
statements. However, what if you receive in an Error Message and cannot advance to the next page in 
the survey? Please click 
here: https://www.screencast.com/users/HealthInnovation/folders/Default/media/c1200dc2-38c5-
4af2-ade1-130fc93c432e 
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Q7 Please rank the ‘Psychological Climate’ of your organisation from the 'Organisation' perspective and 
your 'Self ' perspective with respect to health innovation. The Psychological Climate of an organisation 
includes the: 1.) level of leadership support; 2.) extent to which innovation is championed; 3.) setting 
of expectations for innovation and 4.) use of rewards.   
 Rank 'Organisation' Rank 'Self' 
 1 2 3 4 1 2 3 4 
a. Leaders set 
high 
expectations 
for health 
innovation 
with 
commensurate 
rewards for 
success. 
                
b.Health 
innovation is 
included in 
standard 
policies and 
procedures. 
                
c. Health 
innovation 
ideas, if any at 
all, flow down 
from the top 
of the 
organisation 
and failure to 
implement an 
idea is not an 
option. 
                
d. Leaders 
offer freedom 
to pursue 
health 
innovation, 
but 
proponents of 
ideas are on 
their own to 
succeed or fail. 
                
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Q8 Leader Member-Exchange (LM X) is the quality of the leaders' relationships with workers. Please rank 
the 'LMX' of your organisation from the 'Organisation' perspective and your own 'Self' perspective.   
 Rank 'Organisation' Rank 'Self' 
 1 2 3 4 1 2 3 4 
a. Leaders 
encourage 
quality 
individual 
LMX 
relationships. 
                
b. Quality 
LMX 
relationships 
develop as a 
consequence 
of individual 
initiative 
unless 
discouraged 
by specific 
organisation 
policies and 
procedures. 
                
c. Quality 
LMX 
relationships 
exist, but at 
a risk. Failure 
to precisely 
follow the 
organisation 
rules with 
respect to 
these 
relationships 
could result 
in a harsh 
reaction 
from senior 
leaders. 
                
d. Leaders of 
the 
organisation 
are detached 
with respect 
to these LMX 
relationships. 
                
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Q9 Social Capital is the knowledge gained by leaders through participation in associations, conferences, 
business networks and social media and its dissemination within the organisation. Please rank the 'Social 
Capital' of your organisation from the 'Organisation' perspective and your own 'Self' perspective.     
 Rank 'Self' Rank 'Organisation' 
 1 2 3 4 1 2 3 4 
a. Leaders 
continuously 
leverage 
Social 
Capital to 
transfer 
innovative 
ideas to 
workers. 
                
b. Leaders 
leverage 
Social 
Capital only 
as specified 
by 
organisation 
policies and 
procedures. 
                
c. The 
exchange of 
knowledge 
outside of 
the 
organisation 
is strongly 
discouraged. 
Violation of 
this policy 
may lead to 
dismissal 
from the 
organisation. 
                
d. A leader's 
acquisition 
of Social 
Capital is not 
supported. 
                
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Q10 Leadership Clarity is when leaders understand and communicate organisational objectives, worker 
expectations and a commitment to excellence to health innovation. Please rank the 'Leadership Clarity' 
of your organisation from the 'Organisation' perspective and your own 'Self' perspective.     
 Rank 'Organisation' Rank 'Self' 
 1 2 3 4 1 2 3 4 
a. Leaders 
clearly 
understand 
and 
communicate 
the vision, 
mission and 
values of the 
organisation. 
                
b. Leadership 
Clarity is 
defined as 
following the 
organisation's 
policies and 
procedures. 
                
c. Leadership 
Clarity is 
absent and 
workers are 
cautious 
whether to 
discuss 
innovative 
ideas. 
                
d. Leaders' 
responsibilities 
are unclear 
making it 
difficult to set 
worker 
expectations 
to generate 
new ideas. 
                
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Q11 The degree of 'Organisational Reflectivity' refers to whether leaders create opportunities for 
workers to discuss health innovation projects inside and outside the traditional work environment with 
colleagues or others.  Please rank the 'Organisational Reflectivity' of your organisation from the 
'Organisation' perspective and your own 'Self' perspective.     
 Rank 'Organisation' Rank 'Self' 
 1 2 3 4 1 2 3 4 
a.) Leaders 
facilitate 
opportunities 
for workers to 
discuss 
innovative 
projects by 
organizing 
forums both 
inside and 
outside of the 
organisation or 
providing time 
off to generate 
new ideas. 
                
b.) 
Organisation 
policies and 
procedures 
govern the 
extent workers 
can discuss 
innovative 
projects. 
                
c.) 
Communication 
between 
organisation 
project teams 
is discouraged. 
                
d.) Leaders are 
ambivalent 
regarding the 
need for 
project teams 
to discuss 
innovative 
ideas. 
                
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Q12 'Growth' mindset workers have a willingness to learn from errors and accept change. 'Fixed' 
mindset workers prefer long-term stability. Please rank the mindset of your organisation from the 
'Organisation' perspective and your own 'Self' perspective.   
 Rank 'Organisation' Rank 'Self' 
 1 2 3 4 1 2 3 4 
a. Leaders 
encourage 
workers to 
accept 
change and 
exceed 
their job 
description. 
                
b. Leaders 
principally 
recruit 
'Fixed' 
Mindset 
workers 
who prefer 
long-term 
stability. 
                
c. Leaders 
principally 
recruit 
workers 
who do not 
challenge 
them. 
                
d. Leaders 
recruit 
workers 
without 
regard to 
their 
mindset. 
                
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Q13 Organisation 'Culture' refers to the values and beliefs which set the expectations for innovative 
behaviour. Please rank the 'Organisation Culture' of your organisation from the 'Organisation' 
perspective and your own 'Self' perspective regarding health innovation.   
 Rank 'Organisation' Rank 'Self' 
 1 2 3 4 1 2 3 4 
a. Leaders 
encourage 
workers to 
be open to 
new 
innovative 
ideas and 
take risks 
to develop 
them. 
                
b. Leaders 
expect 
workers to 
follow 
policies 
and 
procedures 
in 
connection 
with 
developing 
new ideas. 
                
c. Leaders 
expect 
workers to 
not 
challenge 
the status-
quo. 
                
d. Leaders 
do not 
appreciate 
the efforts 
of workers 
to develop 
new ideas. 
                
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Q14 Please rank the following question responses solely with respect to senior leadership’s impact upon 
the 'Organisation' and then solely from your ‘Self’ perspective. 
 Rank 'Organisation' Rank 'Self' 
 1 2 3 4 1 2 3 4 
a. Senior 
leadership 
leads the 
organisation 
by example by 
inspiring and 
motivating 
workers to 
experiment 
with new 
ideas. 
                
b. Senior 
leadership 
leads by 
issuing 
organisational 
policies and 
procedures. 
                
c. Senior 
leadership 
does not 
tolerate errors 
and promotes 
a risk-averse 
culture. 
                
d. Senior 
leadership 
delegates 
organisational 
responsibilities 
and does not 
lead by 
example and 
refrains from 
motivational 
efforts. 
                
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Appendix B: Information Note 
 
Research Study- Leadership of Health Innovation: Building an Innovative Health Organisation 
 
Information Note 
 
Date: ___________ 
 
You are being invited to take part in a research study.  Before you decide to participate it is important 
for you to understand why the research study is being performed and what it will involve.  Please take 
time to read the following information carefully and to talk to others about the study, if you wish.  Ask 
me if there is anything that is not clear or if you would like more information.  Take time to decide 
whether or not you wish to take part. 
 
My name is Philip Weintraub and I am a doctoral student at the London School of Hygiene and Tropical 
Medicine. I would like to invite you to take part in a research study of the leadership of health 
innovation of the __________________________. This research study is being conducted with the full 
support of London School of Hygiene and Tropical Medicine (LSHTM) to help health organisations and 
their leaders/managers reflect on their ways of improving the leadership of health innovation 
throughout the health industry sector, but also as part of my doctoral training. 
 
Study Aim:  The overarching aim of the research study is to ascertain the leadership styles of health 
leaders/managers of organisations charged with driving innovation in the UK and in a selected high-
performing comparator in the US and assess how these adopted styles align with leading management 
theories considered most likely to drive much needed health innovation. 
 
Study Objectives: Objectives will include: 1.) Identify empirically tested concepts and theories that should 
promote health innovation; 2.) Map the leadership styles adopted by senior management in the UK and US 
organisations promoting innovation onto the leadership theories and concepts identified in the literature 
review; 3.) Assess the extent to which senior leadership styles in these organisations align with the leadership 
styles of lower levels of leaders/managers of the same organisations; 4.) Assess the extent to which the 
survey instrument captures the leadership styles of the organisations; 5.) Identify the ways in which the 
leadership styles adopted either promote or inhibit innovation in each of the organisations and the extent to 
which this varies in the different ‘Contexts’ in the two countries; and 6.) Compare and contrast leadership 
styles in each country to critically assess the potential to impact on innovation. 
 
Research Methodology: 
  
To accomplish the aim of this research study, the study uses a mixed method approach commencing 
with a review of the literature on leadership styles and innovation, which in turn informs the 
development of an instrument that will be used in a survey questionnaire (estimated 15 minutes 
completion time) for those in leader/manager roles. The survey questions are linked to each supported 
management theory and concept identified in a literature review and seeks to identify the leadership 
style adopted in a health organisation. 
  
I will email the survey questionnaire to participants using the Qualtrics web-based software assuring the 
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each respondent’s completed survey will remain anonymous and secure. Approximately twenty percent 
of the participants (including respondents and non-respondents) will be purposively selected for an 
interview which will last approximately 30 minutes. Questions will be entirely focused on your 
experiences. If at any point you feel uncomfortable and would like to stop, you may withdraw from the 
interview and study without giving a reason.  
 
I, Philip Weintraub, will be responsible for maintaining confidentiality of survey and interview materials. 
All anonymous respondent survey questionnaire replies and transcripts of the interviews will be stored 
in password-secured files. These might be quoted in scientific publications with no reference to your 
name, age, gender or profession, in order to ensure confidentiality. However, you have the option of not 
being quoted anonymously. Along with this information sheet, you will be provided with a separate 
form giving consent to your participation in the interview. The London School of Hygiene and Tropical 
Medicine Ethics Committee has approved the study. My contact details are written below. You can 
contact me at any point with any questions or comments. 
 
Kind regards, 
 
 
Philip Weintraub 
Public Health & Policy, DrPH Student 
 
 
Contact Information: 
Faculty of Public Health and Policy 
Department of Health Services Research and Policy 
London School of Hygiene and Tropical Medicine 
15-17 Tavistock Place 
London 
WC1H 9SH 
Email: Philip. Weintraub @lshtm.ac.uk 
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Appendix C: Consent Form 
 
Philip Weintraub  
Public Health, DrPH Student  
Faculty of Public Health and Policy  
Department of Health Services Research and Policy London School of Hygiene and Tropical Medicine  
15-17 Tavistock Place  
London  
WC1H 9SH  
Email: Philip. Weintraub @lshtm.ac.uk  
  
Informed Consent Form 
  
Project title: Research Study- Leadership of Health Innovation: Building an Innovative Health 
Organisation 
 
Consent form version and date: Version.101, ___________________________ 
Investigator: Philip Weintraub  
                                                                                                      Please initial: 
I confirm that I have read and understood the Information Note 
dated _________________________for the above study.  I have had 
the opportunity to consider the information, ask questions and have 
had these answered satisfactorily  
  
I understand that my participation is voluntary and that I can stop 
the survey questionnaire and the interview at any time without 
giving a reason  
  
I understand that if I decide to stop the survey questionnaire and 
the interview all data collected will be destroyed  
  
I agree to take part in the research study    
I understand that recording the interview is optional.  By ticking this 
box, I agree to have this interview recorded  
  
I understand that any quotations used in writing up the study 
findings will be used anonymously and I consent to this  
  
  
 Name of Participant (please print):  
  
Signed:             Date:  
  
Name of Researcher (please print):  
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Signed:             Date:  
  
  
  
Complete in duplicate  
One copy to be retained by participant  
One copy to be retained by researcher  
 
 
 
Appendix D: Research Protocol 
 
Research Study Summary 
 
The research study is titled: Leadership of Health Innovation: Building an Innovative Health Organisation 
Philip Weintraub is the sole investigator under the supervision of Professor Martin McKee, CBE. In 
addition, each health organisation selected for study will be asked to provide a named main contact for 
Philip Weintraub to help ensure that his purpose and objectives are obtained. The named main contact 
will make staff available to meet with Philip Weintraub as required by his research and provide 
documents as required by his research.  
 
Leadership of innovation has been shown to be a critical element in innovative health research, education 
and improvements in high-quality health care (Storey & Holti, 2013). Yet while leadership has been 
researched extensively, there is a paucity of studies within the health sector, and even less on senior 
leadership and innovation (Goffin & Mitchell, 2010; Ovseiko, et al., 2014; Weberg, 2009; West et al., 2015).  
 
This research study will be undertaken at the office of the: 1.) single researcher in the UK and the US; 2.) 
London School of Hygiene and Tropical Medicine (LSHTM); and 3.) selected participating health 
organisations in connection with interviews. This research study uses a mixed-methods approach. In this 
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instance, an Explanatory Sequential Mixed Method approach was used. This research design initially 
uses quantitative data collection and analysis employing a survey questionnaire to assess theories 
supporting innovation. The survey questions are organized under each supported management theory and 
concept identified and is linked with an organisation’s leadership style. This quantitative approach is followed-
up with qualitative data collection using interviews and analysis. The combined results are then interpreted 
to develop a feasible framework to determine which leadership styles of health leaders/managers are 
most likely to drive much needed health innovation. Consideration has been given to data management, 
dissemination of the research study results and ethical issues. 
 
 
General information 
Protocol: Research Study- Leadership of Health Innovation: Building an Innovative Health 
Organisation-Dated: _________________________ At this time, there is no sponsor. 
 
Supervisor: Professor Martin McKee CBE 
European Centre on Health of Societies in Transition 
London School of Hygiene and Tropical Medicine 
15-17 Tavistock Place 
London 
WC1H 9SH 
Telephone: 2079272229 
Email: Martin.McKee@lshtm.ac.uk 
 
Student/Investigator: Philip Weintraub 
Public Health, DrPH Student 
Faculty of Public Health and Policy 
Department of Health Services Research and Policy 
London School of Hygiene and Tropical Medicine 
15-17 Tavistock Place 
 
London 
WC1H 9SH 
UK Cell: 07908223525 
US Cell: (561) 818-5423 
Email: Philip.Weintraub@lshtm.ac.uk 
 
Rationale and background information 
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The UK and the US health systems are both focused on improving leadership of health innovation as a means 
of improving health outcomes and reducing health system costs. For example, both health systems 
recognize the importance of the diffusion and spread of research innovation to improve health 
outcomes. This is considered the key to meet the health challenges posed by, among other factors, an 
aging UK and US population. The publication, High quality care for all: NHS next stage review final 
report, recommended the formation of “Academic Health Science Centers (AHSCs) to bring together a 
small number of health and academic partners to focus on world-class research, teaching and patient 
care”. AHSCs were originally formed in the US decades prior to this recommendation (Research and 
Development, Directorate, Department of Health, 2006, p.2; Darzi, 2008, p.57). In 2009, this led to the 
formation of the first AHSCs “to foster medical innovation and high quality care throughout hospitals” 
which were initially funded in October 2008 (Ovseiko, et al., p. 4).  In 2012, this recognition led to the 
invitation to form AHSNs as an organisation to network with CLAHRCs, ACHSCs, all parts of the NHS and 
the local community to improve health and wealth. 
 
In order to accomplish the aim of this research study, a pragmatic worldview (i.e., a conceptual framework) 
is used in this research study. A pragmatic conceptual framework focuses attention on the research 
problem and uses “pluralistic approaches to derive knowledge about the problem” (Creswell, 2014a, 
p.11).  
   
Study design: An Explanatory Sequential Mixed Method approach. 
 
A. Quantitative Data Collection and Analysis 
 
The survey questionnaire will be applied to the senior leadership and management of health 
organisations who have the responsibility for leading health innovation in the UK or the US. 
To distinguish these health organisations, selection will be limited to organisations designated 
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either as AHSNs, CLAHRCs or AHSNs to determine a  pattern of leadership style(s). The survey 
questionnaires would be developed using the Qualtrics web-based survey software tool23. This 
survey software tool is used by over 7,000 organisations in 75 countries including over 1600 
colleges/universities (Qualtrics, LLC, 2015).  
 
As noted in the High Timeline, this study is being self-funded by the single researcher who will be 
responsible to arrange for the participation of health organisations in the UK and US. The 
Investigator’s Curriculum Vitae is summarized in the accompanying Research Protocol. The 
survey questionnaires will be emailed to selected participants under the control of the single 
researcher. The survey questionnaire will be structured to facilitate statistical analysis according to pre-
determined respondent categorical nominal variables [i.e., 1.) Individual Respondent: age; sex; 
organisational role; tenure with organisation; years in current role; years employed; and education 
level achieved; and 2.) Organisation: Company age; number of employees] (Mumford et al., 2002 & 
                                                          
23 Security Statement 
Qualtrics, LLC (2015) “uses Transport Layer Security (TLS) encryption (also known as HTTPS) for all 
transmitted data. We also protect surveys with passwords and HTTP referrer checking. Our data is 
hosted by third party data centers that are SSAE-16 SOC II certified. All data at rest are encrypted, and 
data on deprecated hard drives are destroyed by U.S. DOD methods and delivered to a third-party data 
destruction service. Qualtrics deploys the general requirements set forth by many Federal Acts including 
the FISMA Act of 2002. We meet or exceed the minimum requirements as outlined in FIPS Publication 
200. 
HIPAA Statement: With some restrictions, Qualtrics may be designated as a Business Associate when the 
Qualtrics BA Agreement is signed with a Covered Entity—those organizations that are required to 
comply with HIPAA privacy rules. All client data are considered confidential, and treated as such, with 
no specific designation (such as medical (PHI), PII, or public). Therefore there is a duty of care that 
Qualtrics must have with PII data. 
Related to HIPAA, HITECH (Health Information Technology for Economic and Clinical Health Act) are 
updated assessment rules to ensure that data are properly protected and best security practices followed. 
By using secure and certified data centers, Qualtrics ensures the highest protection and testing as per 
HITECH requirements.” 
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Hitt et al., 1997, as cited in Jung, 2003)].  
 
B. Qualitative Data Collection and Analysis 
 
Upon completion of the quantitative data collection, the single researcher will conduct purposively 
selected interviews of approximately twenty percent the leaders/managers of these 
organisations which were selected for testing by survey questionnaires.  These interviews will 
complement the collective results of the survey questionnaires (e.g., offer insight into the operating 
environment of the organisation) and will be conducted either face-to-face, by telephone, email or 
other communication technology depending on the locality and availability of key informants. It is 
estimated that these interviews will last approximately 30 minutes each. The interviews will follow a 
semi-structured, open-ended format allowing the participant to offer further information and 
provide opinions   for the interviewer to pursue other lines of questioning where relevant. 
 
It is initially estimated that survey data will be collected from no more than 150 persons while interviews 
will be conducted with approximately 30 individuals. This is not a hypothesis testing study, but rather one 
to identify emerging themes, so formal sample size testing is not appropriate (Swinscow & Campbell, 
2006). 
 
Methodology 
 
It is estimated that survey data will be collected from no more than 150 individuals and interviews of 
approximately 30 survey questionnaire recipients. Particular attention will be given to preserving 
confidentiality and anonymity.  In order to maintain confidentiality, the following steps will be taken: 
 
1.) The Qualtrics web-based software will be used. This system allows for the survey questionnaire to: 1.) be 
communicated by email; 2.) protect identities of the respondents to remain anonymous; 3.) include pre-
set email reminder notices and 4.) export the results of the survey to perform further analysis. 
2.) To protect the confidentiality of the purposively selected interview participants, each participant 
DRPH THESIS                                                                                                                     183 
 
will be assigned a unique Study Identification Number (SID) and the coding book linking them to 
personal identifiers will be maintained securely. At the completion of the study, the 
identification numbers will be de-linked from personal identifiers. This procedure will ensure 
that no data can be linked back to an individual. 
3.) Data will, in general, be presented in aggregate form in all reports (with the exception of specific 
quotes – see item 4 below).  
4.) If quotations are used to illustrate a point, each participant will be given the opportunity to read 
their section/quotations of the analysis before it is included in any reports and will be given the 
option of not being quoted at all, anonymously or otherwise. 
Data management and analysis 
 
The data will be stored anonymously on a dedicated PC hard disk and appropriate backup on the LSHTM 
server. All data analysis will be performed by Philip Weintraub and reviewed by Professor Martin Mckee, 
CBE.  
 
Dissemination of results 
 
1.) Except as required for the evaluation of Philip Weintraub’s professional doctorate studies the 
research study will be confidential except as specifically agreed with the selected participating 
health organisations. This will include the use of the research by the researcher for articles in 
published journals. 
 
2.) The selected participating health organisations will be free to make any use of any analysis and 
recommendations contained within any reports as they see fit without either seeking further 
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permission from, or by paying any consultancy fee to, either Philip Weintraub or the London 
School of Hygiene and Tropical Medicine. 
3.) The selected participating health organisations shall suitably acknowledge Philip Weintraub’s 
work alongside any subsequent reprinting or quoting of his research. 
4.) Philip Weintraub will periodically discuss the results of his work with selected participating 
health organisations and a final graded copy of the research study included in his thesis will be 
provided, if requested. 
Problems anticipated: None noted-however-the investigator may be contacted at any point with any 
questions or comments. 
 
Project management 
Philip Weintraub is the sole investigator under the supervision of Professor Martin Mckee, CBE. In 
addition, selected participating health organisations will provide a named main contact for Philip 
Weintraub to help ensure that his purpose and objectives are obtained. The named main contact will 
make staff available to meet with Philip Weintraub as required by his research and provide documents 
as required by his research. 
 
Ethical considerations 
Prior to the commencement of the research study at the selected participating health organisations, 
participants in this research study will be informed that the student/investigator is involved in DrPH 
research study in connection with his thesis. They will be provided with information about the research 
study (see attached Information Note) and their agreement for the commencement of the research 
study will be obtained.  In addition, an Informed Consent Form will be provided to each interview 
participant, as necessary. This Research Protocol has been approved by the Observational / 
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Interventions Research Ethics Committee of the London School of Hygiene and Tropical Medicine. 
 
Informed Consent Form- Enclosed. 
 
Investigator Curriculum Vitae: Summary24 
Mr. Weintraub’s prior business experience includes serving as president and chief executive officer of 
companies in the computer information services, investment banking, healthcare consulting and the 
financial services industry as well as an audit partner with the international public accounting firm of 
Deloitte LLP (formerly Deloitte Haskins & Sells). His prior government service includes serving as the 
Special Assistant to the Vice-Chairman of the Board of Governors of the Federal Reserve System. Mr. 
Weintraub received an award recognizing his service to the federal government by a President of the 
United States of America.  
 
Mr. Weintraub was awarded an MSc in Public Health from the University of London and a Post-Graduate 
Diploma in Public Health (DLSHTM) from the London School of Hygiene and Tropical Medicine; the 
United Kingdom’s Graduate Medical School. Mr. Weintraub is attending the London School of Hygiene & 
Tropical Medicine’s DrPH programme in Public Health & Policy, Department of Health Services Research 
and Policy.  
 
Mr. Weintraub has focused on the delivery of quality public health including serving as a trustee, 
member of the executive and finance committees and the treasurer of a medical center. He 
subsequently served as a member of a county’s healthcare district’s finance committee and as a 
member of selected task groups. He has served as a manuscript reviewer for the Annals of Internal 
                                                          
24 A complete Curriculum Vitae is available upon request. 
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Medicine, American College of Physicians, as part of its peer review process. In April 2011, he was 
recognized by the Annals of Internal Medicine as one of the best manuscript reviewers of 2010. In June 
2013, he completed the Quality Matters Applying the QM Rubric (APP) online workshop. In 2015, he 
served as a Doctoral Researcher in connection with an organisational and policy analysis of an AHSN in 
the United Kingdom. As a consequence of his experience, he has high level contacts with leading health 
organisations in the UK and the US. 
 
Since 2011, Mr. Weintraub has developed and taught long distance courses at the Kent State University, 
College of Public Health. These courses include Health Care Finance for the University’s Ph.D. 
programme in Public Health in the specialization of Health Policy and Financial Management for Public 
Health Organisations in the Masters of Public Health in Health Policy and Management Leadership and 
Organisational Change Elective Option. He is an experienced instructor using an integrated instructional 
approach including computer based learning systems such as the Blackboard Learn™ system and ISpring 
Pro© with emphasis on collaborative applications to motivate student performance.  
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Appendix E: UK Health Organisations and US Comparator Organisations 
  Managing Director/Chair 
AHSNs   
East Midlands Rachel Munton 
Eastern Elisabeth Buggins 
Imperial College Health Partners Dr Adrian Bull, Chair, Joint Steering Committee-AHHSN/AHSC/CLAHRC 
Greater Manchester Mike Burrows 
Kent, Surrey & Sussex Guy Boersma 
North East & North Cumbria Seamus O’Neill 
North West Coast Liz Mear 
Oxford Gary Ford 
South London (HIN) Tara Donnelly 
South West Peninsula Rosie Benneyworth 
UCL Partners Lord Ajay Kakkar 
Wessex Martin Stephens 
West Midlands Christopher Parker 
West of England Deborah Evans 
Yorkshire & Humber Andrew Riley 
CLAHRCs   
East Midlands Kamlesh Khunti 
East of England Peter Jones 
Northwest London Derek Bell 
Greater Manchester Ruth Boaden 
North West Coast Mark Gabbay 
Oxford Richard Hobbs 
South London Graham Thornicroft 
South West Peninsula Stuart Logan 
North Thames Rosalind Raine 
Wessex Jessica Corner 
West Midlands Richard Lilford 
West of England Jenny Donovan 
Yorkshire & Humber Sue Mawson 
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AHSCs    
Imperial College Healthcare 
(London)  
Sir Peter Dixon, Chair-Joint Partnership 
Board 
King’s Health Partners (London) 
Professor,  
Sir Robert Lechler, 
Executive Director of King’s Health 
Partners 
UCL Partners (London) Lord Ajay Kakkar, Chair 
Cambridge University Health 
Partners (Cambridge) 
Malcolm Lowe-Lauri CBE, Executive 
Director of Cambridge University 
Health Partners. 
West Midlands Academic Health 
Science Network (Birmingham) 
Dr Christopher Parker CBE, Managing 
Director 
Manchester Academic Health 
Science Centre (Manchester) 
Sir Howard Bernstein 
MAHSC Chairman 
Oxford Academic Health Science 
Network (Oxford) Nigel Keen, Chair 
Health Science Scotland Charles Weller, General Manager 
    
Leading US Health Organisations 
with Interest in Participating in 
Research Study 
Principle Contact Person 
University, Medical Center and 
members of University 
Administration and Faculty and 
AHSC 
Vice Provost for Academic and 
Strategic Planning, Office of Academic 
Affairs 
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Appendix F: Semi-Structured Interviews—Areas of Inquiry 
 
Interview Outline:  
 
Thank you for agreeing to participate in this Research Study- Leadership of Health Innovation: Building 
an Innovative Health Organisation.  
 
[Please execute the following consent to participate. Thank you.]  
 
 
1. Please briefly describe: 
 
Your role in the Organisation  
Number of People in your Department, Overall Organisation 
Length of time with the Organisation 
Your Professional Education and Training for your role 
 
Lead-in Question: In addition, scientific knowledge and technical expertise, what skills are necessary 
to do your role effectively? 
 
How would describe the leadership style of senior management of the ____________. For example, 
would you say it is leadership by example or inspirational?  Would you say it is pretty much by the 
book-that is-you fulfil your job specifications and you will receive an award? Or would you say it is 
described as my way or the highway? Or just do your job and not bother me with the details? A hands 
–off call me when you get there attitude? 
 
Today, we are focusing on health innovation. This is defined as the multi-stage process 
of creating/searching, selection, implementation and capture of the value of new concepts, processes 
and/or products. In the following broad questions, please respond solely to the implication to health 
innovation. In addition, I would like you to focus your responses on how the organisation's leadership 
attempts to gain cooperation and motivate people (i.e., the style of leadership) and whether you agree 
with this form of leadership.  
 
2. Please discuss the Psychological Climate’ of the organisation which includes the: 1.) level of leadership 
support; 2.) championing of innovation; 3.) innovation expectations; and 4.) rewards. That is, the extent 
organisation members believe health innovation is expected, supported and rewarded. 
 
Do you think the physical setting of the campus has an impact on the generation of health innovation? 
 
3.  Describe the Leader Member-Exchange (LMX). That is the quality (trust) of the leaders/managers 
relationship with organisation members.  
 
4. Describe the use of Social Capital in the form of relational and network assets. Social Capital 
possessed by leaders/managers enables them to effectively interpret and use the exponential expansion 
of information/knowledge available to organisations through multiple channels including participation in 
associations, conferences/meetings, business networks and social media. This is especially important to 
break down hierarchical barriers in the health sector. 
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5. Regarding Leadership Clarity, how well do leaders/managers, at all levels of an organisation, 
understand organisational objectives, the expected levels of team participation and commitment to 
excellence. 
 
6. Does the organisation promote Reflectivity [refers to whether leaders/managers create opportunities 
for team members to reflect on health innovation projects inside and outside the traditional work 
environment with colleagues or others]. 
 
7. Organisation members’ mind-sets vary from a willingness to learn from errors and accept change (i.e., 
a growth orientation) versus a fixed mindset that prefers long-term stability. What is your opinion of this 
organisation? 
 
8. Organisation culture refers to the values and beliefs which set the expectations regarding innovative 
behaviour. It is suggested that Organisational Culture significantly influences the performance of the 
organisation to achieve its mission, vision and values. What role does culture serve in this organisation 
with respect to innovation? 
 
9. The preceding questions encompassed all levels of leadership within an organisation adopting the 
viewpoint of Mintzberg (2011) that “leadership is a necessary component of management”. What role 
does the CEO play with respect to leading health innovation with respect to senior leadership’s impact 
upon the 'organisation' and then solely from your ‘self’ perspective. 
 
10. Did you complete the Qualtrics Survey Questionnaire? 
 
Box 5—Interview questions regarding Survey 
The draft interview schedule will be piloted among a group of at least 5 people working in health 
organisations in each country. The piloting will address the following issues: 
1. Will each question measure what it is supposed to measure? 
2. Are all the words used understood? 
3. Do all respondents interpret the interview question in the same way? 
4. Does the interview process create a positive impression that motivates people to respond to the 
questions posed? 
5. How long does it take to complete the interview? 
6. Is the information you want collected? 
 
11. Anything else you would like to add that affects the innovation capacity of the organisation? 
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 Appendix G: Search of Electronic Data Bases 
 
A keyword search string (using the PEO and PIO structure) was prepared using the following 
electronic databases: [Database Field Guide] Books@Ovid July 20, 2015, [Database Field Guide] Global 
Health 1910 to 2015 Week 28, [Database Field Guide] HMIC Health Management Information 
Consortium 1979 to May 2015, [Database Field Guide] Journals@Ovid Full Text July 23, 2015, [Database 
Field Guide] Ovid MEDLINE(R) In-Process & Other Non-Indexed Citations, Ovid MEDLINE(R) Daily, Ovid 
MEDLINE(R) and Ovid OLDMEDLINE(R) 1946 to Present, [Database Field Guide] PsycEXTRA 1908 to July 
13, 2015, [Database Field Guide] PsycINFO 1806 to July Week 2 2015, [Database Field Guide] LSHTM 
Journals@Ovid, [Database Field Guide] Northern Light Life Sciences Conference Abstracts 2010 – 2015 
Week 27, [Database Field Guide] Econlit 1886 to June 2015, [Database Field Guide] Embase 
Classic+Embase 1947 to 2015 July 22, [Database Field Guide] Social Policy and Practice 20150. 
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Appendix H: High Level Timeline 
 
 
Note: This study is self-funded by the single researcher. 
Year 2018 2018
Month 1 2 3 4 5 6 7 8 9 10 11 12 1 2 3 4 5 6 7 8 9 10 11 12 1 2 3 4 5 6 7 8 9 10 11 12 1 2 3 4 5 6
Preparatory work:
Formulated Research Questions
Formulated Research Aims
Created Preliminary conceptual 
Framework
Completed Organisational & Policy 
Analysis Report
Initial Faculty Discussions of 
Research Aims & Planned Work
Commenced Literature review
Prepared Research Proposal Outline 
to Identify Participating Health 
Organizations
Ethical clearance from LSHTM 
Identified Theories Driving 
Innovation
Developed Research Objectives
Developed Research Methods
Wrote & Presented Review Report
Finalize Agreements with 
participating USA Health 
Organizations
Finalize Agreements with 
participating UK Health 
Organizations
Disseminate Qualtrics 
Questionnaires to selected 
Participating Health Organizations
Collect & Analyze Survey Results
Purposive Select Participants to 
Interview
Conducts Interviews-USA
Conduct Interviews-UK
Collect & Analyze Interview Results
Use Qualitative Results to Refine 
Survey Questionnaire
Final write-up & Viva
2015 2016 2017
Year 2018 2018
Month 1 2 3 4 5 6 7 8 9 10 11 12 1 2 3 4 5 6 7 8 9 10 11 12 1 2 3 4 5 6 7 8 9 10 11 12 1 2 3 4 5 6
Monitoring of Thesis:
·         Completion of data 
analysis:
Pilot Study
Other US & UK Studies
·         Complete structure of 
the thesis (with detail of all 
planned chapters) 
·         First and final drafts of:
Literature review
Methods
Results section
Remaining chapters
Discussion and 
Conclusions
·         Examiners selected
·         Examination form 
submitted
·         Approximate date 
planned of viva
·         Corrections due and 
completed
2015 2016 2017
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Appendix I: Analysis of Pre-determined Categorical Respondent Variables 
 
A. US Pilot Study 
 
Q1 - What is your current role in the organisation? 
      
Field Minimum Maximum Mean 
Std. 
Deviation Variance Count 
 What is your 
current role in the 
organisation? 1 3 2.38 0.86 0.73 8 
 
        # Answer % Count 
    1 Executive Leadership 25.00% 2 
    2 Managerial leadership 12.50% 1 
    3 Professional specialty 62.50% 5 
    4 Technical support 0.00% 0 
    
5 
Administrative support  or incl. 
clerical 0.00% 0 
    
 
Total 100% 8 
    
        Q2 - What is your age? 
      
Field Minimum Maximum Mean 
Std. 
Deviation Variance Count 
 What is your age? 2 4 2.88 0.78 0.61 8 
 
        # Answer % Count 
    1 Under 35 0.00% 0 
    2 35-44 37.50% 3 
    3 45-54 37.50% 3 
    4 55 and over 25.00% 2 
    
 
Total 100% 8 
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Q3 - What is your tenure with the Organisation? 
Field Minimum Maximum Mean 
Std. 
Deviation Variance Count 
 What is your 
tenure with the 
Organisation? 3 5 4.14 0.83 0.69 7 
 
        # Answer % Count 
    1 Below 1 year 0.00% 0 
    2 1-2 years 0.00% 0 
    3 2-5 years 28.57% 2 
    4 5 -10 years 28.57% 2 
    5 Over ten years 42.86% 3 
    
 
Total 100% 7 
    
        Q4 - What is the highest level of education you have completed? 
    
Field Minimum Maximum Mean 
Std. 
Deviation Variance Count 
 
What is the highest 
level of education 
you have 
completed? - 
Selected Choice 3 4 3.25 0.43 0.19 8 
 
        # Answer % Count 
    1 4-year College Degree 0.00% 0 
    2 Master's Degree 0.00% 0 
    3 Doctoral Degree 75.00% 6 
    4 Professional Degree (JD, MD) 25.00% 2 
    5 Other 0.00% 0 
    
 
Total 100% 8 
    
        Q5 - What is your gender? 
      
Field Minimum Maximum Mean 
Std. 
Deviation Variance Count 
 What is your 
gender? 1 2 1.63 0.48 0.23 8 
 
        # Answer % Count 
    1 Male 37.50% 3 
    2 Female 62.50% 5 
    
 
Total 100% 8 
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        Q6 - How many people work in your organisation including independent contractors and volunteers? 
 
Field Minimum Maximum Mean 
Std. 
Deviation Variance Count 
 
How many people 
work in your 
organisation 
including 
independent 
contractors and 
volunteers? 1 5 3.63 1.58 2.48 8 
 
        # Answer % Count 
    1 One-fifty 12.50% 1 
    2 51-100 25.00% 2 
    3 101-999 0.00% 0 
    4 1000-4999 12.50% 1 
    5 5000+ 50.00% 4 
    
 
Total 100% 8 
    Source: Qualtrics 
LLC survey 
responses. 
       
         
Note: 1.) Seven out of eight respondents answered the question regarding tenure. For example, the 
resulting percentage of over 10 years in tenure of 42.86% compares reasonably to the actual 
percentage for the population of approximately 46%. This is based upon the researcher’s analysis of 
the University’s web-site profiles as of 6 October 2016. 
B. UK Health Organisations 
 
Q1 - What is your current role in the organisation? 
 
Field Minimum Maximum Mean Standard Deviation Variance Count 
What is your current role in the 
organisation? 1.00 5.00 2.37 0.82 0.67 59 
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# Answer % Count 
1 Executive Leadership 16.95% 10 
2 Managerial leadership 32.20% 19 
3 Professional specialty 49.15% 29 
4 Technical support 0.00% 0 
5 Administrative support  or incl. clerical 1.69% 1 
 Total 100% 59 
 
 
Q2 - What is your age? 
 
Field Minimum Maximum Mean 
Standard 
Deviation 
 
Variance Count 
What is your age? 1.00 4.00 2.70 0.98 0.96 61 
 
 
 
# Answer % Count 
1 Under 35 9.84% 6 
2 35-44 37.70% 23 
3 45-54 24.59% 15 
4 55 and over 27.87% 17 
 Total 100% 61 
 
Q3 - What is your length of time with the Organisation? 
 
Field Minimum Maximum Mean Standard Deviation Variance Count 
What is your length of time with 
the Organisation? 1.00 5.00 3.39 1.01 1.03 61 
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# Answer % Count 
1 Below 1 year 3.28% 2 
2 1-2 years 16.39% 10 
3 2-5 years 31.15% 19 
4 5 -10 years 36.07% 22 
5 Over ten years 13.11% 8 
 Total 100% 61 
 
 
Field Minimum Maximum Mean Standard Deviation Variance Count 
What is the highest level of 
education you have completed? - 
Selected Choice 
1.00 5.00 2.74 1.01 1.01 61 
 
 
Q4 - What is the highest level of education you have completed? 
# Answer % Count 
1 Degree 13.11% 8 
2 Master's Degree 24.59% 15 
3 Doctoral Degree 40.98% 25 
4 Professional Degree (JD, MD) 18.03% 11 
5 Other 3.28% 2 
 Total 100% 61 
 
 
 
Field Minimum Maximum Mean Standard Deviation Variance Count 
What is your gender? 2.00 3.00 2.59 0.49 0.24 61 
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Q5 - What is your gender? 
# Answer % Count 
1 Other 0.00% 0 
2 Male 40.98% 25 
3 Female 59.02% 36 
 Total 100% 61 
 
 
Field Minimum Maximum Mean Standard Deviation Variance Count 
How many people work in your 
organisation including independent 
contractors and volunteers? 
1.00 5.00 2.50 1.19 1.42 60 
 
 
Q6 - How many people work in your organisation including independent 
contractors and volunteers? 
 
# Answer % Count 
1 1–50 18.33% 11 
2 51–100 45.00% 27 
3 101–999 13.33% 8 
4 1000–4999 15.00% 9 
5 5000+ 8.33% 5 
 Total 100% 60 
 
 
Source: Qualtrics LLC survey responses. 
 
   
 
